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Diabetes is a complex chronic disease with many causes, complications and management needs.  
It affects a large proportion of people of varying ages, income levels, races/ethnicities and 
geographic areas.  Approximately 7.0% of Pennsylvanians have been diagnosed with diabetes.  
Diabetes is a major public health challenge due to the enormous impact on the affected 
individual, their families and the health care system.  However, recent research has shown that 
diabetes related mortality and morbidity can be prevented or delayed by controlling risk factors.  
Certain environmental aspects play an important role in the prevention and treatment of chronic 
diseases such as diabetes.  In order to provide the public health community with another tool to 
enhance our understanding of the factors that affect the numbers and types of diabetes cases in 
Pennsylvania, it is important that we undertake a project that will support the analysis of 
geographic distribution in terms of associated risk factors.   
This study proposes to investigate geographical patterns of diabetes hospitalizations, risk 
factors for diabetes complications and glycemic control among individuals with type 2 diabetes 
in predominantly rural regions.  Residents of more rural counties are 11% more likely to be 
hospitalized for uncontrolled diabetes compared to those living in areas that are less rural for 
every increase in rurality ranking after adjusting for individual and community level factors.  
Furthermore, we demonstrated that there is a clear association between the presence of food 
stores, food service places, and health care locations with risk factors for diabetes complications 
 iv 
among individuals with diabetes.  Our findings also indicated that those who live more than ten 
miles from their diabetes management center are 88% more likely to have an HbA1c level 
greater than 7.0% compared to those who live less than ten miles from their center, adjusted for 
individual-level and community level factors.  Results demonstrated that for every mile the 
subjects live from their diabetes management center, they are 2% more likely to have an HbA1c 
level greater than 7.0%. This dissertation was able to demostrate a clear association between the 
built environment and diabetes hospitalizations, risk factors for diabetes complications and 
glycemic control among individuals with type 2 diabetes in rural regions. 
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1.0 INTRODUCTION 
 
Diabetes is a group of diseases marked by high levels of blood glucose resulting from defects in 
insulin production, insulin action, or both.  Diabetes can lead to serious complications and 
premature death, but people with diabetes can take steps to control the disease and lower the risk 
of complications (1).  Pre-diabetes is a term used to describe people who are at increased risk of 
developing diabetes. People with pre-diabetes have impaired fasting glucose (IFG) or impaired 
glucose tolerance (IGT). Some people may have both IFG and IGT.  IFG is a condition in which 
the fasting blood sugar level is elevated after an overnight fast but is not high enough to be 
classified as diabetes (5).  IGT is a condition in which the blood sugar level is elevated after a 
two hour oral glucose tolerance test, but is not high enough to be classified as diabetes.  
Progression to diabetes among those with prediabetes is not certain. Studies suggest that weight 
loss and increased physical activity among people with prediabetes prevent or delay diabetes (5).   
Diabetes is becoming more common in the United States. From 1980 through 2007, the 
number of Americans with diabetes increased from 5.6 million to 17.9 million (2).  It is 
estimated that another 5.7 million Americans are undiagnosed (2).  Approximately 762,000 or 
7.3% (age-adjusted) of Pennsylvanians have been diagnosed with diabetes and is responsible for 
nearly 4,000 deaths in Pennsylvania (6). 
Diabetes is a major public health challenge due to the enormous impact on the affected 
individual, their families and the health care system.  However, recent research has shown that 
diabetes related mortality and morbidity can be prevented or delayed by controlling risk factors 
(7).   
Certain environmental aspects play an important role in the prevention and treatment of 
chronic diseases such as diabetes.  Studies have shown that access to health care, diet, physical 
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activity, housing, income, and environmental exposures contribute to diabetes, which are all part 
an individual’s environment or community (4).  While there are many ways to define 
community, geographic location is one important way to understand the context in which people 
live.  Until recently, there has not been a valid method for defining and analyzing geographic 
areas that make up a community where these risk factors and chronic diseases may cluster.  
Geographical modeling may allow for better identification of the geographic area of 
communities that provide risk for diabetes.  There is great variability in the health and well being 
of residents depending upon where they live.  Health-promotion interventions may need to be 
designed to target the geographic areas that represent clusters of health problems and unhealthy 
lifestyles.     
Geographical Information Systems (GIS) may allow investigators to conduct spatial 
analysis that can to be used to increase comprehension of chronic disease pathogenesis.  First, 
geographical studies may suggest possible causal factors based on geography and play an 
important role in the understanding of the development and control of diabetes (3).  Associations 
between disease and place imply that the population living there possesses inherent traits that 
make it more susceptible to disease.  However, it has been shown that there are certain risk 
factors that cluster in these areas that cause increased risk for disease.  Second, spatial analysis 
can help identify how populations adapt and relate to their environment (3).   
Type 2 diabetes is preventable and can be controlled with intervention.  However, some 
areas may not have resources that would enable its residents to lead a healthy lifestyle.  
Geospatial mapping techniques can be used to show areas with higher prevalence of diabetes and 
where funds need to be targeted. Geospatial analysis tools can be used to discover and analyze 
cause and affect relationships based on geographic proximities.    These maps can provide 
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important clues about the geographic variability of risk factors, disease states and clinical 
services utilization.   
The objective of this thesis is to investigate geographical patterns of diabetes prevalence 
and to identify risk factors for diabetes and its complications among rural regions.  Geographic 
data will be used to find the geographic distribution of diabetes prevalence in rural Southwestern 
Pennsylvania.  More specfically, this geographic representation will then be juxtaposed with a 
variety of potentially related geographic, economic, and health risk factors.  Geospatial analysis 
tools can be used to discover and analyze cause and effect relationships based on geographic 
proximities.  This thesis will assess geographic variation and prevalence of diabetes in this area, 
assess physical accessibility to healthcare, fitness and nutritional facilities as well as access 
barriers of economic, social, and cultural nature for diabetic residents of rural western 
Pennsylvania.  Finally this thesis will determine areas that are underserved and potential 
locations for health care facilities. 
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2.0 DIABETES MELLITUS 
  
Diabetes Mellitus is a group of disorders described by abnormally high blood glucose levels due 
to either insulin deficieny or resistance of the body’s cells to the action of insulin (7).  There are 
two central types of diabetes.  Type 1 diabetes is the third most prevalent chronic disease of 
childhood and is an autoimmune disease that develops when the body’s immune system destroys 
pancreatic beta cells responsible for making insulin (2).  In contrast, type 2 diabetes is 
characterized by the failure of the pancrease to secrete an adequate amount of insulin (2). 
 
2.1 TYPE 1 DIABETES 
2.1.1 Epidemiology 
Type 1 develops predominantly in children and young adults, but may appear in all age groups 
(8).  Type 1 diabetes accounts for roughly 5% to 10% of all diagnosed cases of diabetes (2).  
About one in every 400 to 600 children and adolescents has type 1 diabetes.  Recently, 
considerable research has focused on determining the incidence of type 1 diabetes in children.  It 
has been estimated that the yearly incidence of Type 1 diabetes ranges from 0.6 per 1,000 to 2.5 
per 1,000.  Using this estimate, there are nearly 123,000 individuals under 19 years old in the 
United States with Type 1 diabetes.  The incidence of type 1 diabetes among children under 19 
years old in Allegheny County, PA is 18.2 per 100,000/year (9).  There is less information of the 
prevalence of this disease, but it is estimated that approximately 400,000 Americans have this 
type of diabetes (1).  
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2.1.1.1 Race/Ethnicity and Gender Variation  
There are clear differences in race/ethnicity and gender in the incidence of type 1 
diabetes.  When examined nationally, the highest incidence of type 1 diabetes was among non-
Hispanic Caucasians and Hispanic individuals, followed by African American and Mexican-
American children (10).  Incidence rates for females and males are comparable, although females 
have a slight excess in low-risk populations such as the Japanese (11).  However, in areas such as 
Finland, where there is a high-risk, an excess risk for males was detected. 
Gender does not appear to be a significant determinant of type 1 diabetes, since incidence 
rates are similar for males and females (26).  The age distribution at onset for type 1 diabetes is 
also generally consistent across populations, with a slight peak occurring at roughly 5 years old 
in males and a larger peak is seen in both sexes occurring near puberty (26).  This age pattern 
may be due to exposure to infectious agents during childhood, growth spurts, or hormonal 
changes that occur in adolescence.  The risk of type 1 diabetes increases with age during 
childhood and adolescence.   
2.1.1.2 Temporal and Seasonal Trends  
It has been revealed that the onset of type 1 diabetes occurs in seasonal and temporal 
patterns (10).  Type 1 diabetes is a worldwide disease but occurs with considerable geographical 
and ethnic variations.  The incidence of type 1 diabetes shows a steady increase in its frequency 
during the last few decades, corresponding in some instances to an estimated doubling in 
incidence per generation (8).  The incidence of Type 1 diabetes is characterized by extensive 
differences between populations, from 0.7/100,000/year in Peru to 45/100,000/year in Finland in 
1996.  The incidence is increasing in many populations; in Finland, England, Norway, Israel, 
Austria, and several other countries.  In Finland, the incidence has more than tripled from 1953, 
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when it was 12/100,000/year, with an average increase of 2.4 percent per year (8).  The greatest 
incidence is identified in Nordic countries, particularly in Finland, as compared to the rest of 
Europe.  The geographical pattern is not a simple north to south incidence gradient but in fact 
there are sharp differences between neighboring regions.  Despite its ethnic and cultural 
similarities with Finland, Estonia has an incidence of only one-third that in Finland (8).  
Conversely, the Russian population residing in Estonia presents a disease risk less than that of 
the native Estonians.  So far, the reasons for the wide variation in the risk of Type 1 diabetes in 
Europe are unknown, and the power of genetic variation and environmental factors has yet to be 
established (8).  Some researchers have tried to explain the changing incidence of environmental 
factors, such as breast-feeding habits, but no obvious explanations have yet been identified (8).  
On the other hand, the increasing frequency cannot be attributed to improved survival and 
reproductiveness among type 1 diabetes patients.  Some studies found a correlation between 
apparent leveling off in the increase in incidence with a decline in the occurrence of mumps 
antibodies in newly diagnosed type 1 diabetes children due to the introduction of the mumps, 
measles, rubella vaccine.  This suggests that the temporal variations in the incidence of type 1 
diabetes can be modified, and that the geographical distribution of the disease may change in the 
future due to the implementation of health promotion programs (8).   
 Additionally, there is a seasonality of type 1 diabetes onset, and it is diagnosed more 
often during the winter and fall months, particularly during puberty (11).  Since type 1 diabetes is 
an autoimmune disease and the destruction of the beta cells starts several years before the 
clinical onset, the seasonality probably reflects the importance of certain environmental 
precipitating factors, such as viral infections (8).  However, there is not evident explanation for 
why this pattern exists.  More research dedicated to identifying non-genetic determinants of type 
 7 
1 diabetes is of great importance as these are potentially modifiable with the aim of disease 
prevention. 
2.1.1.3 Geographic Variation 
 Type 1 diabetes is a world-wide disease but occurs with considerable geographical 
variations.  The geographical variation demonstrated in the incidence of type 1 diabetes makes is 
one the largest observed for a noncommunicable disease (10).  The greatest incidence is 
identified in Nordic countries, particularly in Finland, as compared with the rest of Europe (8).  
Overall, Europe encompasses a less than 10-fold difference in incidence annually, ranging from 
roughly 35 new cases in Finland (12) to two to three new cases in Macedonia (13) per 100,000 
children aged 0-14 years.  The geographical pattern is not a simple north to south incidence 
gradient but in fact there are sharp differences between neighboring areas.  For example, Sardinia 
has an incidence of diabetes approaching that of Finland and which is several times greater than 
the rest of Italy (13).  Another region of contrast is Estonia; despite its ethnic and cultural 
similarities with Finland, it has an incidence of only one-third that in Finland.  Conversely, the 
Russian population residing in Estonia presents a disease risk less than that of the native 
Estonians (8).  In the majority of other Caucasian populations in Europe and North and South 
America, incidence rates are moderate.  Much of this variation can be due to the genetically 
heterogeneous population in the United States, compare to a very homogenous population in 
many of the Asian countries (10).  The lowest incidence rates are seen in the Asian countries 
such as Japan, China and Korea.  The Native American, Chilean, Cuban and Mexican 
populations have very low rates of type 1 diabetes (10).    The reasons for this variation in the 
risk of type 1 diabetes in Europe are unknown, and the strength of genetic variation and of 
environmental factors has yet to be discovered.  
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2.1.2 Etiology 
 There are many hypotheses regarding the etiology of type 1 diabetes.  In addition to the 
geographical variation in the incidence of childhood type 1 diabetes, there are also well-
documented secular trends over time, which may also differ from country to country and from 
region to region within a country.  Potential risk factors which may initiate the autoimmune 
process include early fetal events such as blood group incompatibility (12), maternal viral 
infections during pregnancy, (13,14) and early exposure to cow's milk components and other 
nutritional factors such as nitrosamines (15).  Population-based case-control studies have 
identified some protective factors, including a long duration of breast feeding (15), early vitamin 
D supplementation (16), pre-school day care (as a proxy measure of infections) (17) and atopic 
diseases (18).  
Since type 1 diabetes in childhood is associated with estimates of general wealth such as 
gross domestic product (19) it has been suggested that lifestyle habits related to welfare might be 
responsible for the changes in trend. Wealth is a well-known determinant of birth weight and 
childhood growth. 
Different estimates of child growth such as high birth weight, an increased height, 
weight, weight for height and body mass index (BMI) have repeatedly been shown to be risk 
factors for childhood onset diabetes (20).  Rapid growth is associated with high growth hormone 
levels and an increased number of fat cells both leading to insulin resistance and thereby an 
overloading of the beta cell. Although autoimmune mechanisms are responsible for the beta cell 
destruction leading to type 1 diabetes, overload factors may accelerate this process (21,22).  
Overload through accelerated child growth and body fat accumulation in association with a 
lifestyle with a low physical activity are potentially preventable risk factors.  These are examples 
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of the substantial evidence that both genetic and environmental factors are major factors in the 
etiology of type 1 diabetes. 
2.1.2.1 Genetics 
 Islet cell antibodies, insulin and glutamic acid decarboxylase antibodies, markers of 
autoimmune disease, may be detected in the circulation some years before the clinical onset of 
type 1 diabetes, providing a tool for individual assessment of subsequent risk of overt disease 
(8).  Type 1 diabetes clusters within families; it is estimated that the risk of developing the 
disease in siblings and children of type 1 diabetes patients is approximately 5-10%, compared 
with about 0.5% in the general population (23).  More than 80% of cases of type 1 diabetes occur 
in individuals without a family history of the disease.  However, in the remaining 20%, type 1 
diabetes runs in families (26).  The risk is smaller for the children of women with diabetes than 
the children of men with diabetes, and the risk of type 1 diabetes in children seems to be 
increased with advancing maternal age (23).  Such differential risk patterns probably reflect 
selection due to particular features in the reproductive capacity of type 1 diabetes women rather 
than genetic mechanisms.   
 Much of the data on risk of type 1 diabetes in family members are from Caucasian 
populations that have similar incidence rates (26).  In Allegheny County, PA, there was a lower 
risk for developing type 1 diabetes in siblings of African-American type 1 diabetes patients 
compared to Caucasians (2.8% versus 6.5% through  age 30 years) (27).  In Caucasian 
populations, strong type 1 diabetes associations are found in the serologically determined HLA 
markers DR3 and DR4, the heterozygous state DR3/DR4 and the genes which encode them at 
the HLA-DQ loci on chromosome 6 (24).  The HLA is a set of genes referred to as the Major 
Histocompatability Complex (MHC), and it controls many aspects of immune system functions.  
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In recent studies of data from three previous genome-wide scans (United States, United 
Kingdom, and Scandinavia) as well as new families collected for Type 1 Diabetes Genetics 
Consortium, 1435 multiplex families provided evidence for linkage of type 1 diabetes to the 
MHC, insulin, a region that contains several genes, including CTLA4 and seven other 
chromosome regions (25).  
 HLA studies of type 1 diabetes are focusing on the DNA level in populations across the 
world.  Analyses in a variety of racial and ethnic groups have revealed that DNA sequences in 
the DQB1 gene coding fro the presence of an amino acid other than aspartic acid in the 57th 
position (non-Asp-57) is highly associated with developing type 1 diabetes (26).  This 
association is much stronger than the association between type 1 diabetes and HLA-DR3 and 
DR4.   
 Immunogenetic studies have been conducted in areas where the incidence rates are 
geographically diverse including China, Norway, Sardinia, Italy; and African Americans and 
Caucasians in Allegheny County, PA (26).  These studies showed that the prevalence of the 
DQB1 *non-Asp-57 genotypes vary significantly in individuals with type 1 diabetes from these 
five areas (from 6% in China to 100% in Sardinia), as well in non-diabetic individuals (from 0% 
in China to 38% in Sardinia), with an increase in non-Asp-57 homozygosity in regions with a 
high incidence of type 1 diabetes (26).  For Allegheny County Caucasians, the incidence rate for 
type 1 diabetes was highest for non-Asp-57 homozygotes (47.6 per 100,000 per year), 
intermediate for heterozygous individuals (13.0 per 100,000/year), and lowest for Asp-57 
homozygotes (0.45 per 100,000/year), suggesting a does-response relationship between 
susceptibility and type 1 diabetes risk (26). 
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 If the geographic differences in risk of type 1 diabetes are due to variation in genetic 
susceptibility to the disease, then incidence rates for diabetes should be similar in individuals 
with the same genotype across populations.  One study applied the genotype-specific incidence 
rates for Allegheny County Caucasians to the other four populations to predict the overall type 1 
diabetes incidence rate for each area.  Each predicted rate fell within the 95% confidence 
intervals for the rates established through type 1 diabetes registries (26). 
 The DQA1 and DQB1 genes are important in deciding susceptibility to type 1 diabetes 
(28).  The risk of developing this type of diabetes seems to be increased for people who are 
homozygous for both DQB1 *non-Asp-57 and DQA * Arg-52 alleles.  In addition, at least two-
thirds of the incidence of type 1 diabetes can be explained by the contribution of these high-risk 
genes in most populations (26).  Conversely, people wiho are heterozygous at one of the genetic 
loci have a risk for type 1 diabetes that is similar to that for the general population. 
2.1.2.2 Environmental Triggers     
 Several lines of evidence support a critical role of exogenous factors in the pathogenesis 
of type 1 diabetes.  Studies in monozygotic twins indicate that only 13-33% are pairwise 
concordant for type 1 diabetes (29), suggesting that there is either acquired post-conceptional 
genetic discordance or differential exposure to the putative environmental factor (30).  Migrant 
studies have been used sparingly in epidemiological studies of type 1 diabetes.  However, 
available data demonstrates that the incidence of type 1 diabetes has increased in population 
groups who have moved from a low-incidence area to a high-incidence region, emphasizing the 
influence of environmental conditions (31).  Accumulating evidence suggests that the proportion 
of individuals with high-risk HLA genotypes has decreased over the last decades among patients 
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with newly diagnosed type 1 diabetes, whereas the proportion of individuals with low-risk 
genotypes has increased (30).  
 In order to define the characteristics of the trigger(s) of beta-cell autoimmunity, many 
researchers have observed patients with increased HLA-conferred susceptibility to type 1 
diabetes prospectively from birth, with frequent follow-up visits (30).  These studies have 
demonstrated that there is an unequivocal temporal variation in the appearance of the first 
diabetes-associated autoantibodies reflecting the initiation of the disease process and paralleling 
the seasonal variation previously noted in the presentation of clinical diabetes (30).  The pattern 
of the autoantibody appearance strongly points to the role of infectious agents with conspicuous 
seasonal variation as triggers of beta-cell autoimmunity. Such variations are typical for viral 
infections (30).    Strong arguments have been made for the role of exposure to the Coxsackie B 
virus.  Coxsackie viruses have been isolated from the sera of persons with newly diagnosed type 
1 diabetes.  Although it is unknown whether the virus may initiate or accelerate beta-cell 
destruction (26).   
Persistent viral infections as possible triggers of autoimmune disease have recently 
gained more attention (26).  The incorporation of human cytomegalovirus (CMV) gene segments 
into genomic DNA has been significantly associated with type 1 diabetes in recently diagnosed 
individuals (37), and a relationship between CMV genome positivity and islet cell antibodies has 
also been reported (38,39).  Further research is needed to confirm these findings.    
Congenital rubella syndrome (CRS), which results from maternal exposure to the virus 
causing measles during pregnancy, has been associated with the development of type 1 diabetes.  
Nearly 20% of CRS patients in the United States also have type 1 diabetes (38).  It has been 
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hypothesized that exposure to rubella infection in utero triggers an autoimmune mechanism in 
genetically susceptible people, resulting in type 1 diabetes (38).   
Several studies have found a temporal relationship between mumps virus infection and 
the development of type 1 diabetes (40).  However, studies attempting to validate this 
observation have met limited success.  The incidence of type 1 diabetes parallels that of mumps, 
after allowing for a four-year lag period in Erie County, NY, and approximately 50% of children 
with type 1 diabetes in this population had mumps or exposure to mumps roughly four years 
prior to onset of diabetes (40).  As with the Coxsackie virus, it has been hypothesized that a 
particular variant of the mumps virus along with genetic susceptibility is necessary for diabetes 
onset.  However, if mumps is a determinant of type 1 diabetes, it is likely to only be a small 
proportion of cases (26). 
 In addition to viral infectious, one should also consider other environmental variables 
with seasonal variation.  There is seasonal variation in the amount of daylight hours, especially 
in Northern Europe, which the highest incidence of type 1 diabetes in the world.  The sunlight-
dependent synthesis of vitamin D in the skin is the most important source of this 
immunologically active hormone.  Some studies have indicated that the lack of oral vitamin D 
substitution in infancy increases the subsequent risk of type 1 diabetes (31).  However, there is a 
general recommendation that all young children should take daily vitamin D drops in Northern 
Europe, and this recommendation is implemented by more than 95% of parents, at least in 
children up to two years in age (30); and there are regions with a low type 1 diabetes incidence 
rate in Northern Europe such as Russian Karelia, having an annual incidence rate of 7.8/100,000 
children under 15 years (1990-1999) (30). 
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 Various nutritional practices have been associated with the development of type 1 
diabetes.  Data from three population-based case-control studies on cow’s milk intake before 
diagnosis of type1 diabetes are conflicting.  Verge et al. (32) reported that the cow’s milk intake 
had been higher in pre-diabetic children than in control children in New South Wales, Australia.  
In a nationwide Childhood Diabetes in Finland (DiMe) study, a high consumption of cow’s milk 
in childhood was associated with a more frequent appearance of diabetes-associated 
autoantibodies and type1 diabetes in a prospective cohort of initially unaffected siblings of 
children with type 1 diabetes (33).  On the other hand, a Swedish retrospective survey showed 
that the frequency of milk intake had been lower among children who developed type 1 diabetes 
than among unaffected children (34).  The evidence in favor of the role of bovine insulin as a 
driving antigen in the disease etiology is relatively fragmentary, and further research is clearly 
needed to confirm or exclude this hypothesis.  Bovine insulin is definitely present in cow’s milk, 
although the structural components of immunoreactive insulin are poorly characterized in milk 
(30).   
 Gluten proteins have been implicated as potential driving antigens in type 1 diabetes.  
Type 1 diabetes and celiac disease are both HLA associated autoimmune diseases.  Two small 
intervention studies have been performed in family members testing positive for diabetes-
associated autoantibodies to assess whether gluten elimination modifies the natural course of 
beta-cell autoimmunity (30).  In one trial, seven autoantibody-positive first-degree relatives were 
placed on a gluten-free diet for 12 months followed by gluten re-exposure over the next 12 
months.  The autoantibody titers did not change significantly during the gluten-free intervention 
period or during the re-exposure period (35).  Seventeen family members testing positive for at 
least two diabetes-associated autoantibodies were put on a gluten-free diet for another six months 
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in the Italian trial (36) and again on a normal diet for six months.  This trial indicated that a 
gluten-free diet has no effect on the signs of beta-cell autoimmunity in first-degree relatives of 
affected individuals, but such a diet may increase the endogenous insulin secretion in family 
members at increased risk of type 1 diabetes (36).   
 Theoretically, a dietary antigen would fit well into the role as the factor driving the 
disease process toward clinical type 1 diabetes, since the exposure to most dietary factors tends 
to be frequent, and still there is some variation in the exposure both within and across 
populations.  Bovine insulin is an attractive candidate, since an immune response initially 
induced by bovine insulin will cross-react and may target human insulin in the beta-cell (30).       
2.1.2.3 Other Potential Risk Factors    
 Other potential risk factors for type 1 diabetes include maternal age, birth order, stress, 
and socioeconomic status.  Some studies of stress and type 1 diabetes have reported positive 
associations, although most studies have been retrospective and suffered from methodological 
difficulties in assessing stress and measuring its frequency and duration (41, 42).  Factors such as 
maternal age at birth and higher birth order have also been associated with increased type 1 
diabetes risk.  Several investigations have reported a higher prevalence of diabetes in children 
born to older mothers and in children with a higher birth order (43, 44).  These studies concluded 
that of the two related potential determinants of type 1 diabetes risk, higher maternal age (age 
greater than 35 years at child’s birth) was the more significant risk factor.  An explanation for 
this association is unclear, but it has been suggested that it may be related to the intrauterine 
environment.   
 There have been a few studies on socioeconomic status (SES) as a risk factor for type 1 
diabetes.  In northern England, type 1 diabetes incidence rates were highest in the lower SES 
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areas and the lowest in the areas with a higher SES (46).  However, another study reported 
conflicting results, with higher incidence rates in affluent areas (45). 
 This evidence demonstrates that there are numerous potential factors involved in the 
etiology and epidemiology of type 1 diabetes.  This also proves that there is a need for future 
studies on the etiology for greater advances in the prevention of type 1 diabetes. 
 
 
2.2 TYPE 2 DIABETES  
2.2.1 Epidemiology 
Type 2 diabetes mellitus (T2D) is the most common form of diabetes.  Population studies based 
on standardized methods and diagnosis have shown great variation in the frequency of the 
disease, and prospective studies have provided new insights into its associated risk factors and its 
pattern of development (8).  T2D, previously called non-insulin-dependent diabetes mellitus or 
adult-onset diabetes, usually begins as insulin resistance, in which target tissues do not use 
insulin properly.  T2D is distinguished by the body’s inability to efficiently use insulin that is 
produced by the pancreas.  It is characterized by chronic hyperglycemia, reduced insulin 
response, insulin resistance, and an increase in hepatic glucose output.  It accounts for 
approximately 90% to 95% of all diagnosed cases of diabetes (40).  Uniform diagnostic criteria 
for diabetes were first recommended by the American Diabetes Association and the World 
Health Organization in 1979 and 1980 and were updated in the late 1990s (41).  Currently, when 
typical symptoms of diabetes are present (for example, polyuria, polydipsia, or unexplained 
weight loss), a casual plasma glucose level of 11.1 mmol/L (200mg/dL) or greater confirms the 
diagnosis.  Furthermore, the diagnosis can be made with a fasting plasma glucose level of 7.0 
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mmol/L (126 mg/dL) or greater or an oral glucose tolerance test with a 2-hour value of 11.0 
mmol/L or greater (41).  For epidemiologic studies, a single fasting plasma glucose or 2-hour 
oral glucose tolerance test measurement is used to estimate the prevalence of diabetes in a 
population.   
The symptoms of T2D may develop gradually over time.  Some individuals could be 
asymptomatic, while others suffer from one or a combination of symptoms such as nausea, 
fatigue, weight loss, blurred vision, frequent infections and slow healing of wounds (12).  Harris, 
et al. argues that the onset of T2D may occur between nine and twelve years before its clinical 
diagnosis.  This was demonstrated in their research by the fact that the onset of detectable 
retinopathy occurred four to seven years before diagnosis of type 2 diabetes in two population-
based groups of Caucasian patients with type 2 diabetes in the U.S. and Australia (89).  Harris 
and his colleagues concluded that significant morbidity was present at diagnosis and for years 
before diagnosis of T2D.   
Currently, three national surveys track diabetes prevalence in the United States.  The 
National Health Interview Survey and National Health and Nutrition Examination Survey 
(NHANES) use national population-based samples and query persons in face-to-face interviews 
about whether they have been told by their health care provider that they have diabetes.  The 
third survey, the Behavioral Risk Factors Surveillance System (BRFSS), asks a similar question 
of state-based population samples during telephone interviews of residents.  NHANES includes a 
laboratory-based examination that measures glucose levels and identifies persons with 
undiagnosed diabetes (40).  All three surveys provided national estimates of prevalence of 
diagnosed diabetes. 
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In 2002, an estimated 6.3% of the U.S. population (about 18.2 million people) had 
diabetes (40).  There are also nearly 800,000 new cases of type 2 diabetes diagnosed each year.  
In addition, for every two diagnosed cases of type 2 diabetes, there is one undiagnosed case (41).  
According to data from the National Health Interview Survey, persons 65 years of age or older 
make up almost 40% of all persons with diagnosed diabetes, and the prevalence in this age group 
is more than ten times that in individuals younger than 45 years of age (40).  Minority race and 
ethnic groups, including Black, Hispanic, and Native American persons, are disproportionately 
affected; the prevalence of diagnosed diabetes is generally two to four times higher in these 
groups than in the majority population (40).  Because of changing demographic factors, by the 
year 2010, it was been projected that the number of people with T2D will double (42).  The 
prevalence of T2D varies enormously from population to population throughout the world (8).  
The highest rates are recorded in Pima Indians, but also in the Micronesian population living on 
Nauru Island in the Central Pacific.  Proportions in different ethnic groups living in the same 
country may vary considerably (8).  Rates differ in migrants as compared with natives remaining 
in their own country.  Moreover, the ratio in migrants is greater than in the indigenous 
population, and these increases appear to be related to rapidly changing lifestyles (8).  The 
prevalence is parallel with rapidly developing countries and among underprivileged individuals 
in developed nations. 
The National Health Interview Survey found a four to eight-fold increase over the last 
half-century in the number of persons who received a diagnosis of diabetes (1.6 million in 1958 
and 12.1 million in 2000) and the prevalence of diagnosed diabetes in the United States (40).  
Increases occurred across all demographic categories, including sex, race or ethnicity, and age.  
Between 1990 to 2001, data from the Behavioral Risk Factors Surveillance System indicate that 
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the largest relative increases in diagnosed diabetes occurred in persons 30 to 39 and 40 to 49 
years of age (95% and 83%, respectively); increases in other age groups were 40% in persons 18 
to 29 years of age, 49% in persons 50 to 59 years of age, 42% in persons 60 to 69 years of age, 
and 33% in persons 70 years of age or older (41).  These increases can be seen in the incidence 
rates described below in Table 2.0 (213).  In the 1990s incidence began to increase in all age 
groups.  During the 2000s, incidence continued to increase among those aged 18-44 years but in 
the tow older age groups, the rate of increase in incidence appeared to have slowed (213).  
Table 2.0 Incidence of Diagnosed Diabetes per 1,000 Population Aged 18-79 Years, by Age, 
United States, 1990-2007 
 
Year 
18-44 Years Old 45-64 Years Old 65-79 Years Old 
Incidence/1,000 Incidence/1,000 Incidence/1,000 
1990 2.0 6.0 6.0 
2001 2.9 11.4 11.8 
2007 4.4 11.7 12.5 
  
The NHANES found that diabetes is undiagnosed in approximately one third of all 
persons with diabetes and that this fraction has changed little over time.  Many factors have 
affected these increases in the prevalence of diabetes, including changes in diagnostic criteria, 
improved or enhanced detection, decreasing mortality, changes in demographic characteristics of 
the population and growth in minority populations in whom the prevalence and incidence of 
diabetes are increasing (40). 
 
2.2.2 Etiology 
Type 2 diabetes is a heterogeneous disease considered to be the result of a combination of 
genetic factors and external/environmental exposures.  External exposures may include reduced 
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physical activities or increased fat consumption.  The result of reduced physical activity and 
increased caloric intake is the basis for obesity and the rise of type 2 diabetes (30). 
 Insulin resistance is a characteristic that precedes the development of impaired glucose 
tolerance (IGT) and T2D.  Hyperinsulinaemia, especially in the fasting state, represents an index 
of insulin resistance (8).  Insulin resistance show familial aggregation and is associated with 
obesity and physical inactivity.  The development of IGT is predicted by the presence of 
hyperinsulinaemia, and IGT is a strong risk factor for T2D and can be considered as a stage in 
the development of the disease (8). 
 Longitudinal epidemiological studies have demonstrated the hyperinsulinaemia, even at a 
stage when glucose tolerance is within the normal range, is an important predictor of T2D (95).  
The increase in insulin concentration appears to be a compensatory response to increased 
intracellular insulin resistance, which leads to small increases in circulating glucose, and as a 
result an increase in insulin secretion, as well as subsequent increases in both fasting and 
stimulated insulin levels (95).  As insulin resistance degenerates, the glucose tolerance 
deteriorates and IGT eventually occurs.  After IGT develops, when insulin responsiveness 
diminishes, hyperglycemia worsens and diabetes appears. 
2.2.2.1 Genetics 
 Obesity is a major determinant in the incidence of T2D, but only a small proportion of 
obese individuals develop the disease.  Data from the Framingham Heart Cohort Study (214), 
indicated that as their population gained weight, a number of atherogenic traits worsened in 
proportion to the weight gained.  Although this was true on the average, weight gain did not 
explain more than a small fraction of the variation in the atherogenic traits, and some persons are 
able to gain weight without much change in their cardiovascular risk attributes such as glucose 
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tolerance (214).  The relation of obesity to glucose intolerance is well documented and weight 
control is a standard feature in the treatment of diabetes.  However, the mechanism by which 
obesity is related to glucose intolerance is by no means clear, particularly the genetic 
implications of obesity and diabetes (214).   Longitudinal studies among the Pima Indians have 
demonstrated that the likelihood of developing T2D results from an interaction between the 
effect of obesity in the offspring and a parental history of diabetes, which presumably reflects 
inherited susceptibility (90).  Therefore, even when genetic susceptibility is present, the 
expression of the disease is largely dependent on other factors.  The disease shows familial 
aggregation, but there is no evidence on the mode of inheritance or on whether it is caused by 
one or several genes. 
 Family history of type 2 diabetes is reported much more frequently in individuals with a 
medical history of T2D than in all other groups.  For example,  a study conducted using 
NHANES data from 1999-2002 demonstrated that the diabetes prevalence for individuals with a 
family history was more than four times higher than the prevalence for individuals without a 
family history (P< .001) (92).  Among adults with a family history, diabetes prevalence increased 
significantly with a corresponding increase in number of family members with diabetes (P < 
.001) (92).  The diabetes prevalence for individuals with three or more first-degree relatives with 
diabetes (44.4%) was higher than the prevalence associated with any other demographic or risk 
factor the researchers examined (92).  
 In this same study, diabetes prevalence associated with parental history significantly 
increased with the number of affected parents (P < .001).  The diabetes prevalence for 
individuals with a mother with T2D (16.5%) was higher than for individuals with a father with 
T2D (12.4%).  In addition, having a sibling with diabetes conferred a diabetes prevalence 
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approximately 4.5 times higher than the prevalence for individuals without a diabetic sibling 
(92). 
 There have been several twin studies that suggest that T2D is highly concordant among 
monozygous (MZ) twins and less among dizygous (DZ) twins.  Newman et al. found that there 
were concordance rates of 58% for MZ twins and 17% for DZ twins among U.S. veterans (55).  
Similar results were found in a Danish study (56), where the MZ concordance was 
approximately twofold higher than for the DZ twins.   
 There is no clear relationship between HLA genes and T2D, unlike autoimmune type 1 
diabetes (93).  Although there have been numerous linkage studies comparing the prevalence of 
the genetic markers in people with T2D, this research has yet to find major associations between 
the genes for insulin, insulin receptors, glucose transporters and T2D in the general population 
(93).  Type 2 diabetes is genetically complex and involves multiple genes, which may be 
involved with causal mechanisms, and multiple gene-environment interactions (93). There are 
also several limitations in understanding the genetics of T2D.  This limitations cause the mode of 
inheritance of T2D to remain uncertain.  These limitations include the misclassification of T2D, 
premature mortality, late age at onset, multiple polymorphisms, and the genotypic and 
phenotypic heterogeneity of T2D (93). 
 Other evidence for the importance of genetic determinants comes from studies of mixed 
populations and from populations of different genetic backgrounds living in similar 
environments.  Other data come from studies on populations residing in the same environment 
but within which there is a genetic admixture (8).  For example, among the populations of the 
Gila River Indian Community, the prevalence of T2D is twice as great in full-blooded Pima 
Indians as in non-Indians, and the prevalence among those of half-Pima, half-non-Indian 
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ancestry is intermediate (8).  Genetic susceptibility does appear to be a basic step for the 
development of T2D, but the expression of the disease is determined largely by environmental 
factors (8). 
2.2.2.2 Environment   
Many studies support the role of environment/lifestyle factors in the etiology of type 2 
diabetes.  The development of T2D is influenced by exposure to different environments.  Some 
of the environmental effects can be assessed by comparing the frequency of the disease in 
migrants with that among people who remain in the original environment, assuming that both 
groups share similar genetic material.   
There are many lifestyle factors that are thought to be involved in the development of 
T2D.  Diet has been considered a possible cause of diabetes for centuries.  Total caloric intake, 
as well as several components of diet has been considered, including carbohydrates and fats (57).  
High-fat diets have been associated with obesity and altered fat distribution.  A higher dietary fat 
intake was associated with previously undiagnosed T2D and IGT in a random sample of 
Hispanics and non-Hispanic whites screened for glucose intolerance (94).  Studies of severe food 
shortages during wars provide ecological evidence that diabetes mortality and morbidity declined 
abruptly with decreased caloric intake (58). 
Some ecological studies (59, 60) suggest that T2D prevalence is consistently lower in 
populations with higher levels of habitual physical activity.  Cross-sectional and retrospective 
studies have demonstrated that there is a lower prevalence of T2D at higher levels of physical 
activity.  In the NHANES studies (61), physical activity was related to T2D only in Mexican 
Americans and not in U.S. Caucasians or African-Americans.  In these studies, lower physical 
activity was reported after diagnosis of T2D, and this could have been the result of the diabetes 
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rather than its cause.  Conversely, three prospective studies measured physical activity levels 
prior to T2D onset.  In the Nurses’ Health Study (62), women who stated  they at least had 
weekly physical activity, over the next eight years, a relative risk of self-reported T2D of 0.8 
(95% CI 0.7-0.9), compared with those with less activity.  There was no dose-response 
relationship beyond weekly exercise.  Five-year follow-up of a large cohort of male physicians 
(63) yielded a comparable estimate of the protective effect of at least weekly activity (RR=0.7).  
In these men, there was verification of dose-response, and the greatest effect was seen in men 
who were more overweight.  The results of a 15-year follow-up (64) of male college alumni are 
consistent with these results.  In these men, each 500 kcal of increased energy expenditure in 
leisure-time activity per week lowered the risk of T2D by 10%.  This effect was also greater in 
more obese participants. 
It has been hypothesized that this protective effect of physical activity on development of 
T2D is due to the prevention of insulin resistance.  While this is generally accepted, some studies 
of the acute effects of physical training suggest a much more complex picture.  Krotkieski et al. 
and Trovati et al. found that subjects who start an exercise program with high insulin levels 
responded with a drop in insulin levels (65,66).  However, subjects who have lower baseline 
insulin levels increase their insulin levels with exercise.  Furthermore, in some subjects 
undergoing physical training, there were no changes in insulin levels, but C-peptide levels 
(insulin secretion) and insulin sensitivity decreased (65). 
2.2.2.3 Obesity 
Obesity has been recognized as being associated with diabetes for a very long time.  
However, there is substantial controversy about the meaning of the relationship, since non-obese 
individuals develop T2D and many obese persons never develop T2D.  There are several reasons 
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this might occur: 1) obesity is the etiologic pathway of a distinct subtype of T2D, 2) a similar 
genetic predisposition leads independently to both obesity and T2D, and 3) a similar genetic 
defect predisposes to both, but different additional genetic and/or environmental factors complete 
the sufficient causes for T2D and obesity (67). 
Obesity itself is unlikely to completely justify inter-population difference in T2D 
frequency.  For instance, Marshall et al. (68) found that Hispanics in San Luis Valley, CO have a 
twofold higher T2D prevalence and incidence, compared with non-Hispanic whites after 
adjustment for obesity, fat patterning, age, sex and family history of diabetes.  Cowie et al. (69) 
demonstrated that a higher prevalence of type 2 diabetes was also found in Africa-Americans and 
Caucasians after adjustment for obesity and other risk factors.  This racial disparity was present 
particularly at higher levels of obesity and the adverse effect of obesity was greatest in Black 
women. 
 Not only the presence but also the distribution of obesity influences the risk of 
developing T2D.  Central obesity is associated with an increased possibility of developing T2D, 
as has been demonstrated in many different ethnic and racial groups.  Central obesity in many 
populations is also associated with an increased incidence of coronary heart disease, 
hyperinsulinaemia, high serum triglyceride, low high-density lipoprotein (HDL) cholesterol 
levels, hypertension and disturbances in the patterns of sex hormones (91).  Insulin resistance 
appears to be a central feature of this cluster of abnormalities related to abdominal obesity. 
In addition to the level of obesity, duration has proven to also be an important risk factor 
for T2D.  Maximum lifetime BMI was cross-sectionally associated with T2D, independent of 
current BMI (70).  Everhart et al. (71) found that in Pima Indians who attained a BMI ≥30, the 
risk of T2D increased from 24.8/1,000 person-years in those who were obese for <5 years, to 
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35.2/1,000 for obesity of 5-10 years, to 59.8/1,000 for >10 years of obesity.  However, in the 
majority of those participants with normal blood glucose, longer obesity duration was associated 
with lower fasting and post-load insulin concentrations.  The authors speculated that this may 
have occurred if decreased insulin secretion followed prolonged obesity.  It could also be due to 
a “survivor” effect, since individuals who converted to IGT or T2D were excluded from these 
analyses. 
The distribution of body fat is also a strong risk factor for T2D, independent of the 
presence of obesity (72, 73).  Even stronger associations have been found with better 
measurements of intra-abdominal fat, such as CT scans (74).  Some longitudinal studies have 
demonstrated that, as individuals age, both weight gain and increased waist circumference occur; 
even in older persons who lose weight, waist circumference continues to increase (75).  These 
trends may partially be responsible for the increased incidence of T2D with aging. 
2.2.2.4 Pregnancy and Parity 
 It has been shown that increasing parity increases the risk of T2D in women.  Some 
retrospective studies have found both positive (76) and no associations (77,78).  It has also been 
argued that the effect of pregnancy operates through weight gain that accompanies pregnancy 
and that the numbers of births have no independent effects themselves (79).  A study conducted 
in Rancho Bernardo, CA (80) found a positive association between increased parity and T2D, 
adjusted for current BMI, suggesting that parity may have an effect beyond that of obesity.  
Conversely, a prospective study of 113,606 U.S. female nurses proved that increased risk of T2D 
is secondary to obesity (81).  In this study, there was a relative risk of 1.6 (95% CI 1.3-1.9) for 
women with ≥6 births compared with nulliparous women; however, adjustment for age and BMI 
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completely removed any effect of parity.  Therefore, from this large prospective study, it has 
been shown that parity has no independent effect beyond its effect on weight gain. 
2.2.2.5 Urbanization 
 Bennett found that urban residents have T2D rates higher than rural dwellers (82).  A 
number of lifestyle factors implicated in the etiology of T2D (i.e., sedentary lifestyle, greater 
level of stress, and obesity) are associated with an urban lifestyle.  The role of stress as a possible 
T2D risk factor has some support in studies of the neuroendocrine system, especially the 
sympathetic nervous system (83).  An effect of stress may be mediated through abdominal 
obesity, or directly on glucose and/or insulin levels (84).  However, there is little epidemiological 
evidence for this hypothesis. 
 
2.2.3 Prevention and Intervention 
Most previous T2D prevention studies have included programs that alter the lifestyle to reduce 
body weight.  Currently, there is no evidence from randomized interventions that any 
manipulation of specific dietary components prevents progression from IGT to T2D.  One 
randomized study of newly diagnosed T2D patients, a low-carbohydrate diet was compared with 
a modified-fat diet (85).  The participants’ weight decreased slightly more on the low-fat diet, 
but at one year there were no differences in fasting glucose and insulin levels.  Weight reduction 
can reverse insulin resistance and, should prevent progression to T2D in at-risk-persons.  
However, long-term maintenance of a reduced body weight is difficult, and most patients regain 
the lost body weight within three years (67). 
 A few studies have shown that benefits of the addition of exercise programs to dietary 
interventions for enhancing long-term weight loss in obese individuals without diabetes (86).  In 
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one study, obese T2D participants assigned to a 10-week diet and exercise intervention achieved 
significantly greater weight loss at one year follow-up than did subjects assigned to a diet 
intervention only (87).  While most of the intervention studies in T2D patients showed 
improvements in blood glucose control in addition to weight loss, there are no data indicating the 
effectiveness of exercise-induced weight loss in preventing T2D in at-risk individuals (88). 
 The role of physical inactivity, dietary fat, and weight gain in the etiology of T2D is 
established.  What remains to been seen is how these behavioral factors interact with the genetic 
factors to produce diabetes on the individual and population levels.  A better understanding of 
the genetic-environmental interactions and of the heterogeneity of T2D would assist in designing 
ideal measures to prevent the disease. 
 
2.3 PRE-DIABETES 
2.3.1 Epidemiology 
Pre-diabetes is becoming more common in the United States.  The U.S. Department of Health 
and Human Services estimates that about one in four U.S. adults aged 20 years or older, or 57 
million people, had pre-diabetes in 2007 (204).  The Diabetes Prevention Program (DPP) 
illustrated those individuals with pre-diabetes are at extremely high risk for progression to overt 
diabetes (48).  Those with pre-diabetes are likely to develop T2D within 10 years, unless they 
take steps to prevent or delay diabetes (204).  The American Diabetes Association (ADA) 
previously defined pre-diabetes as either fasting glucose (IFG) = 6.1 to 6.9 mmol/L (110-125 
mg/dL) and/or impaired glucose tolerance (IGT) (two-hour postload glucose of 7.8-11.0 mmol/L 
[140-199 mg/dL]).  Recently, the ADA lowered the fasting glucose threshold value for IFG from 
110 to 100 mg/dL (47). 
 29 
 Two recent studies of individuals without diabetes showed that higher fasting plasma 
glucose levels within the normoglycemic range constitute an independent risk factor for type 2 
diabetes and that coronary disease is more severe in those patients with higher postload glycemia 
and hemoglobin A1c levels (51).  The best ways to screen for pre-diabetes are with an oral 
glucose tolerance test and/or a fasting glucose.  One can have a normal fasting glucose but an 
abnormal two-hour postprandial glucose level.  The overlap between subjects with IFG and IGT 
is incomplete and suggests that they describe different pathophysiologic aspects of dysregulated 
glucose and fat metabolism.  Multivariate analyses show that two-hour plasma glucose is closely 
associated with risk factors for diabetes and with cardiovascular variables, including triglycerides 
and apolipoprotein B (51). 
 
2.3.2 Etiology 
Currently, most experts agree that type 2 diabetes is a multi-organ disease involving defects of 
glucose and fat metabolism in several organs, including not only the pancreatic beta cell, liver, 
and skeletal muscle, but also other organs such as the intestines, kidney, brain, and nervous 
system.  Diabetes begins as a pre-diabetes state characterized by insulin in many tissues, 
including the liver, adipose tissue, and muscle.  Pre-diabetes is a central metabolic abnormality.  
Considerable information is available to suggest that a cluster of metabolic abnormalities related 
to insulin resistance and hyperinsulinemia increases cardiovascular risk and that these risk 
factors are present in insulin resistant patients who do not have diabetes (51).  Patients with pre-
diabetes may have a dyslipidemia characterized by high triglycerides and low high-density 
lipoprotein (HDL) levels.  Pre-diabetes begins with an excessive intake of fatty acids in the diet.  
This excessive intake of fatty acids leads to an accumulation of triglycerides in adipose tissue.  A 
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net spillover of fatty acids from adipose tissue to non-adipose tissues such as muscle, liver, and 
the pancreas occurs (51).  The deposition manifests as the visceral accumulation of fat and can 
be measured by computed tomography (CT) scan (51).  This visceral accumulation of fat also 
explains insulin resistance in the lean individual because it is the fat surrounding such organs as 
the liver that leads to insulin resistance, not necessarily subcutaneous fat (51). 
2.3.2.1 Environment 
Recent studies have shown that both lifestyle and pharmacologic therapy can alter the 
progression of pre-diabetes to overt diabetes.  The three largest studies of pre-diabetes prevention 
to date include the Finnish, DPP, and the Study to Prevent Non-Insulin-Dependent Diabetes 
Mellitus (STOP-NIDDM) trials.  In the Finnish Diabetes Prevention Study of more than 500 
overweight subjects with impaired glucose tolerance (IGT) (49), the reduction in diabetes 
incidence in the intervention group was directly related to the degree of improvement in lifestyle 
intervention. The intervention group showed significantly greater improvement in each 
intervention goal.  After 1 and 3 years, weight reductions were 4.5 and 3.5 kg in the intervention 
group and 1.0 and 0.9 kg in the control group, respectively.  Measures of glycemia and lipidemia 
improved more in the intervention group (49).   
In the STOP-NIDDM trial, 1429 subjects were randomized to receive acarbose or a 
placebo.  The subjects experienced a 36% relative risk reduction in their likelihood of developing 
type 2 diabetes compared with subjects taking placebo (50).  In the Diabetes Prevention Program 
(DPP), all 3234 participants were overweight and had pre-diabetes and 45% of the participants 
were from minority groups – African American, Alaska Native, American Indian, Asian 
American, Hispanic/Latino, or Pacific Islander.  These factors are all well-known risk factors for 
the development of T2D as previously discussed.  Participants were randomly divided into 
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different treatment groups.  The first group, called the lifestyle intervention group, received 
intensive training in diet, physical activity, and behavior modification (204).  By eating less fat 
and fewer calories and exercising for a total of 150 minutes per week, the participants aimed to 
lose 7 percent of their body weight and maintain that loss.  The second group took 850 mg of 
metformin twice a day.  The third group received placebo pills instead of metformin.  Both of 
these groups also received information about diet and exercise but no intense motivational 
counseling.  A fourth group was treated with the drug troglitazone (Rezulin), but this part of the 
study was discontinued after adverse affects were discovered (204). 
The DPP’s results demonstrated that millions of high-risk people can delay or avoid 
developing T2D by losing weight through regular physical activity and a diet low in fat and 
calories (204).  The DPP also suggests that metformin can help delay the onset of diabetes.  
Metformin was effective in slowing progression of pre-diabetes to overt diabetes, although 
lifestyle changes were more effective.  Those in the lifestyle intervention group reduced their 
risk of developing diabetes by 58% and this finding was true across all participating ethic groups 
and both sexes (204).  These lifestyle changes worked particularly well for those aged 60 years 
and older, reducing their risk by 71%.  About 5% of the lifestyle intervention group developed 
diabetes each year during the study period, compared to 11% of those in the placebo group.   
Participants taking metformin reduced their risk of developing diabetes by 31%.  
Metformin was most effective in people 25 to 44 years old and in those with a BMI of 35 or 
higher (204).  Approximately 7.8% of the metformin group developed diabetes each year during 
the study, compared to 11% of the placebo group (204).  Because there is now clear evidence of 
the benefit from clinical intervention in the pre-diabetic condition, it is important to identify and 
intervene in people with pre-diabetes. 
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 Cheng et al found in a cohort of young Africa-Americans, an ethnic group at high risk for 
developing diabetes, many subjects with pre-diabetes have IGT without IFG.  Lowering the FPG 
threshold for IFG identifies more subjects with pre-diabetes, but still results in failure to detect 
most of the IGT-defined pre-diabetic cases.  Furthermore, using the lower threshold causes the 
overall prevalence of individuals defined as having pre-diabetes to increase from 20.4% to 
31.9%, substantially adding to the number of individuals labeled as having extremely high risk 
for developing diabetes.  Without performing two-hour post-challenge testing, approximately 
one third of pre-diabetes cases would remain undiagnosed and at risk.  Although use of FPG 
alone is currently favored clinically over two-hour PG because of the relative cost and 
inconvenience associated with OGTT, a substantial proportion of pre-diabetes subjects will be 
missed when FPG alone is used to screen African Americans (47).   
2.3.2.2 Treatment 
 Although current treatment for pre-diabetes includes a pharmacological and lifestyle 
modification approach, lifestyle interventions are the cornerstone of treatment for this condition 
(52).  Insulin resistance is part of the underlying pathology associated with metabolic syndrome, 
and patients identified with insulin resistance may have hypertension, dyslipidemia, visceral 
obesity, and vascular disease.  Obesity, sedentary lifestyle, and high calorie, high-fat diets 
correlate with the development of insulin resistance.  Lifestyle changes and therapeutic dietary 
intervention have been demonstrated to prevent or delay the development of diabetes.    
 Current recommended lifestyle changes include a reduction in energy intake and an 
increase in physical activity.  Both are inversely associated with the degree of insulin resistance.  
Lifestyle changes can prevent the development of diabetes.  A moderate decrease in caloric 
balance (500-1000 kcal/day) results in slow, progressive weight loss when coupled with regular 
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moderate-intensity physical activity (150 min/week of aerobic activity) (51).  Reduction in 
saturated and trans fatty acids and cholesterol intake improves lipid status and insulin sensitivity.   
 Pharamacologic intervention also may prevent the development of diabetes.  The DPP 
concluded that metformin may prevent progression to diabetes in insulin-resistant individuals.  
Participants in the STOP-NIDDM trial with impaired glucose tolerance randomized to acarbose 
had a 25% relative risk reduction in progression to diabetes after 3.3 years (50).   
 In the DPP, metformin was half as effective as diet and exercise in delaying the onset of 
diabetes and was nearly ineffective in older people aged > 60 years, or those with a BMI < 30 
kg/m2 (53).  Metformin was as effective as lifestyle modification in those subjects aged 24-44 
years or in those with a BMI of > 35 kg/m2 (53).  The role of pharmacologic intervention in those 
with pre-diabetes needs further definition and ongoing studies will answer those questions.  
Certainly, anti-obesity drugs are appropriate for some obese patients.  Surgery also has a place in 
the treatment of these patients.  Over the last several years, bariatric surgical intervention has 
played an increasingly important role in the care of morbidly obese patients (51).  Numerous 
studies have demonstrated that in carefully selected patients there is significant weight loss (over 
30% in some studies), decrease in BMI, reduction in blood pressure, and amelioration of insulin 
resistance (54).  There is convincing evidence to suggest that pre-diabetes can be managed 
successfully with lifestyle and clinical interventions.  However, getting patients to make and 
maintain behavior changes and adhere to treatment regimes requires a compelling approach.   
 Along with pharamacological interventions, several recent controlled trials on diabetes 
prevention have confirmed that lifestyle changes targeting diet, activity patterns, and weight 
regulation; however, there is still no consensus on a standard or systematic approach that 
supports sustained behavior change in any of these areas (51).  A significant mediating factor 
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determining successful behavior change is self-efficacy, or one’s belief about his or her ability to 
accomplish something (51).  In addition to the challenges of changing engrained lifestyle habits, 
comorbid conditions such as depression can be a complicating factor when addressing any 
chronic medical condition (51). 
 Traditionally, diabetes education, which is similar to pre-diabetes education, has 
emphasized increasing knowledge about diabetes, risk factors, and diabetes self-care; however, 
many studies have shown that this didactic approach does not result in optimal clinical or 
behavioral outcomes (55).  Biuso et al. believes that efforts should focus on improving coping, 
communication, and control by enhancing self-efficacy, increasing motivation to initiate and/or 
change behaviors, and facilitating an individualized plan of action that takes into account 
personal needs, barriers, and preferences (55).  Therefore, considerable care must be taken to 
implement a behavioral change program that includes these components (51). 
 
 
2.4 COMPLICATIONS IN PERSONS WITH DIABETES MELLITUS 
 
 
Much of the burden of diabetes is due to the development of complications such as 
cardiovascular diseases, retinopathy and nephropathy.  Most adults with diabetes have one 
comorbid condition, and as many as 40% have at least three comorbid conditions.  As patients 
with diabetes get older, they are at higher risk for acquiring chronic diseases associated with age, 
such as osteoarthritis, dementia, and heart failure.  Other chronic conditions, such as thyroid 
disease, other autoimmune disease, and any form of cancer can also complicate the medical 
management of diabetes.  For instance, hyperthyroidism alters glucose metabolism and leads to 
hyperglycemia, whereas hypothyroidism leads to hypoglycemia.  Cardiovascular diseases are the 
 35 
leading causes of death for patients with type 2 diabetes, diabetic retinopathy is estimated to 
account for 5% of all cases of blindness globally (94), and up to 50% of patients receiving renal 
replacement therapy (RRT) have diabetic nephropathy (94).  According to a 2007 fact sheet from 
the Centers for Disease Control and Prevention (89), the costs of medical care and indirect costs 
such as disability and premature death related to diabetes and associated complications totaled 
$174 billion. 
 There are both acute and chronic diabetes complications.  Acute complications include 
diabetic ketoacidosis (DKA), lactic acidosis (LA), hypoglycemia, and hypersolmolar nonketotic 
state (HNS).  Chronic conditions can be further divided into micro and macrovascular 
complications.  Microvascular complications entail conditions related to the kidney or retina, 
neuropathy, which involves changes in the central nervous system (94).  Macrovascular 
complications include coronary artery disease, cerebrovascular disease, peripheral vascular 
disease, or lower extremity arterial disease. 
 
2.4.1 Chronic Complications 
2.4.1.1 Microvascular Complications 
 Microvascular disease is the characteristic consequence of exposure to chronic 
hyperglycemia (94). Overall, the incidence of microvascular complications has declined in recent 
decades, due to improvements in the management of people with diabetes (94).  For example, 
comparison of four cohorts of patients with type 1 diabetes whose disease was diagnosed 
between 1965 and 1984 demonstrated that the cumulative incidences of both diabetic 
nephropathy and proliferative retinopathy over the following 20 years were lowest in the most 
recently diagnosed cohorts (95).  Similarly, for type 2 diabetes, studies in the United States have 
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revealed a marked decline in the proportion of patients with any degree of retinopathy, from 50% 
of patients in the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR) in the early 
1980s (96), to 10% in the Multi-Ethnic Study of Atherosclerosis (MESA) at the beginning of the 
21st century (97).  
Retinopathy  
Diabetes, particularly diabetic retinopathy, is the main cause of new cases of blindness in 
people age 20-74 years in the United States (98).  It has been estimated that more than 12% of 
new cases of blindness are attributable to diabetes, and approximately 8% of those who are 
legally blind are reported to have diabetes as the etiology.  Those with diabetic retinopathy are 
29 times more likely to be blind than those without diabetes (98).  Diabetic retinopathy is 
characterized by alterations in the small blood vessels in the retina.  Diabetic retinopathy has two 
stages: non-proliferative and proliferative retinopathy (98).  The non-proliferative stage is 
characterized by retinal blot hemorrhages, microaneuryisms, exudates, and other lesions (98).  
The growth of abnormal blood vessels and fibrous tissues from the optic nerve or from the inner 
retinal surface are signs of proliferative retinopathy.  Bleeding may occur during the growth of 
the abnormal tissue, which leads to vision loss (98).   An estimated 97% of those who take 
insulin and 80% of those who do not take insulin who have had diabetes for more than 15 years 
have retinopathy; approximately 40% of insulin-taking and 5% of noninsulin-taking persons 
have the most severe stage, proliferative diabetic retinopathy (98).  In the large Wisconsin 
epidemiological study, WESDR (90), proliferative retinopathy was present at baseline or after a 
4-year follow-up in 23% of younger-onset (aged <30 years) diabetic individuals, and in 10% of 
older patients receiving insulin and in 3% of those not taking insulin.  However, type 2 diabetes 
finally accounts for the higher absolute number of cases of proliferative retinopathy (90).  The 
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main risk factors for developing proliferative retinopathy reported in WESDR were longer 
duration of diabetes, high blood glucose and, in the younger-onset group, higher blood pressure 
at base-line (90). 
 Estimates of rates of legal blindness in the United States have been reported by the 
National Society to Prevent Blindness from data of the Model Reporting Area (MRA) registry 
(99).  It was estimated that 7.9% of people who were legally blind reported diabetes as the cause 
of their blindness (99).   Kahn and Hiller demonstrated that prevalence rates for diabetes-related 
legal blindness increased with increasing age to a maximum in persons age 65-74 years; 
thereafter, the rates declined.  This decline may have been due to excess deaths in the elderly 
diabetic population, in which the disease had already progressed to the stage of blindness (100).  
Rates for females were higher than for males (99).  Higher rates of legal blindness were found in 
white females and in nonwhite males and females, compared with white males (99).  Since the 
MRA registry data were based on self-reports and required registration at specific agencies in 16 
states, the rates are thought to underestimate that actual prevalence of legal blindness by as much 
as 50%.  Untreated proliferative retinopathy progresses to blindness within five years in roughly 
20-50% of cases.  Screening and proper care could prevent up to 90% of the cases of blindness 
attributed to diabetes.  However, only approximately 60% of people with diabetes receive annual 
dilated eye exams (101). 
Neuropathy 
 The mechanism of diabetic neuropathy is unclear; however, long-term hyperglycemia 
and tissue ischemia are considered the main pathogenic factors.  Diabetic neuropathy of different 
degrees is thought to be present in as many as 60% of patients with diabetes and can be classified 
into prevalently motor, sensory, or autonomic forms (90).  Motor neuropathy mostly induces 
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limb muscle atrophy and structural alterations in the feet.  Sensory neuropathy alters tactile, 
thermal and pain-related functions.  Autonomic neuropathy mainly affects the microcirculation 
and the heart (90).  Sensory neuropathy plays a crucial role in the pathogenesis of diabetic foot: 
60% of cases are in fact due to neuropathy and other cases to coexisting neuropathy and macro-
and/or microangiopathy (90).  The most common type of neuropathy is distal symmetric 
sensorimotor type, often referred to as distal symmetric polyneuropathy (DSP).  DSP is 
characterized by pain, weakness, altered sensation, affecting the bilateral “stocking glove” 
pattern on the arms and legs (101).  Because of the altered sensation, damage may not be 
detected until a secondary condition occurs, such as an infection.  It has been shown that DSP is 
present in 12% of individuals at the time of diabetes diagnosis and in 25% after 25 years (101).   
Like other complications, the prevalence of neuropathy increases with age, poor glucose control 
and duration of diabetes (103).  
Nephropathy 
 Diabetic nephropathy refers to the presence of elevated urinary protein excretion in a 
person with diabetes in the absence of other renal disease.  Diabetic nephropathy is a frequent 
complication of type 1 and type 2 diabetes and involves about 30% of all diabetic patients.  The 
severity of renal damage is a strong predictor of end-stage renal failure and is the second major 
cause of death during diabetes (90).  Without specific intervention, 20-40% of diabetic patients 
with microalbuminuria will progress to overt nephropathy and, within 20 years, 20% of these 
will develop end-stage renal failure (90). 
 Diabetes is the leading cause of kidney failure, accounting for 44% of new cases in 2005 
(89).  In the United States, the incidence of diabetic nephropathy has increased by 150% in the 
past ten years, a trend that can also be seen in Europe (104).  In 2005, 46,739 people with 
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diabetes began treatment for end-stage kidney disease in the United States and Puerto Rico (89).  
Diabetic nephropathy is typically more common in older and non-white populations and the risk 
of nephropathy is partly determined by genetics (101).  Researchers have shown a familial 
clustering of nephropathy and high rates of cardiovascular events and hypertension among 
relatives of those with T2D and nephropathy (102).  Additional risk factors of nephropathy 
include increased cholesterol levels, smoking, hypertension, elevated HbA1c levels, older age, 
insulin resistance, male sex, non-white race, and high dietary intake (105).  Treatment of some of 
these conditions may reduce diabetes-related kidney disease by up to 50% (105). 
2.4.2.1 Macrovascular Complications 
 Macrovascular complications associated with diabetes consist of coronary heart disease, 
cerebrovascular disease, lower extremity arterial disease, and peripheral vascular disease.  These 
complications are more prevalent in those with diabetes compared with those who do not suffer 
from the disease.  Coronary heart disease is two to four times more common in those with 
diabetes (106).  In 2004, heart disease was noted on 68% of diabetes-related death certificates 
among those aged 65 years or older (89).  Compared to those without diabetes, heart disease in 
those with diabetes appears earlier in life, affects women almost as often as men, and is more 
fatal.  Adults with diabetes are more likely than those without diabetes to have hypertension, and 
dyslipidemia, but some of the increased risk of heart disease associated with diabetes appears to 
be independent of these factors.  Insulin and glucose may act as cardiovascular disease risk 
factors, but data is inconsistent. 
Diabetes is an important component of the complex of ‘common’ cardiovascular risk 
factors, and is responsible for acceleration and worsening of atherothrombosis.  Coronary Heart 
Disease (CHD) causes about 65% of the total mortality in patients with diabetes (90).  In terms 
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of major cardiovascular events, coronary heart disease and ischemic stroke are the main causes 
of morbidity and mortality in patients with diabetes.  Data on cardiovascular disease among the 
diabetes population are limited.  However, in 2000, 37.2% of persons with diabetes age 35 years 
and older reported receiving a diagnosis of a cardiovascular disease (40).  Prevalence of ischemic 
heart disease among persons with diabetes was about 14 times the rate among those without 
diabetes in person 18 to 44 years of age (2.7% vs. 0.2%), 3 times as high in persons 45 to 64 
years of age (14.3% vs. 4.7%), and almost twice as high in those 65 years of age or older (20% 
vs. 12%) (40).  Other studies have shown that the absolute rates of cardiovascular disease in 
persons with diabetes are higher in men than in women (as in the general population), but the 
relative risk (comparing those with and without diabetes) is higher in women that in men 
(relative risk, 2 to 4 for women and 1.5 to 2.5 for men) (40). 
 About 80% of all diabetes patients die from cardiovascular events.  Seventy-five percent 
of such deaths are due to coronary heart disease (CHD), and the remaining 25% to 
cerebrovascular, peripheral or other macrovascular disease (90).  Age is a major additional factor 
for cardiovascular risk, and other main risk factors for cardiovascular morbidity and mortality are 
high total and low-density lipoprotein (LDL)-cholesterol and triglyceride levels, low high-
density lipoprotein (HDL)-cholesterol, in addition to fasting plasma glucose, proteinuria and the 
presence of nephropathy and/or retinopathy (90). 
 The risk of developing an acute MI, as well as other acute coronary syndromes is 
increased 2 –to 4-fold (90), and in the Euro Heart Survey (91), which involved 5000 coronary 
patients, 30% had confirmed diabetes and silent myocardial ischemia was found in as many as 
33% of patients with diabetes (91).  In the OASIS (Organization to Assess Strategies for 
Ischemic Syndromes) register (92), diabetes increased the death rate of patients with unstable 
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angina pectoris by 75%, and it is also noteworthy that coronary syndromes and acute MI are 
more frequent in women with diabetes than men, and that the relative risk of fatal disease is 
much higher in women (90). 
 Previously unrecognized poor glucose tolerance recently emerged as a risk factor for 
severe outcome or death in patients with coronary syndromes.  In the GAMI study (Glucose 
Abnormalities in Patients with Myocardial Infarction), 67% of all acute MI patients considered 
had an altered glucose tolerance during and/or after the acute episode (90).  A large Finland-
based population study on long-term cardiovascular mortality in diabetic or non-diabetic patients 
with or without a previous acute MI suggested that having diabetes could be considered an 
equivalent of a previous acute MI in a non-diabetic individual (93), but this concept has recently 
been questioned.  Recently, even a higher than optimum fasting plasma glucose concentration 
without diabetes, has been shown to be a leading factor for cardiovascular mortality (93). 
 Peripheral vascular disease or LEAD (lower extremity arterial disease) includes such 
conditions as foot ulceration, gangrene, and intermittent claudication, which may lead to lower-
level amputations (106).  Peripheral arterial disease frequently occurs, and is more likely to be 
conducive to critical limb ischemia and amputation than in the absence of diabetes.  An analysis 
of the 1999 to 2000 NHANES found that an estimated 8.1% of the diabetic population age 40 
years or older have LEAD (40).  Individuals with diabetes accounted for 51% of all lower level 
amputations of the toe or foot (106).  An estimated 15% of persons with diabetes will have a 
diabetic foot ulcer during their lifetime; of these, 6% to 43% will ultimately undergo a lower-
extremity amputation (40).  Most of the same risk factors for CHD and stroke are also the risk 
factors for LEAD.  Sex, age, hyperlipidemia, hypertension, and smoking have all been shown to 
be significant risk factors for the development of LEAD (106).  
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 Although there is a large amount of morbidity associated with diabetes, much of it can be 
prevented (6-8).  To prevent diabetes complications and to ultimately decrease diabetes-related 
morbidity and mortality, a team approach to diabetes care should be adopted.  Patient self-care 
behaviors, provider recommendations and adherence to national standards, community support, 
and the use of clinical information systems should work in tandem to accomplish this goal 
(76,77). 
 It is essential for those with diabetes to take the central role in their diabetes self-
management plan by having regular check-ups, being aware of unusual symptoms like vision 
problems or numbness in their feet, self-monitoring their blood glucose regularly, controlling 
their weight, participating in regular physical activity, and seeing a diabetes specialist if 
necessary (78-81).  With the patient taking this role, the provider becomes more of a facilitator, 
making medication changes based on lab values, and ensuring that the standards of care for 
persons with diabetes are met (77,79).  However, if a structure within the community is not in 
place in which the patient can be informed and activated and the provider cannot be prepared and 
proactive, diabetes-related morbidity and morality will continue to rise (1,37,86). 
 
2.4.2 Acute Complications 
 Acute complications of diabetes include DKA, LA, HNS, and hyperglycemia.  While 
HNS and DKA are associated with insulin deficiency, hypoglycemia results from the treatment 
of diabetes with either oral agents or insulin.  LA is associated with other risk factors of diabetes, 
such as cardiovascular disease (40).  Acute complications of diabetes have many precipitating 
risk factors, which include acute illness and poor compliance.  Treatment of these complications 
often includes hospitalization or ambulatory care.  This causes healthcare costs to increase and 
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therefore prevention is an important component in reducing healthcare costs related to diabetes 
(40). 
2.4.2.1 Hyperosmolar Nonketotic State 
 HNS is clinically defined by the presence of relative insulin deficiency and 
hyperglycemia, usually >1,000 mg/dL with associated elevated serum osmolality, dehydration, 
stupor and progression to coma if untreated.  These patients have sufficient circulating insulin to 
prevent ketosis and lipolysis (107).  Hospital discharge data shows that HNS rarely occurs, and 
usually affects those with type 2 diabetes, who are Caucasian, female, and older than 65 years of 
age.  Occurrence of HNS is caused by dehydration, medications such as steroids, or thiazides, 
acute illness, cerebral vascular disease, and older age (107). 
 Prevention of HNS in those with diabetes can be accomplished through education, self-
care, self-monitoring of blood glucose, avoidance of dehydration, and awareness and avoidance, 
if possible, of medications that may trigger the disorder.  Patients with this complication will 
respond well to hydration and small doses of insulin.  These treatments will prevent the 
occurrence of mental disorientation (107). 
2.4.2.2 Diabetic Ketoacidosis 
 Diabetic ketoacidosis is one of the major acute diabetic complications.  DKA is defined 
by absolute insulin deficiency with hyperglycemia, increased lipolysis, ketone production, 
acidosis, and hyperketonemia (107).  DKA usually occurs in those with type 1 diabetes and 
rarely occurs in those with type 2.  When DKA occurs in those with T2D, it may represent a 
transition to insulin deficiency.  The number of hospitalizations in the United States for which 
diabetic ketoacidosis was listed as the first diagnosis increased from 61,200 in 1980 to 99,913 
hospitalizations in 2001 (40).  Under-treatment of DKA can lead to coma and eventually death.  
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Some studies have estimated that DKA-related mortality ranges from 5-45% with the highest 
rates occurring in those aged 75 years and older (109).  Deaths due to DKA are rare and have 
declines between 1980 and 2000 by 28% (32 to 23 per 100,000 diabetic population) (40).  
Incidence rates have been estimated between 4.6-13.4 per 1,000 diabetic-person-years (107;40) 
with rates being the highest in the younger age groups (<30 years old).  Infection is the most 
precipitating factor of DKA, but other risk factors include acute illnesses, lack of diabetes 
education and training, noncompliance, poor self-care, and inadequate glucose monitoring (107). 
 Prevention remains the most important aspect of managing DKA in individuals with 
known diabetes.  Prevention can be accomplished through appropriate education, improved self-
care and compliance, and self-monitoring blood glucose.  Some studies have demonstrated a 40-
50% reduction in DKA hospitalizations accompanying patient education, follow-up care, and 
increased access to medical advice (107;108).  However, for more severe cases of DKA, 
treatment includes hydration, insulin therapy, and electrolyte repletion (107). 
2.4.2.3 Lactic Acidosis 
 LA is characterized by elevated lactic acid (lactic academia, ≥2.0 mmol/L) with acidosis 
(pH ≤7.3) and without ketoacidosis.  Approximately half of the reported cases of LA have 
occurred in patients with diabetes (107).  Currently LA is rarely seen in patients with diabetes, 
particularly since the withdrawal of Phenformin from the market.  When LA occurred, it was 
predominately in individuals older than 45 years old, in women, in Caucasians, and in patients 
for whom diabetes was not listed on the hospital discharge summary (107).  LA is usually 
precipitated by hypoxia and some medications such as Phenformin.  Prevention of LA is very 
difficult.  Often the predisposing conditions, such as acute myocardial infarction with hypoxia, or 
septic shock, are acute events and may not be amenable to immediate prevention other than 
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through long-term control and modification of risk factors.  Usually, LA does not occur in 
conjunction with poorly regulated diabetes unless there is some additional event that produces 
hypoxia (107).  Treatment of LA is similar to that of DKA in terms of hydration, restoration of 
electrolyte balance, correction of acidosis, and correction of hyperglycemia.  Patients with LA 
are usually hospitalized.  Hospitalization may be prolonged because of the underlying condition 
that my have led to the LA.  This extended hospitalization has a considerable economic impact 
as well.  The major morbidity associated with LA is neurological impairment and possible 
cerebral edema (107).  The mortality rate from LA is high.  The higher the lactic acid level in 
association with the acidosis, the higher the mortality rate.  LA accounts for a very small portion 
of the total mortality in patients with diabetes (107).  
2.4.2.4 Hypoglycemia 
 Hypoglycemia is a very common acute complication in those with diabetes, particularly 
occurring in patients who are treated with insulin, but can also occur in those people with 
diabetes who are on oral medications (107).  Hypoglycemia may range from very mild lowering 
of glycemia (60-70 mg/dl) with minimal or no symptoms, to severe hypoglycemia with very low 
levels of glucose (<40 mg/dl) and neurological impairment.  Patients with more severe 
hypoglycemia are more likely to need medical attention and thus are more readily ascertained for 
demographic data analysis.  The Diabetes Control and Complications Trial (DCCT) accounted 
62 hypoglycemic events per 100 patient-years from 1983-1989 in which assistance was required 
in the provision of treatment in the intensive therapy group, as compared with 19 such events per 
100 patient-years in the conventional treatment group (110).  However, it must be noted that the 
intensive-therapy group was rigorously treated with insulin.  Since patients are less likely to this 
intensively treated, the incidence rate is likely to be lower in the general population. 
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 Hypoglycemia is one of the largest contributors to hospitalizations in patients with 
diabetes.  Nearly 64% of hospital records of patients with diabetes, list hypoglycemia in the 
discharge summary (111).  Most hospital discharges for hypoglycemia in patients with diabetes 
occurred in patients older than 65 years old and hypoglycemia represents a greater proportion of 
hospitalizations in females and African-American patients (107). 
 To reduce the frequency of hypoglycemic events, consistent self-monitoring of blood 
glucose is necessary.  It is also important for the patient with diabetes to avoid skipping meals 
after taking insulin.  Prevention of hypoglycemia depends on education regarding diabetes 
management and self-care, self-monitoring of glucose levels, and factors that may precipitate 
hypoglycemia (107). 
 The major morbidity associated with hypoglycemia is temporary neurological deficit and 
coma, seizures with central nervous system injury, and permanent neurological impairment if 
treatment is delayed (107).  Death related to hypoglycemia in diabetes rarely occurs.  There were 
no deaths recorded in the DCCT (111).  The majority of patients with hypoglycemia survive the 
event.  
 
3.0 GEOGRAPHIC INFORMATION SYSTEMS 
 
When Geographical Information Systems (GIS) were first developed in the early 1960’s, they 
were no more than a set of innovative computer-based applications for map data processing that 
were used in a small number of government agencies and universities only.  Today, GIS has 
become an important field of academic study, one of the fastest growing areas of the computer 
industry, and, most important, an essential component of the information technology (IT) 
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infrastructure of modern society (112).  Spatial analyses using GIS have become widespread and 
well accepted.  A GIS is an information system where the database consists of observations on 
spatially distributed features, activities or events, which are definable in space as points, lines, or 
areas.  A GIS manipulates data about these points, lines, and areas to retrieve data for ad hoc 
analyses.   
 
3.1 Definitions of GIS  
Unfortunately, attempting to define GIS is not a very simple task.  Some people see GIS as a 
general branch of Information Technology; others see it more specifically as a computer-assisted 
mapping and cartographic applications, a set of spatial-analytical tools, a type of database 
systems, or a field of academic study.  The United States Geographical Survey defines GIS as “a 
system of hardware, software, and procedures designed to support the capture, management, 
manipulation, analysis, modeling, and display of spatially referenced data for solving complex 
planning and management problems” (113).  Rhind defines GIS as “a computer system capable 
of assembling, storing, manipulating, and displaying geographically referenced information, i.e., 
data identified according to their locations” (114).  Based on these two definitions, GIS can be 
simply defined as computer-based systems specially designed and implemented for two subtle 
but interrelated purposes: managing geospatial data and using these data to solve spatial 
problems. 
GIS is a special class of information systems.  The word “geographic” in GIS carries two 
meanings: “Earth” and “geographic space” (112).  By “Earth,” it implies that all data in the 
system is pertinent to Earth’s features and resources, including human activities based on or 
associated with these features and resources.  By “geographic space,” it means that the 
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commonality of the data in the systems and the problems that the systems aim to solve is spatial 
(or geographic) in nature, i.e., location, distribution, pattern, and relationship within a specific 
geographical reference framework.  This focus on geospatial data and their applications for 
spatial problem solving makes GIS unique among information systems.   
Depending on the nature of the data that they process, information systems in general can 
be classified as spatial information systems and non-spatial information systems.  Non-spatial 
information systems are designed for processing data that are not referenced to any position in 
geographic space.  Systems for accounting, banking, human resources management, and goods 
inventory are typical examples of non-spatial information systems (112). 
Spatial information systems are those designed for processing data pertaining to real-
world features or phenomena that are described in terms of locations.  However, only those 
spatial information systems that are used for processing and analyzing geospatial data, of 
geospatially referenced data, can be labeled as GIS (112).  Geospatial data are a special form of 
spatial data that is characterized by two crucial properties:  1) the reference to geographic space, 
which means that the data are registered to an accepted geographical coordinate system of 
Earth’s surface, so that data from different courses can be spatially cross-referenced and 
integrated and 2) the representation at geographic scale, which means that the data are normally, 
recorded at relatively small scales and, as a result, must be generalized and symbolized (112).  
GIS not only represents the skills and procedures for collecting, managing, and using geospatial 
information but also entails a comprehensive body of scientific knowledge from which these 
skills and procedures are developed. 
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3.1.2 The Evolution of GIS 
Both the technology and functions of GIS have undergone considerable changes since its 
inception in the early 1960’s.  GIS as we understand it today, is very different from its 
predecessors.  The Canada Geographic Information System (CGIS) has been recognized as the 
first GIS ever produced in the 1960s and 1970s (115).  The purpose of CGIS was to address the 
needs of land and resource information management of the federal government of Canada.  In 
1973, the USGS started the development of the Geographical Information Retrieval and Analysis 
(GIRAS) to handle and analyze land-use and land-cover data.  The 1960s and 1970s were 
important formative years of GIS.  During this time, hundreds of software packages for handling 
and analyzing geographic information were produced (115).  These early systems were 
developed and used mainly by government agencies and universities for very specific data 
management and research objectives. 
 In 1982, Environmental Systems Research Institute, Inc. (ESRI) released ArcInfo, 
designed to run on minicomputers.  This particular GIS software package was on the first vector-
based GIS to use the geo-relational data model that employed a hybrid approach to geographic 
data processing (116).  Graphical data are stored using the topological data structure, while 
attribute data are stored using the relational or tabular data structure.  This software is the most 
widely used package today and is very user friendly for academics and businesses alike.   
The development of GIS was greatly accelerated by the growth of computer technology 
in the 1990s.  With advances in operating systems, computer graphics, database management 
systems, and computer-human interaction, GIS became multiplatform applications that ran on 
different computer platforms as stand-alone applications and as time-sharing systems (112).  At 
the same time, as quantitative and analytical techniques were developed in the social and 
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physical sciences, and as more data were collected about different aspects of human activities 
and the environment, the need to find suitable tools to take advantage of the new techniques and 
data became more pressing than ever before (112).   The increasing access to computers and the 
urgent need for effective geospatial data management together pushed the use of GIS to a new 
height.  The applications of GIS were no longer limited to the traditional areas of land and 
resource management but quickly extended to new areas that included facility management, 
vehicle navigation, market research, and business decision support (112). 
Today, GIS has popularized the use of geospatial information by empowering individuals 
and organizations to use such information in areas that earlier generations of GIS users could 
never had thought of.  It is now common for people to use GIS to check the weather and traffic 
conditions before they leave for work, locate the nearest ATM, and find information about the 
city they are about to travel to.  At the same time, GIS has become and indispensable tool for 
government officials to manage land and natural resources, monitor the environment, enforce 
laws, and deliver social services (112).   
 
3.1.3 Components of GIS 
3.1.3.1 The Data Component of GIS 
A GIS, as an information system, is made up of three components, data, technology, and 
application. Geographical data record the locations and characteristics of natural features or 
human activities that occur on or near Earth’s surface.  Geospatial data are represented by three 
basic forms that include vector, raster, and surface.  Vector data represent the real world by 
means of discrete points, lines, and polygons (112).  This data is better for depicting natural and 
artificial features that can be individually identified.  Raster data represent the real world by 
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means of a grid of cells with attribute values.  This data is not good for representing individually 
identifiable features but is ideal for a variety of spatial analysis functions (112).  Surface data 
depict the real world by means of a set of selected points or continuous lines of equal values.  
They can be analyzed and displayed in two or three dimensions and are most suited for natural 
phenomena with changing values across an extensive area (112). 
3.1.3.2 The Technology Component of GIS 
The technology component of GIS can be explained in terms of hardware and software.  
The hardware of GIS is made up of a configuration of core and peripheral equipment that is used 
for the acquisition, storage, analysis, and display of geographic information.  The central 
processing unit (CPU) of the computer is the center of the GIS hardware and performs all the 
data processing and analysis tasks.  On the software side, GIS was conventionally developed 
using a hybrid approach that handled graphical and descriptive components of geospatial data 
separately.  It is now possible to build application software modules with programming 
languages such as Visual C++, and to integrate them with the GIS functions originally supplied 
by the software vendor (112).  GIS applications can obviously benefit from this new approach to 
software development. 
3.1.3.3 The Application Component of GIS 
The application component of GIS can be explained from three perspectives: areas of 
applications, nature of applications, and approaches of implementation.  Academic, business, 
government, industry, and military sectors are the major areas of GIS application today.  As the 
areas of applications have become more diversified, the nature of GIS applications has also 
undergone significant changes over the years (112).  The most important changes occurred when 
GIS started to be implemented within computer networks and with the advent of the Internet.  
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With these additions, GIS became a virtual global system that offers all kinds of geospatial 
information services via a world-wide system of computer networks (112).   
 
3.2 Spatial Analysis 
It is necessary to distinguish between spatial analysis and spatial statistical analysis.  Spatial 
analysis is the study of a spatial pattern using the basic GIS operations such as spatial query and 
join, buffering, and overlaying.  Spatial statistical analysis is the application of statistical theory 
and techniques to the description and modeling of spatially referenced data (128). 
In his article, Mayer (124) discusses two ways that spatial analysis can increase our 
understanding of disease pathogenesis.  First, geographical studies may suggest possible causal 
factors.  Associations between disease and place imply that the population living there possesses 
inherent traits that make it more susceptible to disease or that it may experience some increased 
level of exposure to a risk factor such as air pollution.  Second, spatial analysis can help identify 
how populations adapt and relate to their environment.  Such adaptations may be beneficial and 
protective or maladaptive and detrimental to health (124).  Adaptation to air pollution risk 
provides a good example.  In areas that experience high pollution events, individuals may reduce 
their exposure on high pollution days by staying indoors or avoiding strenuous exercise, or they 
may underestimate the risk and proceed with their daily activities as though no excess risk is 
present (124).  In the latter case, the maladaptive behavior may increase their risk of illness or 
death.   
 Data for spatial analysis must contain two types of information (127).  The first class 
includes attributes of spatial features measured in interval or ratio variables such as population 
size, mortality rates, population estimates, or ordinal and nominal variables such as disease 
 53 
severity, name, or soil type.  The second type involves the location of a spatial feature described 
by position on a map measured in one of many geographic coordinate or referencing systems 
(125).  In bringing these two classes of information together, spatial analysis seeks to assess non-
independence or association in values of attributes at the same or nearby locations or locations 
likely to experience spatial interaction (e.g., airports with connections to other distant airports).   
 Because much of the available health and covariate data is collected for purposes other 
than spatial analysis, data integration and quality control are important precursors to the 
application of spatial-analytic techniques.  A recent user-needs assessment survey of 30 health 
professionals in Canada revealed data availability, consistency, and cost as the main challenge to 
the expanded use of GIS and allied methods for health surveillance.  Although over 80% of the 
respondents said they planned to expand the use of spatial analysis in health research and policy, 
many expressed concern about the data needed to support such analyses (126).  In the United 
States and some European countries, the myriad of private medical care suppliers will probably 
make the task of developing national-level data capable of supporting spatial analysis even more 
difficult.  Institutional structures for data collection, management, and dissemination lag behind 
the statistical techniques and technology available for spatial analysis (127). 
 Although all studies do not follow the same steps, they tend to take the following steps: 
(1) getting data into GIS; (2) transforming data; (3) spatial analysis; (4) spatial statistical 
analysis; and (5) visualization or mapping.  The first two steps constitute data preprocessing 
stage; the next two constitute data processing stage.  The last step is usually the ultimate goal of 
using GIS to visualize the findings. 
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3.2.1 Data Preprocessing Stage 
Although there are several options for getting data into GIS, perhaps geocoding, a tool for 
translating location information into corresponding latitudes and longitudes in health databases, 
is increasingly more popular (128).  Automated geocoding coupled with automatic address 
standardization and cleaning functions, has helped promote GIS-based analysis of data.  
Geocoding levels vary depending on the reference data used.  The most accurate geocoding 
comes from the use of tax parcel-level database.  The Topologically Integrated Geographic 
Encoding and Referencing (TIGER) system that provides a national computer-readable map 
database for geocoding operations enables street-level geocoding.  Geocoding with census tracts 
or zip codes (or zip + 4 codes) can be available for lesser accuracy (128). 
 Transformation processes constitute data preprocessing stage.  Correlated or redundant 
information is also removed in this stage.  Also the same scale of observation is applied to all 
maps before looking for a spatial pattern.  Determining the degree of aggregation and 
simplification is made in this stage as well.  Spatial data analysis often requires transformation of 
data formats.  There are basically two types of geographic data: vector data, based on 
coordinates, comes as points, lines, or polygons, while raster data, based on grids or pictures, is 
more commonly associated with spatial analysis (128).  Points represent a single location and 
generally have associated data for the specific even or location.  Polygons represent areas, and 
most often have aggregated data associated with them.  Raster data does not have direction or 
inside/outside features, but does have a cell size and extent with data attached to each cell (128).  
While the data is numeric, it can represent measurements or categories.  GIS tools are available 
for converting one format to another before spatial analysis is taken.  Data may also be in 
different units or at different scales.  One might have counts per county, or city, zip code, or 
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census tract.  Location information in health data (e.g., death certificates, hospital discharge, and 
health care provider data) is most often available at the level of zip code.  Census data come in 
different spatial units.  A GIS allows users to combine all this information in a meaningful way, 
using overlay, buffering, geoprocessing, zonal averages, and proportional allocation (128). 
 
3.2.2 Data Processing Stage 
In general, things that are closer together tend to be more alike than things that are farther apart.  
This “local” spatial structure is a fundamental geographic principle for spatial analysis.  GIS 
users define local neighborhoods using their preferred spatial proximity measures.  Once the 
spatial structure is defined by the chosen spatial proximity measure, a local spatial analysis can 
be done.  That is, an observed value for each region can be replaced with a “local” value 
calculated on the basis of values for the neighboring regions with a pre-specified contributing 
weight.  For example, O’Neill (129) created distance between the pair of residential zip code and 
nearest hospital emergency department using transportation-specialized GIS software.  Instead of 
the Euclidean distance, the distance was defined as the shortest path along the road network (in 
minutes) between centroids.  Then this distance measure was exported to SAS to do a logistic 
regression analysis to estimate the probability of in-hospital mortality and emergency admission 
as a function of hospital distance. 
 
3.3 Spatial Statistical Analysis 
Smoothing and Cluster Detection Statistics 
 Statistical methods such as smoothing and approaches to identify clusters provide 
objective tools for measuring data quality and for accounting for data uncertainties in mapping 
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and assessment of spatial patterns.  In public health spatial statistical analysis, various smoothing 
procedures are used to eliminate variance instability in disease rates or proportions.  Observed 
rates are often extreme when the population at risk is too small (e.g., rural areas) or the disease 
being studied is rare.  Its ultimate goal is to control this high variance, find areas with an excess 
rate, and interpret its categories (128).  The most popular methods for smoothing are kernel 
density smoothing, Empirical Bayes smoothing, and locally weighted regression. 
 If disease data have been geographically coded to their latitude and longitude 
coordinates, or to quite small areas such as zip code, census tracts, census block areas, or to other 
small postal code areas, they can be spatially aggregated in very flexible ways according to the 
needs of the user.  One popular technique for creating a continuous map from such “point” data 
is kernel density smoothing (128).  A point data is mapped by creating a grid using an inverse 
distance weighting function.  GIS software allows users to select the distance or the number of 
points to be smoothed and create a grid of user-selected fineness (128).  Each point is averaged 
with the weighted value of every other point within a specified distance of that point based on a 
specified weight scheme such as the inverse square of the distance (128).  For example, Talbot et 
al. (129) used kernel density smoothing techniques while working with the numbers of low birth 
weights (LBW) as well as the total number of births aggregated for each zip code in New York 
State.  All births in a particular zip code were then assigned to the geographical coordinates of 
the population-weighted zip code centroid.  Then this zip code was overlaid with a layer with 1-
km spacing of the grid points.  The nearest zip code centroid to the grid point is located.  If the 
number of births is less than the minimum number, then the next nearest zip code centroid is 
located and the number of births are added to those from the previous zip codes.  This process is 
continued until the total number of births captured is greater than or equal to the minimum 
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number of births.  At this point, the total number of births and LBWs captured in the selected zip 
codes are assigned to the grid point. 
 Many disease mapping studies use empirical Bayes smoothing.  In this technique, 
observed rates are calculated as disease cases/population at risk.  The rates are assumed to follow 
a binomial, or Poisson, random variable (128).  Empirical Bayes methods shrink observed rates 
differentially toward the mean of the distribution of rates in proportion to their expected 
variability based on the number of observations in the small areas.  For example, when the 
observed rates are based on small populations the Bayes estimator is closer to the prior mean 
(much local smoothing).  However, when the population is large, the Bayes estimator approaches 
the observed rate (little local smoothing) (128). 
 Unlike the first two methods, a locally weighted regression (LOESS) is a nonparametric 
smoothing method.  In locally weighted regression, points are weighted by proximity to the 
current value in question using a kernel.  A regression is then computed using the weighted 
points.  It performs a regression around a point of interest using only data that are “local” to that 
point (128).  The estimator variance is minimized when the kernel includes as many points as 
can be accommodated by the model.  Too large a kernel includes points that degrade the fit; too 
small a kernel neglects points that increase confidence in the fit (128).  There are a number of 
ways one can set the smoothing parameter.  As the parameter decreases, the regression becomes 
more global.  The variance-based method usually gives the best performance (128).   
 There are some issues regarding the use of spatial statistical analyses in the health field.  
First, commercial GIS packages such as ArcGIS or MapInfo, do not allow the users to do spatial 
analyses without leaving their systems.  Studies had to leave GIS systems to use other programs 
to make meaningful spatial statistical analyses (127-129).  Secondly, health data come in 
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different units from different sources.  Health researchers who deal with various data sources 
often have to aggregate data.  The third issue is the intrinsic nature of data that are often 
available to health researchers: health data are mostly count data aggregated over a geographical 
region.  Some smoothing methods used were originally designed for continuous spatial data such 
as elevation readings, agriculture crop, or mining deposit.  So applying smoothing methods 
originally developed for raster (image) data to the polygons for which health data are commonly 
available can be very arbitrary (128).  HIPAA compliance issues can also prevent researchers 
from having detailed health data.  In this case, the technique for disaggregating rather than 
aggregating data may be demanded by health researchers.  For example, when screening data is 
available for zip codes and cancer incidence data is available for census tracts, area interpolation 
is needed to estimate the screening rates for census tracts (128).  The efforts to expand the use of 
GIS to other than traditional GIS-favorite fields have not been successful at least in terms of use 
of spatial statistical analyses in GIS.  More statistical tools suitable for health data should be 
integrated into GIS. 
The analytic capabilities of geographic information systems have developed rapidly in 
recent years.  Public health is now presented with the opportunity to examine key relationships 
between the health characteristics of populations and physical, environmental and human 
characteristics.  It is evident that there is now a need for the development of a more structured, 
organized system of disease surveillance in which geo-referenced data systems are available.  
GIS will be valuable in identifying certain areas where there are higher disease prevalence and 
risk factors.  This could later lead to the development of focused programs that can reduce risk 
factors and possible disease rates.        
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4.0 GEOGRAPHIC INFORMATION SYSTEMS AND PUBLIC HEALTH 
 
Today, GIS are increasingly being used to investigate diverse public health and medical 
problems.  For example, environmental health researchers are using GIS to conduct risk analyses 
of the spatial diffusion of air and water pollutants.  Epidemiologists are using GIS to investigate 
possible etiological risk factors of various acute and chronic diseases.  Community health 
scientists are using these systems to study the disparities in disease and mortality rates among 
various ethnic and racial groups.  Emergency planning and management researchers are studying 
their anticipated responses to possible natural disasters and terrorist attacks at various geographic 
locations (123). 
Advances in computer technology, the encouragement of its use by the federal 
government, and the wide availability of academic and commercial courses on geographic 
information systems are responsible for the growing use of GIS in public health and medicine.  
The greatest potential of GIS lies in their abilities to clearly and convincingly show the results of 
complex analyses through maps.  Unlike tables and spreadsheets with seemingly endless 
numbers, maps produced by GIS have the ability to transform data into information that can be 
quickly and easily communicated.  These systems also extend the range of problems that can be 
solved using technology by allowing users to more efficiently complete complex problems (123). 
Certain environmental aspects play an important role in the prevention and treatment of 
chronic diseases.  Studies have shown that access to health care, diet, physical activity, housing, 
income, and environmental exposures contribute to chronic disease, which are all part an 
individual’s environment or community (130, 131, 132).  While there are many ways to define 
community, geographic location is one important way to understand the context in which people 
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live.  What has been lacking, until recently, is a valid method for defining and analyzing 
geographic areas which make up a community where these risk factors and chronic diseases may 
cluster. Geographical modeling may allow for better identification of the geographic area of 
communities which can provide information regarding risks for chronic disease.   There is great 
variability in the health and well being of residents depending upon where they live.  Health-
promotion interventions may need to be designed to target the geographic areas that represent 
clusters of health problems and unhealthy lifestyles. 
Associations between disease and place imply that the population living there possesses 
inherent traits that make it more susceptible to disease or that it may experience some increased 
level of exposure to a risk factor.  Second, spatial analysis can help identify how populations 
adapt and relate to their environment.   
Chronic diseases are preventable and can be controlled with intervention.  However, 
some areas may not have resources that would enable its residents to lead a healthy lifestyle.  
Geospatial mapping techniques can be used to show areas with higher prevalence of chronic 
diseases and where funds need to be targeted.  These maps can provide important clues about the 
geographic variability of risk factors, disease states and clinical services utilization.   
 
4.1 The Built Environment  
 The built environment refers to human-modified places such as homes, schools, workplaces, 
parks, industrial areas, farms, roads, and highways (154).  The built environment encompasses 
all buildings, spaces and products that are created or modified by people.  It extends overhead in 
the form of elective transmission lines, underground in the form of waste disposal sites and 
subway trains, and across the county in the form of highways (154).  It impacts indoor and 
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outdoor physical environments (e.g., climatic conditions and indoor/outdoor air quality) as well 
as social environments (e.g., civic participation, community capacity and investment) and 
subsequently our health and quality of life (154).  The built environment has an influence on 
health since 80% of North Americans live in cities and towns and spend 90% of their time 
indoors (155).  Much discussion of the built environment has focused on the challenges of 
providing adequate transportation, urban sprawl, air pollution and the diminishing natural 
environment.   
New evidence, however, increasingly recognizes that the places we live and work clearly 
affect our health (155,156).  Access to green open space can increase physical activity and 
mental wellbeing, because most sustained exercise is incorporated into daily routine activities 
(163).  Recent research explores the effect the built environment on physical activity (157), 
asthma (158), obesity (159), cardiovascular disease, lung cancer mortality (160), and mental 
health (161,162).  The growing health burdens and rising economic costs associated with higher 
chronic disease incidence require such research efforts.  These complex diseases are attributable 
to an interaction of genetic and environmental influences, and many of the latter can be directly 
connected to the built environment.  Research investigating the association between public health 
and quality-of-life benefits of sustainable communities is necessary. 
 
4.1.1 Housing, Transportation, and Sedentary Lifestyles 
The association between substandard housing and health has long been recognized (164,165).  
However, only recently has a growing body of evidence emerged suggesting that physical and 
mental health problems – anxiety, depression, attention deficit disorder, substance abuse, 
aggressive behavior, asthma, heart disease, and obesity – related to the built environment, 
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particularly to poor urban planning and inadequate housing (158,166).  Housing disrepair 
exposes individuals to lead, pests, air pollution, contaminants, and greater social risk (158). 
 Over decades, unimproved sidewalks decay as utility crews dig up concrete, tree roots 
push up paved areas, and weather erodes surfaces.  Many cities lack the resources to repave or 
replace sidewalks as frequently as needed.  As a result, neighborhoods frequently have broken or 
impassable sidewalks.  While sharply contrasting with the problem of no sidewalks in may rural 
communities, broken sidewalks in urban areas have a similar result, less leisure walking (172).  
Lack of safe sidewalks in growing urban areas has resulted in a reduction in the number of 
children walking or biking to schools, and adults walking to work or for recreation.  Today, only 
10% of children walk or bicycle to school – a 40% reduction over the last 20 years (154).  This 
has contributed to an increasingly sedentary lifestyle for children, possibly factoring into the 
growing rates of childhood obesity (154).    
Mounting evidence suggests that there are social, health, and economic consequences to 
isolated and sedentary lifestyles (154).  Unfortunately, the physical and social construct of the 
urban environment promotes isolation (154).  Certain features of the built environment such as 
cul de sacs, lack of parks, and high speed traffic may function to discourage activity and 
ultimately increase obesity risk (169).  Studies find that people who live close of parks are more 
likely to use them and to be physically active than those who live farther from them (154,169).  
Neighborhoods with a mixture of land use types including commercial, industrial, residential, 
and office, also appear to promote physical activity (170), while neighborhoods consisting 
exclusively of housing seem to dampen activity (171).  Higher rates of television viewing, 
increased computer usage, concern about crime, little contact with neighbors, and geographic 
isolation have created communities that are not interconnected (154).  This isolation may result 
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in a lack of social networks, which can contribute to obesity, cardiovascular disease, mental 
health problems, and increased rates of mortality (167,168).     
 Coinciding with the health risk of physical inactivity is the reality of food insecurity.  
Many older neighborhoods no longer have a local supply of fresh, healthful food and they often 
lack transportation access to supermarkets (172).  Supermarkets are less likely to locate in inner 
cities and rural areas and small stores are more likely to sell low quality, non-fresh food and have 
higher prices, a situation that would contribute to poorer nutrition and lower health status (172).   
 
4.2 GIS and Disease Mapping 
GIS analysis can be further used to identify geographic regions in which disease is localized.  
The use of GIS is an important way in which to better illuminate how individuals interact with 
their environment in terms of their health.  While there are many ways to define community, 
geographic location is one important way to understand the context in which people live.  There 
is great variability in the health and well being of residents depending upon where they live 
(119).  GIS-based analysis can be used to identify these areas.  Health-promotion interventions 
can then be designed to target the geographic areas that represent these clusters of health 
problems and unhealthy lifestyles. 
There have been significant developments in disease mapping in the past few decades.  
The continual development of statistical methodology in this area is responsible for the growing 
popularity of disease mapping because of its potential usefulness in regional health planning, 
disease surveillance and intervention, and allocating health funding. 
Geographic information systems are increasingly used to analyze the geography of 
disease, specifically the relationships between pathological factors (causative agents, vectors and 
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hosts, people) and their geographical environments.  GIS applications in the United States have 
described the sources and geographical distributions of disease agents, identified regions in time 
and space where people may be exposed to environmental and biological agents, and mapped 
and analyzed spatial and temporal patterns in health outcomes (117).  
 Some of the earliest GIS applications with implications for the study of disease involved 
mapping point sources releasing toxic chemicals into the environment (117).  The Agency for 
Toxic Substances and Disease Registry (ATSDR) was an early supporter for the use of GIS in 
environmental health studies, adopting the technology in 1990 and sponsoring a workshop on 
GIS applications in public health and risk analysis in 1994, underscoring its commitment to GIS 
as a tool for assessing “real risks to real people” (118).  Researchers have been using GIS to 
describe environmental health studies for quite some time.  Information on environmental 
contamination is integrated with population or human health outcome data in a GIS.  Studies 
limited to modeling the sources and distributions of environmental agents have evolved, and now 
GIS are being used to implement EPA recommendations for managing sources of groundwater 
contamination in wellhead protection areas, integrating data from a variety of sources on the 
distribution of agents (117).   
 An example of how GIS is often used in environmental studies is a pilot study conducted 
by Hunter (120), of carcinogens in water drawn from domestic wells in Anne Arundel County, 
Maryland, used a GIS to determine which wells to sample.  The GIS application identified areas 
potentially at risk for contamination based on commercial and industrial land use associated with 
volatile organic compounds (120).   
 Because of data limitations, investigating the sources and geographical distribution of 
biological agents of disease using GIS has proven more difficult than modeling environmental 
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sources (117).  Air and water quality monitoring systems have traditionally emphasized 
monitoring physical and chemical properties rather than detection of biological agents.  Indeed, 
the presence of these agents is often determined after a disease outbreak.  In the case of 
infectious diseases which are transmitted directly from person to person, unlike diseases 
transmitted though air and water, monitoring the distribution of the disease agent is essentially 
reduced to surveillance of people who carry the disease.  This is controversial because of threats 
to privacy and confidentiality and also because health service providers and their business 
partners have a proprietary interest in administrative records.  Over the past several decades, 
administrative data rather then data from publicly maintained disease surveillance systems have 
been an important source of data on population morbidity (117), but only for those who have 
access to the data.  Because there are geographical differences in the availability and utilization 
of health services, the underlying spatial pattern of morbidity in the population may not be 
accurately captured in these data (117). 
 Numerous empirical studies have been conducted to investigate whether minority and 
low-income populations are disproportionately exposed to pollution and GIS have clearly played 
a role in these studies.  In a study using 1990 census population data and 1995 geographical data 
from the City of Minneapolis, two proximity measures commonly used in GIS-based assessment 
of environmental equity were used to evaluate potential exposure to airborne chemicals for 
minorities, the poor, and children (121).  A geographic randomization methodology was 
developed to assess the significance of the results derived from the proximity measures. 
 Health agencies in the United States have long been involved in the preparation of atlases 
to display the spatial distributions of health outcomes.  These projects are now taking advantage 
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of advances in computer-assisted cartography, GIS, and online mapping.  Some of these directly 
address disparities by racial, ethnic, and income groups.     
Research conducted in San Diego explored whether residences near highly traveled roads 
were associated with asthma in children from low-income households (122).  The locations of 
residences of 5996 children 14 years old or younger diagnosed with asthma in 1993 were 
compared to a random control group of children with non-respiratory diagnoses including 2284 
diagnoses.  The number of medical care visits made by children with asthma was also evaluated 
in relation to traffic levels.  Traffic counts at the highest traffic street, the nearest street, and all 
streets within a 500-ft buffer around the residence were calculated from available traffic data.  
Analysis of the distribution of cases and controls by quintiles and 90th, 95th, and 99th percentiles 
showed no significantly elevated odd ratios.  Among children with asthma, however, children 
whose nearest street had low traffic flows to have made two or more medical visits for asthma 
during the year than to have made only one visit.  The results suggest that exposure to motor 
vehicle exhaust may aggravate symptoms among those diagnosed with asthma. 
 The analytic capabilities of geographic information systems have developed rapidly in 
recent years.  Public health is now presented with the opportunity to examine key relationships 
between the health characteristics of populations and both physical environmental and human 
characteristics.  From reviewing these studies, it is clear that there is a need for a system of 
disease surveillance which also uses geographical data.  GIS will be valuable in identifying 
certain areas where there are higher disease prevalence and risk factors.  This could later lead to 
the development of focused interventions that can reduce these risk factors and possible disease 
rates. 
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 Trooskin et al. (181) conducted a study aimed to use GIS to document the non-random 
distribution of hepatitis C (HCV), identify infection cluster areas, and describe the demographic 
characteristics of these areas.  The investigators conducted spatial analysis of newly reported 
positive hepatitis C cases using the Connecticut Hepatitis C Reporting Database.  Spatial filtering 
was used to eliminate random noise generated by sparsely populated towns or small number of 
cases per town.  Cluster analysis was used to determine whether cases of HCV infection tend to 
occur closer in space to other cases than would be expected by chance alone.  The study 
determined that areas with the highest concentration of HCV reports roughly correspond to the 
major metropolitan areas of Connecticut.  Four of the six significant clusters indentified were 
located in the most densely populated and most urban areas in the state.  All but one identified 
cluster had been described previously as areas of substantial injection drug use.  The findings of 
this study suggest that spatial analysis may assist in the identification of clusters that would not 
otherwise be suspected based on local demographics or other characteristics (181). 
 Timander and Mclafferty (182) performed an exploratory spatial analysis of breast cancer 
clustering in the community of West Islip on Long Island, New York.  Using address-level data 
from a survey of women in this community, the researchers analyzed the existence and locations 
of breast cancer clusters among long-term community residents.  Spatial and geographical 
methods were used to estimate a logistic regression model of disease as a function of known risk 
factors and to analyze spatial clustering among the cases of breast cancer not explained by the 
modeled risk factors (182).  This method determines the actual locations of clusters so that if 
there is a potential causal factor in the environment it can be identified for further study.  
Although the researchers found little evidence of clustering, the methods they described have a 
utility for exploratory spatial analysis in many different health contexts. 
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 Jacquez and Greiling (183) conducted a two-part study that employed a multi-methods 
approach to elucidate geographic variation in cancer incidence in Long Island, New York, and to 
evaluate spatial association with air-borne toxics.  The researchers used the local Moran statistic 
to identify cancer hotspots and spatial outliers.  They evaluated the geographic distributions of 
breast cancer in females and colorectal and lung cancer in males and females in Nassau, Queens, 
and Suffolk counties, New York.  The researchers identified significant local clusters of high and 
low standard mortality rate (SMR) and significant spatial outliers for each cancer-gender 
combination (183).  This study did not consider any economic, ethic, or environmental exposure 
data so these factors could not be related to the clusters. 
   
4.2.1 GIS in Diabetes and Obesity Research 
Few spatial analysis studies have been conducted that investigate diabetes, obesity or risk factors 
related to these conditions.  Since spatial analysis was mainly used for environmental studies, 
most spatial analysis public health studies focused on environmental exposure studies.   
Obesity in the United States has been linked to individual income and education.  
Drewnowski et al. (132) conducted a study to determine whether obesity rates in King County, 
Washington, at the zip code scale, were associated with area-based measures of socioeconomic 
status and wealth.  In a model adjusting for covariates and spatial dependence, property values 
were the strongest predictor of the area-based smoothed obesity prevalence (132).  Geocoding of 
health data provides new insights into the nature of social determinants of health.  Disparities in 
obesity rates by zip code area were greater than disparities associated with individual income or 
race/ethnicity (132). 
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 Gesler et al. (130) used GIS technology in diabetes health intervention research.  
Successful intervention programs to prevent diabetes require information about where target 
populations live and carry out their activities.  Gesler and colleagues used geographic analysis to 
obtain this information by using maps of where people live and carry out their daily activities to 
plan diabetes intervention programs.  Researchers used Global Positioning System and GIS 
technologies to map residences, activity spaces using symbols and standard deviational ellipses 
(SDEs), and sites where diabetes information has the potential to be welcomed, for a sample of 
low income African American, Latino, and white females and males in a small, rural, southern 
town.  Standard deviational ellipses are particularly effective at capturing the spatial 
characteristics of a population group (e.g., places participants visited in the past week) and have 
been widely used in crime analysis and social studies.  SDEs were derived from spatial locations 
and weighted by the total amount of time spent at each point (130).  The ellipses produced 
represent approximately 95% of the group’s activities.  The maps produced by this study 
provided data on the best locations for diabetes prevention programs and educational materials to 
target individuals at high risk for the development of type 2 diabetes (130). 
The high prevalence of obesity may result from the interaction of environmental, 
behavioral, and genetic factors.  Broadly defined environmental factors such as changes in 
agriculture, food processing and marketing, transportation, and the contextual effect of 
residential areas create the context for the population distribution of adiposity (192).  
Environmental characteristics that have recently received attention as determinants of physical 
activity include aspects of urban sprawl (193), accessibility of recreational resources (194,195), 
and neighborhood safety (196,197).   
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In addition, food availability at the neighborhood level has recently received attention as 
a possible environmental determinant of health.  Researchers have documented disparities in the 
costs of foods (198-200) among areas, while others have shown differences in the availability of 
certain types of food stores (198-203).  Moreland, Roux, and Wing (192) conducted multilevel 
modeling in order to calculate prevalence ratios of the associations between the presence of 
specific types of food stores and cardiovascular disease risk factors.  The researchers used 2004 
data from a cross-sectional study of men and women participating in the third visit (1993-1995) 
of the Atherosclerosis Risk Communities (ARIC) Study.  This analysis demonstrated that the 
presence of supermarkets was associated with a lower prevalence of obesity and overweight 
(obesity prevalence ratio [PR] = 0.83, 95% CI=0.75-0.92; overweight PR=0.94, 95% CI=0.90-
0.98), and the presence of convenience stores was associated with a higher prevalence of obesity 
and overweight (obesity PR=1.16, 95% CI=1.05-1.27; overweight PR=1.06, 95% CI=1.02-1.10).  
The results from this study suggest that characteristics of local food environments may play a 
role in the prevention of overweight and obesity (192). 
Inagami et al. (206) found residents in poor neighborhoods have a higher body mass 
index (BMI) and eat less healthfully. One possible reason might be the quality of available foods 
in their area. The researchers examined the location of grocery stores where individuals shop and 
its association with BMI.  The 2000 U.S. Census data were linked with the Los Angeles Family 
and Neighborhood Study (L.A.FANS) database, which consists of 2620 adults sampled from 65 
neighborhoods in Los Angeles County between 2000 and 2002.  Inagami and colleagues used 
multilevel linear regressions to estimate the associations between BMI and socioeconomic 
characteristics of grocery store locations after adjustment for individual-level factors and 
socioeconomic characteristics of residential neighborhoods.  They found that individuals had a 
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higher BMI if they reside in disadvantaged areas and in areas where the average person frequents 
grocery stores located in more disadvantaged neighborhoods. Those who own cars and travel 
farther to their grocery stores also had a higher BMI.  When controlling for grocery store census 
tract socioeconomic status (SES), the association between residential census tract SES and BMI 
became stronger.  They were able to conclude that where people shop for groceries and distance 
traveled to grocery stores are independently associated with BMI.   
Another study describing diabetes used a spatial scan statistic method to test for the 
presence of diabetes clusters.  The spatial scan statistic, which works by aggregating together the 
unique combinations of small-area geographies which have a high probability of being clusters, 
is an especially powerful tool to use in low-prevalence and low-incidence situations.  Green et al. 
(131) used GIS to identify the socio-demographic, environmental, and lifestyle factors associated 
with the geographic variability of diabetes.  Predictor and outcome data were aggregated for 
analysis using the spatial scan statistic to aggregate study data into highly probable diabetes 
prevalence clusters.  Predictor and outcome data were aggregated to existing administrative 
health areas.  Analysis of variance and spatial and non-spatial linear regression techniques were 
used to explore the relationship between predictor and outcome variables.  Mapping and 
statistical analysis revealed substantial clustering in the prevalence of diabetes in the City of 
Winnipeg, Canada.  The observed variations were associated with variations in socioeconomic, 
environmental, and lifestyle characteristics of the population (131).   
 Samuelsson and Löfman (204) investigated geographic clusters of type 1 diabetes in 
children and adolescents in south east Sweden.  Ordinary kriging was used for estimation of 
spatial distribution of incidence and the population at risk was obtained directly from the 
population registry for the years and geographical area levels used for the cases.  The researchers 
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found a clear geographical variation in the risk for children and adolescents to develop type 1 
diabetes between the municipalities in the south east region of Sweden.  They further explained 
that apart from chance, the most probable explanation of this is that local environmental factors 
play a part in the process leading to the development of type 1 diabetes (204). 
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5.0 ACCESS TO HEALTH CARE IN RURAL AREAS 
 
Patients in rural areas may use less medical care than those living in urban areas (133).  This 
difference in access to health care in rural areas may be dependent on a number of variables.  
These include patient-specific factors such as age, race, ethnicity, and perceptions of quality, as 
well as extrinsic factors such as insurance coverage and health care costs (133).  Another 
potential factor related to health care utilization is travel time and distance (134,135).  Research 
has suggested that utilization is adversely affected by long travel times.  Indeed, patients may 
forgo free care if it is greater than 20 miles away (134).  Several state health departments have 
proposed a standard in which rural residents should not have to travel more than 30 minutes to 
see a physician (133). 
 Our current framework of the rural-urban hierarchy of care is one in which rural areas are 
very dependent on urban ones for health care, in particular specialty care.  In this “hub-and-
spoke model,” rural patients must, and be willing to, travel long distances for their care.  
However, more recently, a much less dependent model had been put forward, wherein most 
specialty care is obtained in larger rural cities (e.g., rural cities of >25,000 population) (133).  
Most research studies determine rural status of a geographical area by linking the patient zip 
code to its rural-urban commuting area code (RUCA) (136).  This rural-urban taxonomy is 
typically selected because RUCAs are now the basis of a wide range of federal programs.  
RUCAs use Census Bureau information to differentiate areas based on their city/town size and 
work commuting patterns to larger cities and towns.  There are four categories designated by the 
RUCA: urban (population 50,000 or greater), large rural city (in or associated with a large rural 
city of 10,000-49,999), small rural town (in or associated with a rural town of 2,500-9,999), and 
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isolated rural town (in a town of less than 2,500 population and/or not associated significantly 
with a larger town via work commuting flows (133). 
 
5.1 Access to Care  
Chan, Hart and Goodman (133) used Medicare billing data from 1998 to study geographic access 
to health care for rural Medicare beneficiaries living in Alaska, Idaho, North and South Carolina, 
and Washington.  The authors found that 96% of visits by those living in urban communities 
were either in the patient’s home zip code or in an urban area.  In contrast, only 21% of visits by 
those living in large rural areas were in urban areas.  The vast majority (75%) of these visits were 
in large rural areas or in the patient’s home zip code.  Only about 30% of visits by those living in 
a small and isolated rural area were in urban areas.  The majority of these visits took place in 
other rural areas.  Thus, rural residents received the vast majority of their visits within rural 
areas.   
The authors also found that rural residents have fewer overall visits and see fewer 
medical specialists and more generalists for their care than their urban counterparts.  In addition, 
they found residents of small and isolated rural areas have greater travel distance and time 
compared to those living in urban areas.  Median one-way travel time was less than 30 minutes 
for all patients, including those living in isolated small rural areas.  However, some patients with 
specific diagnoses or undergoing specific procedures needed to travel much farther.  Less than 
30% of those living in all rural areas traveled to urban areas for their care.  The vast majority 
were seen in their area or traveled to a larger rural location (133).   
The impact of health status of the disparity in geographic access to medical specialists 
remains unclear.  These differences certainly create costs for rural residents, including increased 
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money for travel; increased time spent traveling, and the possibility of delays in care.  Some 
research suggests that rural residents do not rely on urban areas for the majority of their care 
(133,134).  Only about 30% of visits by those living in small and isolated rural areas were in 
urban areas.  Indeed, for those living in large rural areas, this figure was only 20% (133).  This 
has several implications.  First, it appears that patients are unwilling or are unable to travel great 
distances for their care.  Secondly, these individuals rely heavily on care by generalists, such as 
internists and those in family practice (134).  Overall, this research suggests that those living in 
small and isolated rural areas have decreased geographic access to health care providers, in 
particular medical specialists, and rely heavily on generalists for the majority of care.  
Additionally, these individuals have fewer visits overall (9.9% fewer for those in isolated rural 
areas) and must travel longer distances to access certain types of care (133).   
Rural older adults are often viewed as especially vulnerable for a number of reasons.  
Rural areas are frequently characterized by poorly developed and fragile economic 
infrastructures, resulting in fewer available per capita hospital beds, doctors, nurses, and other 
health care services (135).  In addition to socioeconomic hardships rural residents face 
substantial physical barriers, including a lack of public transportation, difficult terrain, and long 
distances to services (136,137).  It still remains unclear how rural elders perceive barriers to 
health care access and how they cope with those perceived barriers.  Researchers Goins, 
Williams, Carter, Spencer, and Solovieva (134) examined what barriers rural elders report 
experiencing when accessing needed health care.  To determine this, the authors conducted focus 
groups with community-dwelling rural elders in six rural counties in West Virginia to discuss the 
barriers they believe prevent them from accessing care in general.  In response to the questions 
posed to the focus group participants, five categories of barriers to health care emerged from the 
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discussions: transportation difficulties, limited health care supply, lack of quality health care, 
social isolation, and financial constraints (134).   
Discussion regarding health care supply included concerns about the limited number of 
physicians and long-term care options.  The limited number of physicians included difficulty 
with recruitment and retention, need for more specialists, overall limited choice of physicians, 
and aging of local doctors (134).  Many rural residents depend on care provided by physician 
assistants (PAs) and international medical graduates (IMGs), which can be perceived as a 
problem.  Comments regarding IMGs concerned rural elders’ reluctance to see these doctors or 
their dissatisfaction with past experiences, primarily due to perceived language barriers. 
Lack of quality health care emerged as a third barrier.  Issues included difficulty getting 
accurate diagnoses, lack of trust in health care providers, physicians’ perceived lack of interest in 
patients, difficulty scheduling an appointment, and/or long waiting times at such appointments.  
Some participants felt that physicians were not interested in them as patients, particularly since 
they were older adults.  Participants also expressed dissatisfaction with waiting too long to be 
seen by their physician. 
Social isolation reflected some aspects of rural norms and values, such as the strong sense 
of self-reliance and reluctance to use formal services.  Some participants were unaware of or did 
not have accurate information about available services.  Participants also suggested that it would 
be helpful if older adults had information on services that might help meet their needs (134). 
Financial constraints posed considerable barriers to accessing needed health care among 
study participants, including issues related to health care expense, inadequate health care 
coverage, income ineligibility to Medicaid, and the high cost of prescription medications.  
Participants commented they were not poor enough to qualify for Medicaid but did not have 
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enough financial resources to afford health care (134).  Rural areas have significant gaps in the 
continuum of care since home-based and community-based long-term care services are often 
unavailable (136).  Beyond having a limited supply of health care providers, rural respondents 
also reported physicians are inadequate and lack professionalism.  In rural areas, local physicians 
are often perceived as having poor interpersonal skills and/or lower quality care than what is 
available in more populated areas (138).  
 
5.2 Access to Transportation and Driving Distance    
One of the most often cited attributes of rural areas that affects health care utilization is low 
population density, isolation, and large distances between residences and services (139).  The 
opportunity for health care consumers to have a vehicle to transport them to a practitioner or 
facility is especially important in rural settings where distances are relatively great, roads may be 
poor quality, and public transportation is seldom available (139). 
 The South Carolina Rural Health Research Center took advantage of a highly detailed, 
nationally representative survey of travel conducted by the U.S. Department of Transportation, 
the 2001 National Household Travel Survey (NHTS) to explore the potential for disparities in 
access associated with rural residence.  The NHTS asks participants to record each of their trips 
and its purpose; one purpose was medical/dental care.  The researchers found that nationally, the 
average distance traveled for medical/dental care was 10.2 miles (205).  Rural trips averaged 
17.5 miles, versus 8.3 miles for urban residents.  In multivariate analysis, they found that rural 
residents remained more likely to travel more than 30 minutes for care (OR 1.80, CI 1.09-2.99) 
(205).  Rural populations, more likely to perceive the price of gas as a problem, are likely to be 
particularly affected by current gasoline prices (205).   
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 Conceptually, transportation can be examined from two perspectives.  Within the Health 
Behavior Model, it is an important enabling factor for accessing health care (144), particularly in 
rural areas.  Recent analyses have begun to focus on the effects of transportation access in rural 
communities.  Lovett and colleagues (146) use geographic information system analysis to show 
that in rural areas of the United Kingdom, there are pockets in which car journeys to the nearest 
general practitioner are greater than 10 miles and there is no regular bus service.  These pockets 
of limited transportation have the highest health need indicators.  Nemet and Bailey (147) 
measured perception of ease in getting a needed ride among rural elders in Vermont.  Their 
measure of transportation access (“If you have to get somewhere in a car, how difficult is it for 
you to get there? -very difficult, somewhat difficult, not at all difficult?”) was not significant in 
predicting health care visits in the face of distance from provider.  Gesler et al. (148) found that 
over 85% of the transportation for health care visits in the previous year among the residents of 
two rural North Carolina communities was by private car, with 13.5% having walked.  However, 
an important finding was that those who drove themselves to care and those who had to be 
driven (car riders) formed two groups with distinct characteristics.  Car riders in both towns were 
more likely to be older, female, African American (vs. white), unmarried, poor, and less 
educated than those who drove themselves.  Car riders were also more likely to be in fair or poor 
health as opposed to good or excellent health, to lack medical insurance, and to travel 20 minutes 
or more annually to health care. 
 A need for transportation programs will only increase as the rural population ages during 
the coming decades; it is the elderly who have the greatest limitations in the use of personal 
transportation (driving a car) as well as a great need for health care (142).  Damiano et al. (145) 
found that those individuals in Iowa City, IA, who used public transportation had four more 
 79 
annual chronic care visits that those who did not.  Access to public transportation for health care 
in rural communities is far from universal, and where it is available, it is often restricted to those 
with special characteristics, such as older adults and those with certain kinds of chronic 
conditions.  Providing effective public transportation systems is difficult.  These are expensive 
services that are more easily cut during difficult economic periods than are direct patient 
services. 
 
5.2.1 Diabetes Health Care Access 
According to the Rural Healthy People 2010 survey, diabetes was identified as the third highest 
ranking rural health concern (177).  In this national survey of local and state rural health leaders, 
diabetes was ranked third among the most frequently nominated rural priorities, after access and 
heart disease and stroke (178).   Diabetes was also among the top five priorities in all four 
geographic regions of the survey.  The prevalence of diabetes also varies by urbanicity and 
degree of rurality.  In 1995, the self-reported 3.6% prevalence of diabetes in non-metropolitan 
statistical areas (MSAs) of the United States was higher than in central cities (3.19%) and all 
MSAs (3.24%) (179).   
Despite the availability of effective treatments, many patients with diabetes do not 
receive optimal glycemic control.  As previously discussed for all health care, travel burden may 
be one of many obstacles for diabetes patients, especially in rural areas.  Travel burden includes 
arranging transportation, the time required to travel, arranging child care, the cost of missing 
work, and the cost of the transportation.  Driving distance is one aspect of travel burden, and may 
serve as a marker for at least some of the burden of obtaining diabetes care.  Strauss et al. (149) 
examined the relationship between glycemic control and the driving distance from a patient’s 
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home to the site of primary care.  The authors found that driving distance was significantly 
associated with glycemic control in their population of older, rural subjects.  Each 22 miles of 
driving distance was associated with a 0.25% increase in HbA1c.  The effect was more 
pronounced among insulin users.  Several mechanisms may contribute to this relationship.  
Longer driving distances may mean fewer office visits and less monitoring (149).  In addition, 
those who live farther away may be perceived to be at greater risk for hypoglycemic 
complications, leading to less aggressive care (149).  Littenberg et al. (150) found that the greater 
the driving distance for adults with diabetes to their source of primary care, the less likely they 
are to be using insulin.  The authors suggest that patients and physicians are concerned about the 
risks of insulin and are reluctant to use it if they feel the patient lives too far away from care for 
rescue in the event of hypoglycemia.  Travel burden might influence therapy through the 
frequency of medical contact (150).    It may be useful to minimize travel burden for patients 
with diabetes, perhaps by enhanced public transportation, more clinic locations in rural areas, 
telephone or other electronic links, or home care.   
In the face of a steadily increasing prevalence of diabetes, the health care system has 
failed to prevent, detect, and manage diabetes adequately, especially in rural areas.  Rural 
residence is a significant risk factor for never receiving an ophthalmic examination, which can 
detect early signs of diabetic retinopathy (178).  When rural residents do see a doctor, they are 
more likely to see a generalist than a specialist for treatment of diabetes and related 
complications.  Rural patients with a history of gestational diabetes are at high risk for 
developing T2D, yet only 30% have adequate follow-up by their physicians (179). 
 Because diabetes self-management education has been shown to be effective at 
improving short-term behavioral and physiologic outcomes for patients with diabetes, decreased 
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access to education is an important barrier in rural settings.  In addition, busy rural primary care 
practices often lack the organizational support and computerized tracking systems to initiate 
practical interventions to improve diabetes care (151).  The Park County Diabetes Project, a 
partnership between three primary care clinics, the Livingston Memorial Hospital, and the 
Montana Diabetes Control Program, initiated a collaborative effort in October 2000 to improve 
diabetes care and community awareness among Park County residents (151).  Beginning in 
October 2000, the Park County Diabetes Project made a number of changes in the delivery of 
diabetes care and patient education.  These included establishing and maintaining the patient 
registries, nurses conducting mail and telephone outreach to patients in need of services, and 
providing ongoing continuing education workshops.  This is one of only a few studies 
documenting improved diabetes care, outcomes, and reduced self-management barriers in a rural 
population.  The changes in diabetes self-management barriers are notable, as in the decrease in 
the A1c and blood pressure values for this patient population over the three-year period.  For 
rural communities, one of the key areas in which change is needed may be improving access to 
diabetes education.  This could be accomplished through distance communication strategies, 
such as telemedicine, or through the provision of educational support and resources to assist 
health professional to improve their diabetes education skills and their ability to develop quality 
education programs (151).  These findings suggest that system changes in primary care practices 
and the implementation of accessible diabetes education can improve care and reduce barriers for 
rural patients with diabetes on a countywide level.  
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6.0 CONCLUSION 
 
Diabetes is a complex chronic disease with many causes, complications and management needs.  
It affects a large proportion of people of varying ages, income levels, races/ethnicities and 
geographic areas.  Diabetes is becoming more common in the United States. From 1980 through 
2007, the number of Americans with diabetes increased from 5.6 million to 17.9 million (2).  It is 
estimated that another 5.7 million Americans are undiagnosed (2).  Approximately 762,000 or 
7.0% of Pennsylvanians have been diagnosed with diabetes and is responsible for nearly 4,000 
deaths in Pennsylvania (6).  Diabetes is a major public health challenge due to the enormous 
impact on the affected individual, their families and the health care system.  However, recent 
research has shown that diabetes related mortality and morbidity can be prevented or delayed by 
controlling risk factors (7).   
Certain environmental aspects play an important role in the prevention and treatment of 
chronic diseases such as diabetes.  Studies have shown that access to health care, diet, physical 
activity, housing, income, and environmental exposures contribute to diabetes, which are all part 
an individual’s environment or community (4,5).  While there are many ways to define 
community, geographic location is one important way to understand the context in which people 
live.  Until recently, there has not been a valid method for defining and analyzing geographic 
areas that make up a community where these risk factors and chronic diseases may cluster.  
Geographical modeling may allow for better identification of the geographic area of 
communities that provide risk for diabetes.  There is great variability in the health and well being 
of residents depending upon where they live.  Health-promotion interventions may need to be 
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designed to target the geographic areas that represent clusters of health problems and unhealthy 
lifestyles.     
Geographical Information Systems (GIS) may allow investigators to conduct spatial 
analysis that can to be used to increase comprehension of chronic disease pathogenesis.  
Geographical studies may suggest possible causal factors based on geography and play an 
important role in the understanding of the development and control of diabetes.  Associations 
between disease and place imply that the population living there possesses inherent traits that 
make it more susceptible to disease.  However, it has been shown that there are certain risk 
factors that cluster in these areas that cause increased risk for disease.  Also, spatial analysis can 
help identify how populations adapt and relate to their environment.  More research is needed to 
study how the built environment relates geographically to chronic diseases such as diabetes in 
order to develop public health prevention programs and improve diabetes management and 
outcomes. 
 There is a growing recognition that the built environment has an impact on health. For 
example, one may expect more physical activity and healthier diets among persons in 
communities with convenient, safe walking paths and accessible sources of fresh fruits and 
vegetables. On the other hand, poorer health indicators may be expected among residents of 
communities with high crime rates, few parks or walking paths, numerous alcohol and tobacco 
outlets, and little access to fresh food.  Low-income and/or rural communities are more likely to 
be sites of hazards and less likely to be conducive to physical activity and healthy eating.  
Chronic diseases, such as diabetes, are leading health concerns which are influenced by the built 
environment.  Decisions about zoning, transportation, land use and community design influence 
the distances people travel to health care facilities, the convenience of purchasing healthy foods, 
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and the safety and attractiveness of neighborhoods for walking.  It is clear from the health 
implications of these decisions that public health should be a strong ally to ensure that decisions 
about neighborhood design are made with the health of community members at the forefront.  
However, decisions about the built environment have traditionally been made without 
active inclusion of public health.  To facilitate public health's participation, this project provides 
a concrete example that demonstrates the importance of the built environment as well as 
illustrates potential roles for public health.  A greater understanding of opportunities to improve 
health outcomes through altering the built environment will strengthen linkages between public 
health, city planners and others involved in community design.  
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7.0 METHODS 
 
7.1 OBJECTIVE AND SPECIFIC AIMS 
In order to provide the public health community with another tool to enhance our understanding 
of the factors that affect the numbers and types of diabetes cases in Pennsylvania, it is important 
that we undertake a project that will support the analysis of geographic and geospatial factors in 
terms of associated risk factors.  Geospatial analysis tools can be used to discover and analyze 
relationships based on geographic proximities.  These factors include the location of various 
disease prevention and healthcare facilities (pharmacies, foot and eye care centers hospitals, rural 
health clinics, physcians’ offices), locations of healthier food options (large supermarkets, 
farmers markets, full-service restuarants) and areas for physical activity (parks, recreational 
centers, golf courses, gyms) and public transportation routes and sidewalk availability to identify 
areas in greater need of these services. The concentration of diabetes cases in areas of greater 
need of services will also lend information regarding issues of access and the potential 
consequences these issues.   
This study proposes to investigate geographical patterns of diabetes hospitalizations, risk 
factors for diabetes complications and glycemic control among individuals with type 2 diabetes 
in rural regions.  Geographic data will be used to explore the geographic distribution of diabetes 
hospitalization rates in rural Southwestern Pennsylvania in Allegheny, Armstrong, Cambria, 
Greene, Indiana, Fayette, Somerset, Washington, and Westmoreland counties.  This geographic 
data will be juxtaposed with a variety of potentially related geographic, economic, and health 
risk factors.  As a part of this investigation, we aim to: 
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1. To identify an association between county rurality hospitalization rates for uncontrolled 
diabetes in southwestern Pennsylvania. 
a:  Individuals who reside in counties with increased rurality will be more likely to be 
hospitalized for uncontrolled diabetes than counties that are more urbanized.   
2. To determine if there is an association between the availability of disease prevention and 
health care facilities, the local food environment and risk factors for complications of diabetes in 
Southwestern Pennsylvania.  
 a.   The presence of supermarkets, full-service restaurants, physicians’ offices, hospitals 
and pharmacies will decrease the likelihood of having the risk factors for diabetes complications 
in individuals with type 2 diabetes.  
3. To examine the association between glycemic control and improvement in individuals with 
type 2 diabetes, and travel burden to diabetes management centers in southwestern Pennsylvania. 
a. Individuals who have uncontrolled diabetes will be less likely to live as close to their diabetes 
management center as those who are in glycemic control.  Also, those who live closer will be 
more likely to have improved glycemic control than those who live farther from the diabetes 
centers.  
 
7.2 STUDY DESIGN 
7.2.1 Overview 
This study is an observational, ecological cross-sectional study that took place in rural 
Southwestern Pennsylvania including Allegheny, Armstrong, Cambria, Fayette, Greene, 
Westmoreland, Indiana, Somerset, and Washington Counties. 
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7.2.2 Data Collection 
In an effort to improve diabetes education and care, the University of Pittsburgh Diabetes 
Institute started a regional health care collaboration, the Pittsburgh Regional Initiative for 
Diabetes Education (PRIDE).  Nine counties (Allegheny, Armstrong, Cambria, Fayette, Greene, 
Indiana, Somerset, Washington, and Westmoreland) were selected from the study area where the 
partners of PRIDE diabetes centers are located.  The patient data was collected using a data 
management system, Delphi.  This system was used by the University of Pittsburgh Diabetes 
Institute in order to collect data on individuals with diabetes attending diabetes centers 
throughout southwestern Pennsylvania.  The participating centers include: The Center for 
Diabetes Care at the Indiana Regional Medical Center, Community Medical Services, 
Centerville Clinics, Inc., Conemaugh Diabetes Institute, The Diabetes Center at Uniontown 
Hospital, Highlands Hospital Diabetes Center and the Washington Hospital Diabetes Education 
& Management Program.  The Delphi Data Management System allowed the staff of these 
centers to enter patient data into an organized system.  Individual-level data such as home 
addresses, demographics, lab test data, medications, health indicators, comorbid conditions, and 
complications were entered into this data system from June 2005 to January 2007.  The variable 
list is included in Table 9.6, Appendix B.  All of the individuals 18 years and older that were 
entered into the Delphi system (n=3367) were diagnosed by their physician with diabetes prior to 
be being referred to the diabetes center.   
 Data from the Pennsylvania Health Care Cost Containment Council (PHC4) was obtained 
to determine diabetes hospitalization rates in the counties of interest (PCH4, 2006).  PCH4 is an 
independent state agency responsible for addressing the problem of escalating health costs.  The 
council collects, analyzes and makes available to the public data about the cost and quality of 
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health care in Pennsylvania.  PHC4 collects over 4.5 million inpatient hospital discharge and 
ambulatory/outpatient procedure records each year from hospitals and ambulatory surgery 
centers in Pennsylvania.  This data, which includes hospital charge and treatment information as 
well as other financial data, is collected on a quarterly basis and is then verified by PHC4.  The 
Council also collects data from managed care plans on a voluntary basis.  The Council shares 
this data with the public through free public reports.  The PHC4 data used for this study is a 
customized data set obtained through the Council’s Special Requests division.  The data set 
included all hospitalizations with any diagnosis of diabetes or diabetes-related complications in 
the counties within the study area.  Control patient data was also obtained for those hospitalized 
with a primary diagnosis for fractures (ICD-9 codes 800-829) in the same counties. The variable 
list is included in Table 8.8, Appendix A.  
 All persons who were hospitalized during the 2007 calendar year with a diagnosis for 
diabetes in any diagnosis code fields were used to calculate the hospitalization rates.  
Hospitalizations rates per 10,000 adult residents were calculated for diabetes as the principal 
diagnosis only and any listed diagnosis (includes the admitting, principal, or any of the eight 
secondary diagnoses).  For these events, the International Classification of Diseases, Ninth 
Revision, Clinical Modification codes (ICD-9) for diabetes (250.xy; where, x = 
0,1,2,3,4,5,6,7,8,9 and y = 0, 1, 2, 3) as the diagnosis code were used to calculate rates.  The 
hospitalization rates were age and sex-adjusted using the standard 2000 U.S. population 
estimates from the U.S Census Bureau (207).  The hospitalization rates for uncontrolled diabetes 
(250.02; 250.03) as any listed diagnosis and long-term complications of diabetes (250.xy; where, 
x = 4,5,6,7,8,9 and y = 0,1,2,3) as any-listed diagnosis were also calculated.  The hospitalization 
rates for short-term complications diabetes (250.xy; where, x = 1,2,3 and y = 0,1,2,3) as any 
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listed diagnosis and end stage renal disease (250.40-250.43, 996.62, 996.73, and 996.81) as any 
listed diagnosis were calculated as well.  A more descriptive listing of these ICD-9 codes is 
displayed in Table 8.7, Appendix A.  Age-adjusted rates were calculated by stratifying the 
population into four age groups: 18-44, 45-64, 65-74, and 75 years of age and greater.  These age 
categories were used to follow the age categories of the Centers for Disease Control and 
Prevention (CDC) (211).  The zip code of the patients’ residence was used to define the county 
of residence, and to prevent calculating rates for the county in which the patient was 
hospitalized.  Since this study is interested in the geographical variance associated with the 
patients’ residence and not necessarily hospitalizations rates due to diabetes, it was important to 
make this distinction.   
 Municipal data such as county, city and political borders were downloaded in shape file 
format from the United States Census website (www.census.gov) (180-184).  The Census 
website was also used to download demographic and socioeconomic information such as percent 
of the population living below the poverty level, median household income, population by age, 
and education levels for each county, zip code and census tract (185,186).  Road centerline data 
was collected by a project partner, L. Robert Kimball & Associates, from each county municipal 
office (187).   The locations of waterways such as lakes and streams, public recreational areas 
such as parks and state forests, and industrial sites such as brown fields were downloaded from 
the Pennsylvania Spatial Data Access website (www.pasda.psu.edu) (188).  Business data such 
as locations of restaurants, supermarkets and grocery stores, convenience stores, fresh fruit and 
vegetable markets, meat and fish markets, fitness and other recreational centers, and health care 
facilities (including rural health clinics, private physicians offices, diabetes clinics, dialysis 
centers, eye care, and hospitals) were purchased from ESRI, a GIS and mapping software 
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company that also provides geographical datasets (189).  With the exception of the business data, 
all of these geographical data sets are publicly available.   
 
7.2.3 Address Geocoding 
The type of data used for this project is known as quasi geospatial data because by using the 
addresses alone it is not possible to pinpoint locations on a map and to integrate address-based 
data with other forms of geospatial data for spatial analysis (112).  To locate addresses on a map, 
it is necessary to determine their grid references in an accepted geo- referencing system.  
Address geocoding, also known as address matching, is the process by which grid references 
(e.g. latitude/longitude) are added to point locations described by street addresses from the 
county road centerline data (112).  Address geocoding is an important geospatial data input 
function in many GIS software packages, including the software used for this project, ArcView 
GIS.   
The Concept of Address Geocoding 
 The objective of address geocoding is to match addresses in data files that have grid 
references (the reference theme) to those addresses in data files that do not (the event table).  The 
primary source of reference theme data in this project will be the road centerline data acquired 
from each individual county.  When this reference theme data was unavailable, either TIGER 
(Topologically Integrated Geographic Encoding and Referencing) files from the Bureau of the 
Census or StreetMap from ESRI will be used.  Although the structures of different reference 
theme data files may be different from one another, they all contain the street network and the 
address ranges on both sides of the street that are necessary for geocoding (112).  On the other 
hand, addresses in the event table are normally recorded as text strings that contain components 
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such as house number, street name, city name, and postal code.  The event table was stored in the 
specific format of a database file as a dBASE dbf file. 
 The software module that performs geocoding is usually referred to as the geocoding 
editor.  It is necessary for the two types of data to be in a compatible format in order to compare 
the reference theme data with event table data in address geocoding.  This means the creation of 
a geocoding index from the geographical reference theme by the geocoding editor.  The 
geocoding index is a database table.  An associated geocoding information file is also created to 
record the characteristics of the geocoding index, such as address style and the address attribute 
fields.  During the address geocoding process, the application software first reads the records in 
the event table one by one (112).  It pareses the address into separate components (i.e., street 
number, street name, city name, and postal code) and standardizes the components according to 
the specifications of a selected address style supported by the geocoding editor.  It then 
determines the street segment where the particular address is found by geocoding index.  The 
actual grid reference of the address within the street segment is finally computed by interpolating 
between the two end points of the street segment according to the numerical relationship between 
the street number and the address range of the street segment (112). 
The Process of Address Geocoding  
 Address geocoding is multi-step process that can be carried out in batch or interactive 
modes, or a combination of both.  The procedure of geocoding can be generalized into the 
following sequence of steps (Figure 1): 
 1. Data preparation.  The objective of this step is to prepare the reference theme and the 
event table for geocoding.  For the reference theme, it is necessary to ensure that the address 
style used is one of the address styles supported by the geocoding editor, for example, U.S. street 
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address with zone, U.S. street address without zone, ZIP + postal codes, and five-digit ZIP postal 
codes (112).   
All addresses for both patients and businesses were standardized to support one address 
style, U.S. street address with zone.   For the event table, it was made certain that all components 
of the street address were stored according to the format specified by the geocoding editor in 
ArcView.  All abbreviations were spelled out.  Addresses with rural routes or former highway 
numbers were compared to standardized 9-1-1 address databases and were corrected.  If PO 
Boxes were the only address provided, then the 9-1-1 address database was used to locate the 
street address associated with the PO Box.   The geocoding editor supports some name aliases 
(e.g. City Hall, St. Patrick’s Hospital) in addition to the street addresses, so a separate alias table 
for common place names was created. 
 2. Loading the reference theme and event table.  The reference theme and the event table 
were loaded into the geocoding editor, which then built the geocoding index and the geocoding 
information file for using information from these two input files. (112). Street centerline data 
provided by each county municipal office was used as the reference theme.  ArcView Street Map 
was also used to provide another layer of detail for the reference theme table. 
 3. Geocoding.  The geocoding process was performed in both batch and interactive 
modes.  The process was started in batch mode, which let the geocoding editor run until the last 
record of the event table was reached.  At the end of the batch run, a dialog box showing the 
number of matches that were made was displayed.  There were various reasons why a perfect 
match was not achieved, such as spelling mistakes, incorrect house numbers, and outdated data 
in the reference theme or event table.  At this point, an interactive rematch was performed by 
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which each of the unmatched addresses was examined and geocoded with the aid of the 
geocoding editor. 
 4. Saving and populating the geocoding data.  On completion of the interactive 
geocoding process, the results to data files were saved as required by the geocoding editor so that 
they could be used for further analysis. 
 Once the addresses in the event table were geocoded, they were integrated with other 
types of geospatial data to create new maps and perform spatial analysis.  A typical map is called 
an electronic pin map, which displays the locations of various events by address.  Geocoded 
addresses were also used in advanced spatial query and analysis, such as location-allocation 
modeling to determine the optimal locations of new service centers or facilities.  
 
7.2.4 Network Analyst 
The ArcGIS Network Analyst extension was used in this study to find driving distances between 
study subjects and various outcome locations.  Network Analyst allowed us to build a network 
dataset and perform analysis on a network dataset (212).  This extension is composed of a 
number of parts: a wizard to create a network dataset (in ArcCatalog), a dockable Network 
Analyst window (in ArcMap), a Network Analyst toolbar (in ArcMap), and a number of 
geoprocessing tools contained within ArcToolbox.  A network dataset includes highways 
connecting to cities, streets interconnected to each other at street intersections, and sewer and 
water lines that connect to houses (212). 
7.2.4.1 Building a Network Dataset 
First, the sources for appropriate roles inside the network dataset must be prepared.  The 
sources should have fields that represent the network impedance values such as distance, travel 
 94 
time, etc.  For best results, these fields should be named the same as the units of the impedances, 
as these fields will automatically be detected by the New Network Dataset wizard (212).  If one-
way streets are modeled, the edge sources should have a field specifying one-way street 
information.  The network dataset can then be created using the Network Dataset Wizard.  The 
Wizard will wizard will walk the user through naming the network dataset, identifying the 
network sources, setting up the connectivity, identifying elevation data, if necessary, specifying 
turn sources, if necessary, defining attributes (such as costs, descriptors, restrictions, and 
hierarchy), and setting up the directions reporting specifications (212).  Finally, when a network 
dataset is created or an existing network dataset is edited, it must be built. Building is a process 
of creating network elements, establishing connectivity, and assigning values to the defined 
attributes (212). 
7.2.4.2 Route Analysis  
 Creating a route can mean finding the quickest, shortest, or most scenic route, depending 
on the impedance chosen. If the impedance is distance, as used in this study, then the best route 
is the shortest route.  Thus, the best route can be defined as the route that has the lowest 
impedance, or least cost (212). Any cost attribute can be used as the impedance when 
determining the best route.  When e a new route analysis layer is created, it is displayed in the 
Network Analyst Window, along with related three categories which are stops, barriers, and 
routes (212).  
The stops feature layer stores the network locations that are used as stops in route 
analysis.  In this study, the diabetes management center that the subjects visited was used as the 
location stops.  Barriers are used in route analysis to denote points from which a route cannot 
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traverse through.  The Route feature layer stores the resultant route of route analysis.  Once the 
best route is found, it is displayed on the Network Analyst Window. 
7.2.4.3 Creating an Origin-Destination Cost Matrix 
Using Network Analyst, an origin-destination (OD) cost matrix was created for the 
homes of subjects to each diabetes centers they visited.  The parameters for the OD cost matrix 
were specified and paths from each home to the particular center they visit. 
There are four components of an OD cost matrix analysis layer: origins, destinations, barriers, 
and line feature classes.  The origins layer stores the network locations that are used as origins in 
OD cost matrix analysis.  In this study, the home addresses of the subjects were used as the 
origins.  Destinations feature layer stores network locations that are used as destinations in OD 
cost matrix analysis. In ArcMap, this layer behaves exactly like the Origins feature layer.  In this 
study, the diabetes management centers were used as the destinations.  Barriers feature layers are 
used in closest facility analysis to denote points where a route cannot traverse and were not 
needed in this study.  The Lines feature layer stores the resultant paths of OD cost matrix 
analysis (212). 
 
7.3 STATISTICAL ANALYSIS 
 
Before any hypotheses were tested, the distribution of and descriptive statistics for all variables 
of interest were performed to determine mean, range, distribution, and other characteristics 
necessary to determine appropriate statistical analyses to be performed.  The measures of central 
tendency (e.g. means, standard deviations, medians, proportions, etc.) were also used for all of 
the descriptive analyses. 
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Specific Aim 1:  
Nine Pennsylvania counties (Allegheny, Armstrong, Cambria, Fayette, Greene, Indiana, 
Somerset, Washington, and Westmoreland) were selected from the study area.  These counties 
were chosen for this specific aim because these are the counties in the study area for all three 
manuscripts.  Age and age-sex-standardized diabetes hospitalization rates were calculated for 
each of the nine counties using the patient data collected by PHC4.  Demographic information 
included with this data set was used to calculate diabetes hospitalization rates per 10,000 people 
for each county with respect to population information from Census 2006 data.  The dataset was 
stratified into four groups: 18-44, 45-64, 65-74, and 75 years and older. 
Each county was ranked by rurality based on criteria from the United States Department 
of Agriculture Economic Research Service (USDA) (210).  Based on the continuum from the 
USDA, the definitions of the nine counties in this study are as shown in Table 8.6 in Appendix 
A.  The counties were further ranked based on total population, population density, miles of 
roads/highways, and daily vehicle miles traveled, miles of highways/roads in combination with 
the USDA’s continuum codes (Table 8.5, Appendix A).  The counties were ranked for rurality on 
a scale from 1 to 9 with respect to the previously described measures above.  The overall 
rankings of rurality were calculated for each county by averaging the scores for each of the six 
measures.  The population data was obtained from the Census 2000, which was obtained from 
the U.S. Census Bureau, 2005 (207,208).  The traffic-related data was obtained from the 
Pennsylvania Department of Transportation (209). 
 This specific aim seeks to determine whether diabetes hospitalization rates were 
associated to area-based measures of race/ethnicity, income, poverty, type of hospital admission, 
and type of insurance.  Multi-level analysis using logistic regression/General Estimating 
 97 
Equations (GEE) was used to test the association between uncontrolled diabetes rates and county 
rurality by calculating odds ratios (OR) and their 95% confidence intervals (CI).  A binary 
variable for the outcome was calculated for those individuals hospitalized for uncontrolled 
diabetes (= 1) versus those hospitalized for all other diabetes ICD-9 codes (= 0).  Individual 
variables that were thought to be important characteristics in those with diabetes such as age, 
race, and gender were added to the model.  Age was entered into the model as both a continuous 
individual variable and as a county mean age to assess differences between the counties.  Since 
this data was not available at the individual-level for these hospitalization events, the study 
employed county averages of the percentage of residents living below the poverty level and the 
percentage of residents with a high school diploma or higher degree to determine the distribution 
of socioeconomic data for each county.  The insurance information for each patient was also 
included in the analysis as a measure of poverty.  In the full model, gender and percent living 
below the poverty level were not statistically significant.  Each of these variables was removed 
from the model individually with no changes to the model.  However, due to the importance of 
the two variables to diabetes outcomes, they remained in the final regression model.  Statistical 
analyses were performed with SAS 9.1, GeoDa, and Excel to determine the odds ratios, county 
rankings, and spatial autocorrelation.  All estimates of significance were at p = .05 level.   
Cloropleth maps of the hospitalizations rates for each of the counties were created using 
ArcMap Software (Figures 8.12-8.16, Appendix A).  These maps use a color gradient to 
symbolize the classifications of rates.  GeoDa Software was employed to analyze spatial 
autocorrelation and whether the hospitalization rates of in one county correlate with neighboring 
counties.  The presence, absence, or characteristics of some spatial objects may sometimes have 
significant impacts on the presence, absence, or characteristics of the neighboring objects (7).  
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Moran’s I was the indicator used to examine spatial autocorrelation between the county’s rates 
(Figures 8.9 – 8.11, Appendix A). 
Specific Aim 2:  
The distribution of and descriptive statistics for all variables of interest were performed to 
determine distribution, mean, median, and other characteristics necessary to determine 
appropriate statistical analyses to be performed.  To estimate odds ratios (OR) of diabetes 
complications risk factors associated with the presence of different types of food stores, multi-
level logistic regression was performed using the PROC GENMOD program in SAS 9.1 (28).  
This is a multilevel test that takes census tract and individual-level data into account and the 
repeated measures option was used to account for the clustering of subjects within the census 
tracts.  Each of the risk factors of hypertension, hypercholesterolemia, overweight, obese, and 
hyperglycemia was modeled separately.  First, dichotomous variables characterizing ‘any’ versus 
‘none’ of that type of facilities within the census tract were created for each type food service 
place (fast food, limited-service, and full-service restaurants), food store (supermarkets, grocery 
stores, and convenience stores), offices of physicians and pharmacies.  Indicator variables were 
also created to represent the presence of specific combinations of types of food stores: (a) 
Supermarkets only, (b) Grocery stores only, (c) Convenience stores only, (d) Supermarkets, 
grocery stores, and convenience stores, (e) None, (f) Combination of stores; and food service 
places: (a) Full-service restaurants only, (b) Limited-service restaurants only, (c) Fast food 
restaurants only, (e) None, and (f) Combination of places.  The dichotomous variables were 
modeled for each of the risk factors, while controlling for age, gender, and duration of diabetes.  
Since individual-level socioeconomic status (SES) information was not available, census tract 
information was used in the model to control for these factors.  The percentage of residents 
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living below the poverty level, percentage of residents reporting Black as their race, median 
household income, and percentage of residents with a high school education or higher for each 
census tract were also considered in the regression models.  Descriptive analysis was conducted 
to calculate the mean and percentages of laboratory values, age, gender, duration of diabetes, co-
morbidities and complications of diabetes.    
Specific Aim 3: 
 The analyses for specific aim 3 will build on the analyses for specific aims 1 and 2.  
Again, descriptive statistics for all variables of interest were performed to determine distribution, 
mean, median, and other characteristics necessary to determine the appropriate statistical 
analyses to be conducted.  Patient outcomes such as BMI, blood pressure, LDL, HDL, HbA1c 
from the Delphi database was used to make comparisons between those that are in glycemic 
control and those who are not.   
Travel burden will calculated by determining the shortest distance from the subject’s 
home to the diabetes management center they visited.  The subjects will be categorized 
dichotomously as living less than or greater than ten miles from the diabetes center.  The driving 
distances of subjects that are in glycemic control and those who are not will be compared with 
Χ2 tests.  Multi-level logistic regression will be used to test the association between control 
(present or absent) and each marker of travel burden (distance in miles and dichotomous 
variable) by calculating odd ratios.  The analysis will be adjusted for individual level factors such 
as age, sex, BMI, type of insurance, and duration of diabetes as well as community level factors 
such as percent of census tract living below the poverty level, median household income, and 
percent of census tract with a high school degree or higher.   
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8.1 ABSTRACT 
 
Objective - To consider an association between county rurality and hospitalization rates for 
uncontrolled diabetes in southwestern Pennsylvania. 
Hypothesis: Individuals who reside in counties with increased rurality will be more likely to be 
hospitalized for uncontrolled diabetes than those in counties that are more urbanized.   
Research Design and Methods: Nine counties in Southwestern Pennsylvania (Allegheny, 
Armstrong, Cambria, Fayette, Greene, Indiana, Somerset, Washington, and Westmoreland) were 
selected from the study area where diabetes centers are located.  Age-standardized diabetes 
hospitalizations rates using Pennsylvania Health Care Cost Containment Council were 
calculated.  Each of the counties was ranked by rurality based on criteria from the United States 
Department of Agriculture Economic Research Service.  Statistically significant contributions to 
the diabetes hospitalization rates by each of the independent individual and county level 
covariates (county rank, age, gender, race, poverty, education, income) were examined by 
logistic regression/GEE analysis. 
Results: The analysis included 54,703 patients from nine counties who were hospitalized with a 
diagnosis of diabetes (ICD-9 250.0-250.9) during the 2007 calendar year.  Patients were 
predominantly older (59.2% age 65 or more), female (53.6%), and Caucasian (88.9%).  
Allegheny County had the highest percentage of Blacks (19.8%) and Washington County had the 
highest mean age (68.2 years old).  During 2007, diabetes was the principal diagnosis upon 
admission in 14.5 per 10,000 adult residents, and for any-listed diagnosis in 246.8 per 10,000 
adult residents for the entire study area.  Hospitalization rates for uncontrolled diabetes (ICD-9 
codes 250.02; 250.03) as any-listed diagnoses upon admission were also calculated for the study 
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area.  The rate was 8.2 per 10,000 adult residents.  The results indicated that residing in a more 
rural area (OR = 1.11, P = <0.0001), being younger (OR = 0.98, P = <0.0001), non-white (OR = 
1.25, P = 0.002), being uninsured or receiving Medicaid (OR = 0.96, P = <0.0001) and having a 
high school degree or higher (OR = 0.89, P = <0.0001) were significant contributors to being 
admitted to the hospital for uncontrolled diabetes while gender was not significant (OR = 1.04, p 
= 0.46). 
Conclusions: Results of this study indicated an association between the rurality of a county and 
the diabetes hospitalization rates of the county’s residents.  Residents of more rural counties are 
11% more likely to be hospitalized for uncontrolled diabetes compared to those living in areas 
that are less rural for every increase in rurality ranking. 
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8.2 INTRODUCTION 
 
There are 23.6 million children and adults in the United States, or 7.8% of the population, who 
have diabetes.  While an estimated 17.9 million have been diagnosed with diabetes, 
unfortunately, 5.7 million people (or roughly 25%) are unaware that they have diabetes.  
Diabetes affects approximately 7.0% of the population of Pennsylvania (5).  This disease is a 
major public health challenge due to the enormous impact on the affected individual, their 
families and the health care system.  However, recent research demonstrates that diabetes related 
mortality and morbidity can be prevented or delayed by controlling risk factors (1). 
Studies demonstrate that access to health care, diet, physical activity, housing, income, 
and environmental exposures contribute to chronic disease, which are all part an individual’s 
environment or community (2-4).  Environmental factors associated with rurality may contribute 
to geographical differences in diabetes-related hospitalization rates.  Areas with a higher rurality 
ranking in terms of population density, miles of highways/roads, median household income, and 
average daily vehicle miles may have higher rates of diabetes hospitalizations.  These more rural 
areas typically have less public transportation, fewer health care facilities and services, lower 
levels of education, and lower income.  Patients in rural areas may use less medical care than 
those living in urban areas (4).  This difference in access to health care in rural areas may be 
dependent on a number of variables.  These include patient-specific factors such as age, race, 
ethnicity, and perceptions of quality, as well as extrinsic factors such as insurance coverage and 
health care costs (4).  Another potential factor related to health care utilization is travel time and 
distance (27,28).  Research has suggested that utilization is adversely affected by long travel 
times.  A study found that rural patients may forgo free care if it is greater than 20 miles away 
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(27).  Several state health departments have proposed a standard in which rural residents should 
not have to travel more than 30 minutes to see a physician (4). 
There is great variability in the health and well being of residents depending upon where 
they live.  Health-promotion interventions may need to be designed to target the geographic 
areas that represent clusters of health problems and unhealthy lifestyles as well as those that are 
socioeconomically disadvantages. 
The objective of the current study was to identify an association between county rurality 
and hospitalization rates for uncontrolled diabetes in southwestern Pennsylvania.  We 
hypothesized that individuals who reside in counties with increased rurality will be more likely 
to be hospitalized for uncontrolled diabetes than those in counties that are more urbanized. 
 
8.3 METHODS 
 
8.3.1 Study Population 
In an effort to improve diabetes education and care, the University of Pittsburgh Diabetes 
Institute started a regional health care collaboration, the Pittsburgh Regional Initiative for 
Diabetes Education (PRIDE). Nine counties (Allegheny, Armstrong, Cambria, Fayette, Greene, 
Indiana, Somerset, Washington, and Westmoreland) were selected from the study area where the 
partners of PRIDE diabetes centers are located. The participating centers included: The Center 
for Diabetes Care at the Indiana Regional Medical Center, Community Medical Services, 
Centerville Clinics, Inc., Conemaugh Diabetes Institute, The Diabetes Center at Uniontown 
Hospital, Highlands Hospital Diabetes Center and the Washington Hospital Diabetes Education 
& Management Program.   
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As prevalence of diabetes could not be directly measured, data were obtained from the 
PHC4 to estimate the prevalence of diabetes in the study area.  The Pennsylvania Health Care 
Cost Containment Council (PHC4) is an independent state agency responsible for addressing the 
problem of escalating health costs.  The council collects, analyzes and makes available to the 
public data about the cost and quality of health care in Pennsylvania.  This data, which includes 
hospital charge and treatment information as well as other financial data, is collected on a 
quarterly basis and is then verified by PHC4.  The Council also collects data from managed care 
plans on a voluntary basis.  The PHC4 data used for this study is a customized data set obtained 
through the Council’s Special Requests division.  The data set included all hospitalizations with 
any diagnosis of diabetes or diabetes-related complications in the counties within the study area.   
 
8.3.2 Study Design 
Each county was ranked by rurality based on criteria from the United States Department of 
Agriculture Economic Research Service (6).  The USDA ERS used Rural-Urban Continuum 
Codes (6) to form a classification scheme that distinguishes metropolitan (metro) counties by the 
population size of their metro area, and non-metropolitan (nonmetro) counties by degree of 
urbanization and adjacency to a metro area or areas.  The metro and nonmetro categories were 
subdivided into three metro and six nonmetro groupings, resulting in a nine-part county 
codification.  All U.S. counties and county equivalents were grouped according to their official 
metro-nonmetro status announced by the Office of Management and Budget (OMB) in June 
2003, when the population and worker commuting criteria used to identify metro counties were 
applied to results of the 2000 Census.  Metro counties were distinguished by population size of 
the Metropolitan Statistical Area of which they are part.  Nonmetro counties were classified 
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according to the aggregate size of their urban population.  Within the three urban size categories, 
nonmetro counties were further identified by whether or not they have some functional 
adjacency to a metro area or areas.  A nonmetro county was defined as adjacent if it physically 
adjoins one or more metro areas, and has at least two percent of its employed labor force 
commuting to central metro counties.  Nonmetro counties that do not meet these criteria are 
classed as nonadjacent.  Based on the continuum described above, the USDA defines the nine 
counties in this study as shown in Table 8.6 in Appendix A. 
The counties were further ranked based on total population, population miles of 
highways/roads in combination with the USDA’s continuum codes (Table 8.5, Appendix A).  
The counties were ranked for rurality on a scale from 1 to 9 with respect to the previously 
described measures above.  The overall rankings of rurality were calculated for each county by 
averaging the scores for each of the six measures.  The population data was obtained from the 
Census 2000, which was obtained from the U.S. Census Bureau, 2005 (13, 14).  The traffic-
related data was obtained from the Pennsylvania Department of Transportation (15). 
  
8.3.3 Case Definitions 
The hospitalization data for adults 18-106 years of age obtained from PHC4 contained the 
admitting, principal, and eight secondary diagnosis codes for each hospitalization event that 
occurred within in the study area during 2007.  The Principal Diagnosis Code is the ICD.9 
diagnosis code assigned at discharge as the reason for the hospitalization as supplied by the 
facility.  It may differ from the admitting diagnosis.  The secondary diagnosis codes 1-8 are 
additional ICD.9 diagnosis codes assigned to describe additional conditions that coexist at 
admission or are discovered during the hospitalization as supplied by the facility.   The age 
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variable was calculated by PHC4 and outliers were investigated through their research 
department.  The outliers were verified to the best of the researcher’s knowledge and remain in 
the analysis.  All persons who were hospitalized during the 2007 calendar year with a diagnosis 
for diabetes in any diagnosis code fields were used to calculate the hospitalization rates.  
Hospitalizations rates per 10,000 adult residents were calculated for diabetes as the principal 
diagnosis only and any listed diagnosis (includes the admitting, principal, or any of the eight 
secondary diagnoses).  For these events, the International Classification of Diseases, Ninth 
Revision, Clinical Modification codes (ICD-9) for diabetes (250.xy; where, x = 
0,1,2,3,4,5,6,7,8,9 and y = 0,1,2,3) as the diagnosis code were used to calculate rates.  The 
hospitalization rates were age and sex-adjusted using the standard 2000 U.S. population 
estimates from the U.S Census Bureau (13).  The hospitalization rates for uncontrolled diabetes 
(250.02; 250.03) as any listed diagnosis and long-term complications of diabetes (250.xy; where, 
x = 4,5,6,7,8,9 and y = 0,1,2,3) as any-listed diagnosis were also calculated.  The hospitalization 
rates for short-term complications diabetes (250.xy; where, x = 1,2,3 and y = 0,1,2,3) as any 
listed diagnosis and end stage renal disease (250.40-250.43, 996.62, 996.73, and 996.81) as any 
listed diagnosis were calculated as well.  A more descriptive listing of these ICD-9 codes is 
displayed in Table 8.7, Appendix A.  Age-adjusted rates were calculated by stratifying the 
population into four age groups: 18-44, 45-64, 65-74, and 75 years of age and greater.  These age 
categories were used to follow the age categories of the Centers for Disease Control and 
Prevention (CDC) (17).  The zip code of the patients’ residence was used to define the county of 
residence, and to prevent calculating rates for the county in which the patient was hospitalized.  
Since this study is interested in the geographical variance associated with the patients’ residence 
and not necessarily hospitalizations rates due to diabetes, it was important to make this 
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distinction.  To control for individuals hospitalized more then once in the 2007 calendar year, a 
unique patient identifier was used to calculate the hospitalization rates.  This unique number was 
randomly generated for each patient in the data set and supplied by PHC4.  The rate presented 
reflect only one hospitalization event per unique identification number. 
 
8.3.4 Statistical Analysis 
The multi-level data was analyzed using General Estimating Equations (GEE) regression to test 
the association between uncontrolled diabetes rates and county rurality by calculating odds ratios 
(OR) and their 95% confidence intervals (CI).  This data is considered multi-level because the 
dataset contains both individual and county level variables.  A binary variable for the outcome 
was calculated for those individuals hospitalized for uncontrolled diabetes (= 1) versus those 
hospitalized for all other diabetes ICD-9 codes (= 0).  Individual variables that were thought to 
be important characteristics in those with diabetes such as age, race, and gender were added to 
the model.  Race was coded for non-whites and whites so that the minorities were grouped 
together due to low numbers in this category.  Age was entered into the model as both a 
continuous individual variable and as a county mean age to assess differences between the 
counties.  Prior studies cited factors related to educational attainment and income as contributing 
to poor health outcomes (8-12).  Since this data was not available at the individual-level for these 
hospitalization events, the study employed county averages of the percentage of residents living 
below the poverty level and the percentage of residents with a high school diploma or higher 
degree to determine the distribution of socioeconomic data for each county.  The insurance 
information for each patient was also included in the analysis as a measure of poverty.  In the full 
model, gender and percent living below the poverty level were not statistically significant.  Each 
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of these variables was removed from the model individually with no changes to the model.  
However, due to the importance of the two variables to diabetes outcomes, they remained in the 
final regression model.  Statistical analyses were performed with SAS 9.1, GeoDa, and Excel to 
determine the odds ratios, county rankings, and spatial autocorrelation.  All estimates of 
significance were at p = .05 level.   
Cloropleth maps of the hospitalizations rates for each of the counties were created using 
ArcMap Software (Figures 8.12-8.16, Appendix A).  These maps use a color gradient to 
symbolize the classifications of rates.  GeoDa Software was employed to analyze spatial 
autocorrelation and whether the hospitalization rates of in one county correlate with neighboring 
counties.  The presence, absence, or characteristics of some spatial objects may sometimes have 
significant impacts on the presence, absence, or characteristics of the neighboring objects (7).  
Moran’s I was the indicator used to examine spatial autocorrelation between the county’s rates.  
The Queen weighting algorithm was used, which defines neighboring counties as those that meet 
around the borders.  Moran’s I statistic is based on a scale of 1 to -1; 0 indicates no correlation 
and 1 indicates perfect correlation (Figures 8.9 – 8.11, Appendix A). 
 
8.4 RESULTS 
 
8.4.1 Description of the Population 
The analysis included 54,703 patients from nine counties who were hospitalized with an ICD-9 
code for diabetes, any-listed diagnosis during 2007.  They were predominantly older (59.2% age 
65 or more), female (53.6%), and Caucasian (88.9%).  Allegheny County had the highest 
percentage of Blacks (19.8%) and Washington County had the highest mean age (68.2 years 
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old).  Table 8.4 includes the population characteristics by county.  Based on the county rurality 
ranks, Armstrong and Greene Counties were ranked the most rural; Westmoreland and 
Allegheny Counties were ranked the least rural. 
Age-adjusted adult diabetes hospitalization rates (per 10,000 residents) among those with 
diabetes for each county are displayed in Figures 8.0-8.8, Appendix A.  The unit of analysis for 
these rates is the individual; the total number hospitalizations were unavailable therefore, the 
total number of diabetes hospitalizations was used to calculate the following rates.   During 
2007, diabetes was the principal diagnosis among all diabetes hospitalizations upon admission in 
14.5 per 10,000 adult residents, and the any-listed diagnosis in 246.8 per 10,000 adult residents 
for the entire study area.  Allegheny County, which ranked as the least rural county, had the 
highest age-adjusted diabetes hospitalization rate as a principal diagnosis (17.8 per 10,000).  This 
rate was also high in Washington County (14.1 per 10,000), which also ranked among the least 
rural.  The age-adjusted rates per 10,000 adult residents for the other counties in order from most 
rural to least are as follows: Armstrong (7.9); Greene (4.4); Fayette (11.9); Cambria (7.4); 
Indiana (9.7); Somerset (12.5); and Westmoreland (12.7) (Figure 8.1).  At a rate of 49.1 per 
10,000, non-Hispanic Black residents had hospitalization rates for diabetes as a principal 
diagnosis 3.6 times that of non-Hispanic Whites (13.4 per 10,000).  At a rate of 409.1 per 10,000, 
non-Hispanic Black residents had hospitalization rates for diabetes as any-listed diagnosis 1.5 
times that of non-Hispanic whites (282.3 per 10,000). 
  Uncontrolled diabetes as any-listed diagnoses upon admission hospitalization rates were 
also calculated for the study area, 8.2 per 10,000 adult residents (Table 8.4).  The hospitalization 
rates for all types of diabetes diagnoses examined in this study were slightly higher in male than 
in females in all counties; Hospitalization rates for uncontrolled diabetes as an any-listed 
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diagnosis was 7.9 per 10,000 adult residents in males and 7.2 per 10,000 adult residents in 
females; 15.2 and 12.6 per 10,000 adult residents for diabetes as a principal diagnosis, 
respectively; and 237.9 and 211.4 per 10,000 adult residents for diabetes as an any-listed 
diagnosis at hospitalization.  Additionally, the highest rates of uncontrolled diabetes 
hospitalization occurred in the 45-64 years age group.  In general, males and females had similar 
hospital admission rates for diabetes in 2007, 16.8 and 15.2 per 10,000 adults respectively.  
Similar rates were also found in uncontrolled diabetes hospitalization rates as well as 
hospitalization rates due to diabetes complications. 
The hospitalization rates for short-term complications of diabetes were the highest in 
Somerset and Westmoreland Counties (5.2 and 4.8 per 10,000, respectively) and the lowest in 
Armstrong, Greene and Indiana Counties (2.3, 2.5 and 2.5 per 10,000, respectively (Figure 8.6, 
Appendix A).  Similarly, hospitalization rates for long-term complications of diabetes were 
highest in Washington and Westmoreland Counties (58.6 and 45.1 per 10,000) and lowest in 
Greene County (13.9 per 10,000 adult residents) (Figure 8.7).  Hospitalization rates for End-
Stage Renal Disease were highest in Washington and Cambria Counties (16.5 and 10.8 per 
10,000) and lowest in Greene and Indiana Counties (2.5 and 6.8 per 10,000 residents) (Figure 
8.8, Appendix A).  
The proportion of hospitalizations by type of patient insurance was calculated for each 
county.  The proportion of patients with Medicare was the highest type of insurance coverage 
among all counties ranging from 48.9% in Cambria County to 66.2% in Armstrong County 
(Table 8.4).  The proportion of hospitalizations by type of admission was also calculated.  
Individuals who were hospitalized for uncontrolled diabetes were overwhelmingly more likely to 
be an emergency or urgent admission (67.9% - 96.3%).  An emergency admission was defined 
 112 
by PHC4 as the patient required immediate medical intervention as a result of severe, life 
threatening, or potentially disabling conditions.  An urgent admission was defined as the patient 
required immediate attention for the care and treatment of a physical or mental disorder; an 
elective admission occurred when the patient’s condition permitted adequate time to schedule the 
availability of a suitable accommodation.  A trauma admission was defined as a visit to a trauma 
center/hospital involving trauma activation. 
 
8.4.2 GEE Regression 
Univariate analysis was conducted to explore differences between the counties for age, gender, 
race and the measures of poverty.  The differences among counties for all four of these variables 
were found to be significant.  The significant p-value attained for the race variable was 
accounted for by the considerably higher percentage of Black residents in Allegheny County.  
Using GEE regression, county rurality rank, age, gender, and race, percentage of residents living 
below the poverty level, percentage of residents with a high school degree or higher, and 
percentage of patients who are uninsured or receiving Medicaid were assessed for their 
contribution to the adult uncontrolled diabetes versus all other diabetes hospitalization rates for 
any-listed diagnosis.  The results indicated that residing in a more rural area (OR = 1.11, P = 
<0.0001), being younger (OR = 0.98, P = <0.0001), non-white (OR = 1.25, P = 0.002), percent 
uninsured or receiving Medicaid (OR = 0.96, P = <0.0001) and percent with a high school degree 
or higher (OR = 0.89, P = <0.0001) were significant contributors to the model while gender was 
not significant (OR = 1.04, p = 0.46) (Table 8.1). 
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Table 8.1: Odds Ratios and 95% Confidence Intervals (CI) for Likelihood of Being 
Hospitalized for Uncontrolled Diabetes Compared to All Other Diabetes Diagnoses 
 
Parameter P-value Odds  95% CI 
County Rurality Rank <0.0001 1.11 1.06, 1.17 
% Uninsured/Medicaid <0.0001 0.97 0.96, 0.98 
Age (continuous) <0.0001 0.98 0.98, 0.99 
Race - Non-white 0.005 1.23 1.06, 1.41 
Sex- Male 0.47 1.04 0.94, 1.14 
% Graduated High School <0.0001 0.91 0.87, 0.95 
% Living Under Poverty Level 0.10 1.02 1.00, 1.04 
County Mean Age 0.001 1.28 1.09, 1.50 
 
The diabetes hospitalization rates for uncontrolled and all diabetes for each county were 
entered into GeoDa software to examine spatial autocorrelation.  The Moran’s I for rates of 
diabetes as the principal and any-listed diagnosis as well as uncontrolled diabetes as any-listed 
diagnosis indicated no significant spatial autocorrelation to neighboring counties (-0.11,   -0.19, -
0.29, respectively).  Moran’s I graphs are included in Figures 8.9 – 8.11. 
 
8.5 CONCLUSIONS 
 
Results of this study indicate an association between the rurality of a county and the diabetes 
hospitalization rates of the county’s residents.  Residents of more rural counties were 11% more 
likely to be hospitalized for uncontrolled diabetes compared to all other diabetes hospitalizations, 
for every increase in rurality rank.  For example, a resident in Armstrong County (Rurality Rank 
= 1) is 27% more likely to be hospitalized for uncontrolled diabetes than a resident in the same 
age category, gender, and race in Allegheny County (Rurality Rank = 9).  This relationship may 
not be reflected in the hospitalization rates that were calculated for each county because these are 
rates that are based on the total population of the county and is per 10,000 adult residents of said 
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county.  The relationship that was explored here analyzed the relationship between those 
hospitalized for uncontrolled diabetes compared to those hospitalized for all other diabetes-
related diagnoses.  This is an important distinction to address and is explored in more detail in 
the following sections.  Furthermore, the diabetes hospitalization rates may be higher in those 
counties that are less rural, however, according to data from the Pennsylvania Department of 
Health, the diabetes and cardiovascular disease mortality rates are higher in more rural counties 
(Table 8.2).  This may indicate that those with diabetes in more urban counties are seeking health 
care at a greater rate but those in more rural counties are dying from diabetes-related causes.  
This may be reflected in the results from this study that indicated that residing in a more rural 
area (OR = 1.11, P = <0.0001), being younger (OR = 0.98, P = <0.0001), non-white (OR = 1.25, 
P = 0.002), percent uninsured or receiving Medicaid (OR = 0.96, P = <0.0001) and percent with 
a high school degree or higher (OR = 0.89, P = <0.0001) were significant contributors to the 
model while gender was not significant (OR = 1.04, p = 0.46).  Furthermore, these findings 
reflect the estimates from the National Center of Health Statistics which found that in 1995, the 
self-reported prevalence of diabetes in non-metropolitan statistical areas (NMSAs) of the U.S. 
(3.6 percent) was higher than in central cities (3.19 percent) and all MSAs (3.24 percent) (17).   
Diabetes is the sixth leading cause of death and imposes a costly burden on the American 
health care system (1).  It is important to examine the rates of hospitalization in order to find 
solutions to reduce the number of hospital visits in those with diabetes.  Diabetes is a chronic, 
lifelong disease with no cure.  Further, those with diabetes undergo costly treatment with less 
than half achieving clinical goals (5).  According to the National Hospital Discharge Survey, 
diabetes is the sixth leading cause of hospitalization in the U.S. for men at least 45 years old, and 
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the seventh overall for women of comparable ages (21).  In 1996, diabetes was listed as a 
discharge diagnosis in 3.8 million individuals (21).  
According to the Rural Healthy People 2010 survey, diabetes was identified as the third 
highest ranking rural health concern (16).  In this nationwide survey of state and local rural 
health leaders, diabetes was ranked third among the most frequently nominated rural health 
priorities, after access and heart disease and stroke (16).  The issue of rural-urban disparities for 
diabetes is quite complex; however, the prevalence appears to be higher in developed rural areas, 
such as the areas examined here, and lower in undeveloped ones (18-20).  As the difference 
between rural and urban lifestyle disappear, higher rural prevalence may reflect differences in 
socioeconomic, racial/ethnic, or age status, more so than rurality per se.  Several measures of 
socioeconomic status (SES) were used here to explore these differences among the study 
counties.  The proportion of individuals that were uninsured (self-pay or charity/indigent care) or 
receiving Medicaid was significantly higher in Cambria County (27.5%) and Somerset County 
(25.3%) compared to the other counties in the study area.  The other measures of SES were at the 
county-level and are described in Table 8.5. 
One way to monitor the cost and quality of care received by individuals with diabetes is 
to examine the number and type of hospital admissions for diabetes (ref).  These admissions add 
to the high cost of this disease and suggest that individuals with diabetes might not have 
sufficient access to appropriate preventive care (ref).  Furthermore, in 2007, 15.2 percent of 
patients with diabetes in the study area were hospitalized two or more times, perhaps confirming 
other studies.  This study chose to focus on uncontrolled diabetes.  Hospital admissions for 
uncontrolled diabetes reflect the quality of outpatient care, self-management and other aspects of 
health care, and are of interest to comprehensive health care delivery systems (5).  Admissions 
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for uncontrolled diabetes can be prevented and therefore reduce the number of hospitalizations.  
This could lead to a decrease in health care related costs due to diabetes.  Hospitalizations for 
diabetes, particularly for uncontrolled diabetes, may be preventable because appropriate care can 
generally be provided on an outpatient basis (1).  If a patient reaches the point where 
hospitalization for diabetes is required, a breakdown in care, or access to care, may have already 
occurred.  It is important to note that an overwhelming proportion of the uncontrolled diabetes 
hospitalizations were emergency or urgent admissions.  In this study, these hospitalizations may 
be due to Type 1 diabetes for acute hyper or hypoglycemia could be prevented with proper self-
management through diabetes education and access to quality diabetes care.  Those that were 
hospitalized for uncontrolled diabetes were significantly younger than those who were 
hospitalized for other diabetes-related causes.  This may be because some of the hospitalizations 
for uncontrolled diabetes were attributed to Type 1 Diabetes, which is seen in the younger 
population.     
  A study conducted by the American Diabetes Association (ADA) estimated that in 
2007, the direct medical costs attributable to diabetes reached $116 billion (22).  People 
diagnosed with diabetes, on average, have medical expenditures that are roughly 2.3 times higher 
than those without diabetes (22).  Diabetes-related hospitalizations totaled 24.3 million days in 
2007, an increase of 7.4 million from the 16.9 million days in 2002 (23).  The average cost for a 
hospital inpatient day due to diabetes is $1,853 and $2,281 due to diabetes-related chronic 
complications, including neurological, peripheral vascular, cardiovascular, renal, metabolic, and 
ophthalmic complications (23).       
During 2007, diabetes was the principal diagnosis upon admission in 14.5 per 10,000 
adult residents, and the any-listed diagnosis in 246.8 per 10,000 adult residents for the entire 
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study area.  The hospital rates that examined principal diagnosis suggest that the reason for the 
admission was a direct result of diabetes and therefore an important distinction to make.  
Hospital admission rates for diabetes increased with age; the highest rates were found in those in 
the 75 years and older age category.  At a rate of 49.1 per 10,000, non-Hispanic Black residents 
had hospitalization rates for diabetes as a principal diagnosis 3.6 times that of non-Hispanic 
whites (13.4 per 10,000).  At a rate of 409.1 per 10,000, non-Hispanic Black residents had 
hospitalization rates for diabetes as any-listed diagnosis 1.5 times that of non-Hispanic whites 
(282.3 per 10,000). According the Centers for Disease Control and Prevention non-Hispanic 
Blacks are 1.6 times as likely to have diabetes as non-Hispanic whites of similar age, on average.   
Short-term complications of diabetes include acute, life-threatening events, such as 
diabetic coma and diabetic ketoacidosis.  Hospitalization admission rates for these events may be 
an immediate reflection of how well patients are managing their diabetes.  PHC4 found that the 
hospitalization for short-term complications in the state of Pennsylvania was 4.9 per 10,000 
residents in 2004.  Similar any-listed diagnosis hospitalization rates were found in the study area, 
ranging from 2.3 – 5.2 per 10,000 residents.  Also, it should be noted that the figures presented 
by PHC4 reflect hospitalizations, not persons.  An individual hospitalized on two separate 
occasions during 2004 was counted twice.  This may account for the over-estimation of their 
hospital rates.   
Long-term complications of diabetes include chronic problems such as stroke, kidney 
disease, neurological complications, etc. that develop over a period of years.  Hospitalizations for 
these events may be a reflection of how well individuals are managing their diabetes over a long 
period.  Rates for these any-listed diagnosis hospitalizations in the study are ranged from 13.9-
58.6 per 10,000 adult residents.   
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The literature demonstrates that diabetes encompasses behavioral, environmental, social, 
and clinical factors, all which play an important role in the management of the disease.  It is 
assumed that behavioral characteristics of individuals with diabetes are affected by their access 
to health care and disease prevention facilities, a healthy local food environment and physical 
activity locations.  Furthermore, it is believed that those living in more rural areas have less 
access to these locations and therefore will have higher rates of disease.  We believe that our 
work in this report will provide further evidence for this theory. 
This current study also adds to the existing literature by describing a population at the 
individual-level for a small geographic area.  Most of the data collected for diabetes rates are 
extrapolated from larger random surveys and exact rates are not available at the county-level for 
many states.  This study uses individual-level data to calculate county-level data.  It also focuses 
on hospitalizations for uncontrolled diabetes which can be an indication of how well the health 
care system in an area is performing.  The majority of the literature on the geographic variation 
of chronic diseases and diabetes examines urban areas and does not focus on rural populations.  
The rurality of an area is difficult to define and several factors were considered in this study.  
Larger differences between the rural counties and less rural counties may have been found if 
different or other factors were accessed.  Population density and daily vehicle miles traveled may 
not be the most important determinants of rurality in terms of diabetes care.    
Green et al. (24) used GIS to identify the socio-demographic, environmental, and lifestyle 
factors associated with the geographic variability of diabetes.  Mapping and statistical analysis 
revealed substantial clustering in the prevalence of diabetes in the City of Winnipeg, Canada.  
The observed variations were associated with variations in socioeconomic, environmental, and 
lifestyle characteristics of the population (24).  High rates of diabetes prevalence were strongly 
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correlated with indicators of low socioeconomic status, and poor environmental air quality.  
These prevalence rates were based on aggregate data from the Canadian Health Service, and did 
not include individual-level data. 
 Samuelsson and Löfman (25) investigated geographic clusters of type 1 diabetes in 
children and adolescents in south east Sweden.  The authors sought to estimate the spatial 
distribution of incidence.  The population at risk was obtained directly from the population 
registry for the years and geographical area levels used for the cases.  The researchers found a 
significant geographical variation in incidence rate were found between the municipalities 
(p<0.001) but not between the counties. The variation became somewhat weaker when excluding 
the six largest municipalities (p<0.02).  They further explained that apart from chance, the most 
probable explanation of this is that local environmental factors play a part in the process leading 
to type 1 diabetes (25).  The authors did not further investigate the environmental factors that my 
attribute to the increased rate in some areas. 
This is the first study, to our knowledge, to consider diabetes hospitalization rates at the 
geographic scale of the county-level and link it to the rurality of the county.  The methodology 
used in this study can be transported to any other geographical area to determine disparities in 
urban and rural areas.  Furthermore, it is one of the only studies to focus on hospitalizations for 
uncontrolled diabetes, which may be a predictor of a breakdown in health care or access to care.  
This study did have limitations.  First, this study did not have the number of total hospitalizations 
for 2007 in the study area.  This did not allow for the calculation of rates based on all 
hospitalizations and allow for comparisons of age, gender, and race for those who were not 
hospitalized for diabetes.  Although a number of potential confounders were controlled for in the 
multivariate analyses, residual confounding by unmeasured variables such as health care 
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insurance cannot be ruled out.  A distinction between the principal diagnosis and any-listed 
diagnosis was also made.  Oftentimes although diabetes is the underlying cause of the 
hospitalization, other diagnoses are listed as the principal diagnosis by hospitals.  By looking at 
both principal and all of the secondary diagnoses, a clearer picture of the burden of diabetes 
becomes apparent (Figures 8.0, 8.1).  Ideally, as many counties as possible should be considered 
in the analysis to include a larger geographical scale.  However, due to funding issues, this 
geographical area was chosen.  The results of this study may not be generalizable to all other 
geographical areas and may be unique to Southwestern Pennsylvania.  This area has many 
unique characteristics in terms of geography, climate, public health infrastructure, and cultural 
norms that make it an important are to study for health disparities.   
Based on the findings of this study, residents of rural counties have higher rates of 
uncontrolled diabetes hospitalizations compared to all diabetes hospitalizations.  This is 
significant to public health because diabetes is a serious, costly disease, in which hospitalizations 
continue to rise.  It is responsible for $174 billion in direct medical costs and indirect (work loss, 
disability, premature death) medical expenditures every year.  Diabetes also has an enormous 
impact on the affected individual, their families, and the health care system.  Understanding 
where gaps in health care and diabetes management education exist may lead to changes in 
policy and the local neighborhood environment to increase the access of rural residents.  It is 
important to further investigate the access residents of these counties have to health care 
facilities, other disease prevention facilities, and the local food and physical activity 
environments.  This will shed more light on how the environment of individuals with diabetes 
affects their overall health and their ability to control their diabetes. 
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8.6 TABLES 
Table 8.2 Measures of Rurality and SES and Rankings of Nine Counties in Pennsylvania 
County 
% 
Under 
Poverty 
Levela 
Median 
Household 
Incomea 
%  
High 
School 
Diplomaa 
Total 
Pop. a 
Population 
Density 
(persons/mi2)a 
Miles of 
Hwys/ 
Roadsb 
Daily 
Vehicle 
Miles 
Traveledb 
% Black 
Residentsa 
Age-
Adjusted 
Diabetes 
Mortality 
Ratesd 
Age-
Adjusted 
CVD 
Mortality 
Ratesd 
USDA 
Rural-
Urban 
Continuum 
Codese 
Overall 
Rankc 
Armstrong 13.3 50,007 87.0 
72,392 
(8) 106 (7) 
1,855 
(7) 23.6 (8) 0.8 27.4 280.6 1 9 
Greene 18.0 36,647 83.1 
40,672 
(9) 69 (9) 
1,468 
(9) 40.5 (1) 3.9 28.4 349.4 6 8 
Fayette 19.7 31,637 81.9 
144,556 
(5) 183 (5) 
2,081 
(6) 21.3 (9) 4.0 38.6 318.7 1 7 
Cambria  12.6 34,387 85.7 
144,995 
(4) 211 (4) 
1,724 
(8) 24.5 (7) 3.4 23.8 325.5 3 6 
Indiana  16.0 38,735 84.6 
87,690 
(6) 107 (6) 
2,090 
(5) 29.5 (5) 2.0 31.0 265.8 4 5 
Somerset  12.3 33,837 81.4 
77,861 
(7) 72 (8) 
2,287 
(4) 38.3 (2) 2.2 23.8 302.9 4 4 
Washing-
ton  10.0 45,789 87.9 
205,553 
(3) 240 (3) 
2,873 
(3) 35.1 (3) 3.3 29.8 277.4 1 3 
Westmore-
land 9.3 45,289 89.9 
369,993 
(2) 353 (2) 
3,731 
(2) 32.6 (4) 2.2 23.1 302.2 1 2 
Allegheny 12.4 45,266 90.6 
1,281,666 
(1) 1670 (1) 
5,688 
(1) 28.0 (6) 12.7 22.1 294.9 1 1 
a Data from U.S. Census Bureau (13) 
b Data from the Pennsylvania Department of Transportation (15) 
c Average of the four measures of rurality and SES (9 = most rural to 1 = least rural) 
d Data from PADOH; A rate that appears in bold for a county denotes a significantly higher value compared to the state’s rate (26) 
e United States Department of Agriculture Economic Research Service (6) 
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Table 8.3 Age-Adjusted Diabetes Hospitalization Rates, per 10,000 Adult Residents, by County, 2007 
County 
Armstrong             
n =1,156 
Greene         
n =465 
Fayette          
n =3,293 
Cambria           
n =3,386 
Indiana           
n =1,779 
Somerset       
n =2,151 
Washington     
n =5,954 
Westmoreland    
n =11,258 
Allegheny       
n =25,261 
Total Area               
N =54,703 
Uncontrolled 
Diabetes,  
Any-Listed 
Diagnosis 2.1 5.5 9 3.7 10.8 6.3 12.3 10 8.2 7.9 
Diabetes, 
Principal 
Diagnosis 7.9 4.4 11.9 7.4 9.7 12.5 14.1 12.7 14.5 17.8 
Diabetes, 
Any-Listed 
Diagnoses 230.1 138 243.6 138 242.6 288.4 314.9 322.6 221.7 246.8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Most Rural         Least Rural 
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Table 8.4 Population Characteristics, by County, N = 54,703 subjects 
  
County 
Allegheny       
n =25,261 
Armstrong             
n =1,156 
Cambria           
n =3,386 
Fayette          
n =3,293 
Greene         
n =465 
Indiana           
n =1,779 
Somerset       
n =2,151 
Washington     
n =5,954 
Westmoreland    
n =11,258 
Total Area               
N =54,703 p-value 
Age                     <. 0001 
Mean [sd] 66.5 [14.8] 66.9 [14.7] 67.3 [14.1] 65.9[14.1] 63.7 [14.2] 67.1 [14.5] 68.1 [13.7] 68.2 [13.93] 67.9 [14.4] 66.9 [14.5]   
Range 18 - 105 19 - 98 18 - 102 18 - 101 19 - 93 18 - 96 18 - 98 19 - 106 18 - 106 18 - 106   
Race n(%)                     <. 0001 
Asian/Isl. Pac. 50(0.2) 1(0.1) 3(0.1) 3(0.1) 0(0.0) 2(0.1) 3(0.1) 9(0.2) 11(0.1) 82(0.2)   
Black 4993(19.8) 14(1.2) 113(3.3) 113(3.4) 3(0.4) 12(0.7) 7(0.2) 290(4.9) 392(3.5) 
5941 
(10.9)   
Native American 13(0.1) 0(0.0) 1(0.03) 2(0.1) 0(0.0) 1(0.1) 0(0.0) 2(0.03) 3(0.03) 22(0.04)   
White 
20200 
(79.9) 1141(98.7) 
3269 
(96.5) 3175(96.4) 463(99.6) 
1764 
(99.1) 
2141 
(99.7) 5653(94.9) 
10852 
(96.4) 
48658 
(88.9)   
Gender n(%)                     0.022 
Female 
13671 
(54.1) 645(55.8) 
1853 
(54.7) 1754(53.3) 257(55.3) 967(54.4) 
1119 
(52.0) 3169(53.2) 5888(52.3) 
29323 
(53.6)   
Male 
11590 
(45.9) 511(44.2) 
1533 
(45.3) 1539(46.7) 208(44.7) 812(45.6) 
1032 
(48.0) 2785(46.8) 5370(47.7) 
25380 
(46.4)   
Insurance n(%)                     <.0001 
Uninsured 307(1.2) 4(0.4) 929(27.5) 22(0.7) 6(1.3) 122(6.9) 544(25.3) 45(0.8) 183(1.6) 2162(4.1)   
Medicare 
15159 
(60.1) 765(66.2) 160(48.9) 2139(65.2) 270(58.2) 
1130 
(63.5) 
1091 
(50.8) 3753(63.2) 7264(64.6) 
31731 
(59.7)   
Medicaid 1951(7.7) 93(8.0) 211(6.3) 417(12.7) 69(14.9) 118(6.6) 100(4.7) 453(7.6) 631(5.6) 4043(7.6)   
Comm./Govt 7668(31.0) 283(25.4) 567(17.3) 678(21.4) 117(25.6) 390(23.0) 396(19.2) 1642(28.4) 3048(28.1) 
14789 
(27.8)   
Unknown 154(0.6) 10(0.9) 20(0.6) 28(0.9) 2(0.4) 19(1.1) 16(0.8) 48(0.8) 112(1.0) 409(0.8)   
Admission Type 
n(%)                     <.0001 
Emergency 
12072 
(47.8) 571(49.4) 
1503 
(44.4) 1501(45.6) 50(10.8) 292(16.4) 961(44.7) 1508(25.3) 4848(43.1) 
23306 
(42.6)   
Urgent 2270(8.9) 122(10.6) 24(0.7) 319(9.7)) 170(36.6) 581(32.7) 16(0.7) 2557(42.9) 998(8.9) 
7057 
(12.9)   
Elective 8487(33.6) 235(20.3) 
1708 
(50.4) 617(18.7) 124(26.7) 596(33.5) 
1129 
(52.5) 1185(19.9) 3605(32.0) 
17686 
(32.3)   
Trauma 97(0.4) 2(0.2) 39(1.2) 6(0.2) 1(0.2) 6(0.3) 1(0.1) 22(0.4) 29(0.3) 163(0.3)   
Unknown 2335(9.2) 226(19.6) 112(3.3) 850(25.8) 120(25.8) 304(17.1) 44(2.0) 682(11.5) 1778(15.8) 
6491 
(11.9)   
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9.1 ABSTRACT 
 
Objective: To determine if there is an association between the availability of disease prevention 
and health care facilities, the local food environment and risk factors for diabetes complications.  
Hypothesis: The presence of supermarkets, full-service restaurants, physicians’ offices, hospitals 
and pharmacies will decrease the likelihood of having the risk factors for diabetes complications 
in individuals with type 2 diabetes.  
Research Design and Methods: Data on 3367 individuals with diabetes were collected from 
seven diabetes centers.  Data containing the 2007 location of businesses including fast food, 
limited-service and full-service restaurants, convenience and grocery stores, and supermarkets; 
physicians’ offices, hospitals and pharmacies were geocoded to the census tract level.  Individual 
risk factors included hypertension, hypercholesterolemia, overweight, obesity and A1c level.  
GEE regression was used to estimate odds ratios (OR) for having each risk factor and their 
association with the presence of different types of food stores and health care locations, 
controlling for individual level (age, race, gender, duration of diabetes) and community level 
(percent living below the poverty level, median income, percent of Black residents, and percent 
with a high school degree or higher) factors. 
Results: The analysis included 3,367 individuals with diabetes from seven diabetes centers in 
Southwestern Pennsylvania.  They were predominantly older (mean age = 67.9), female (56.8%), 
and Caucasian (94.6%).  Over 75% of the individuals had hypertension, 52.7% had 
hypercholesterolemia, 68.7% were overweight, 46.4% were obese and 50.4% had uncontrolled 
diabetes.  Nearly 57% of the individuals lived in census tracts with convenience stores, while 
only 24.3% lived in census tracts with large supermarkets.  Sixty-percent of individuals lived in 
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census tracts with fast food restaurants while only 41.0% lived in areas with full-service 
restaurants.  Approximately 57% of the population lived in census tracts with a physician’s 
office, 56.7% lived in an area with a pharmacy and only 8.0% lived near a hospital.   
While supermarkets and grocery stores were associated with a decrease in the likelihood 
of hypertension, hypercholesterolemia, being overweight and obese, the presence of convenience 
stores was associated with an increase in the likelihood of individuals having hypertension, 
hypercholesterolemia, being overweight, obese, and hyperglycemia, after adjusting for individual 
and community level factors.   
A similar trend was found in food service places.  The presence of full-service and 
limited-service restaurants was associated with a decrease in the likelihood of having 
hypertension, being overweight and obese while the existence of fast food restaurants was 
associated with an increased likelihood of having these factors.  The presence of any of the 
health care locations was associated with a decrease in the likelihood of having these factors.  
Conclusions: Results from this study indicate that the local food and health care environment at 
the neighborhood level is a possible ecological determinant of health.  There is a clear 
association between the presence of food stores and service places, and health care locations with 
risk factors for diabetes complications among individuals with diabetes.  The local environment 
has a significant impact on public health by possibly restricting a population’s food and health 
care choices and opportunities that affect health.   
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9.2 INTRODUCTION 
 
Diabetes has reached epidemic proportions and continues to grow as one of the most significant 
public health issues of modern times.  Individuals with diabetes are at increased risk for vascular 
disease, including microvascular complications (i.e., retinopathy, nephropathy, and neuropathy), 
macrovascular complications (i.e., stroke, coronary heart disease, lower extremity arterial 
disease).  Certain environmental aspects play an important role in the prevention and treatment 
of chronic diseases including as diabetes and its complications.  Studies show that access to 
health care, diet, physical activity, housing, income, and environmental exposures contribute to 
chronic diseases, which are all part an individual’s environment or community (1,2,3).  Diet is an 
important part of the treatment of diabetes and maintenance of glycemic control.  The American 
Diabetes Association recommends that people with diabetes consume a diet low in fat and high 
in fiber-containing foods such as fruits, vegetables, and whole grains.  The availability of these 
and other recommended foods in neighborhood food stores may influence the food choices of 
adults with diabetes (29).  Risk factors for diabetes complications include obesity and 
overweight, hypertension, hyperglycemia and high cholesterol.  These risk factors may be 
associated with certain environmental aspects of a population.   
 An increasing number of studies in the public and environmental health literature 
demonstrate that individuals’ health and health behaviors are affected by their surroundings (12-
14).  Recently, researchers in Canada determined that areas in which the number of places selling 
wine increased, wine consumption by residents also increased (15).  Investigators more than a 
decade ago found that physical proximity to a medical facility or doctor’s office affected 
utilization of healthcare resources (16). 
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 The role that diet plays in the causation and prevention of diabetes and diabetes-related 
complications has been studied for several years.  An individual’s ability to meet dietary 
recommendations for a healthy diet has been a concern of public health researchers and 
practitioners for many years as well.  Previous work demonstrates that dietary choices may be 
influenced by many factors including taste, nutrition, weight control, convenience, and cost (17).  
Some studies show that cost is the most significant predictor of dietary choices, making healthy 
eating habits difficult to achieve for the economically disadvantaged (18-20).  Research also 
suggests that low-income individuals generally cannot afford healthier foods (21).  Other data 
indicates that food costs more for people of low socioeconomic status because purchases are 
made in lesser quantities at convenience and small grocery stores and there is more reliance on 
processed food.  Residents in lower income areas may need to depend on these smaller stores 
with limited selection of foods at substantially higher prices (22). 
 Cost is an important barrier; however, very few studies have attempted to focus on 
locality as a factor that may inhibit a population’s ability to acquire a healthy diet.  A study 
conducted in San Diego, CA compared supermarkets, neighborhood grocery stores, convenience 
stores (i.e., Seven-Elevens), and health food stores.  The authors found that supermarkets had 
twice the average number of “heart-healthy” food compared to neighborhood grocery stores and 
four times the average number of such foods compared to convenience stores (23).  There is little 
other data on the contents of convenience stores, but they are assumed to carry a larger 
proportion of energy-dense foods.  Since the food choices that people make are limited to what is 
available to them, and convenience is an important predictor for food habits (24, 17), it is 
hypothesized that individuals living in areas with few food choices other than convenience stores 
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may be more likely to adopt an energy-dense diet.  Alternatively, food environments offering a 
greater variety of healthy food options at affordable prices may lead to healthier food choices.  
Despite the availability of effective treatments, many patients with diabetes do not 
receive optimal care.  Driving distance is one aspect of travel burden, and may serve as a marker 
for at least some of the burden of obtaining diabetes care (28).   
In the face of a steadily increasing prevalence of diabetes, the health care system has 
failed to prevent, detect, and manage diabetes adequately, especially in rural areas.  When rural 
residents do see a doctor, they are more likely to see a generalist than a specialist for treatment of 
diabetes and related complications (28).   
 The impact of location of food stores and food service has on individuals’ diets remains 
unclear.  The few studies that have addressed locality have not investigated if the number and 
types of food stores and food services places are associated with risk factors of residents (8).  
Additionally, those with diabetes who reside rural areas are believed to be less likely to visit a 
physician than their urban counterparts, and fewer of them have insurance coverage for 
medications (8).  No studies at the time of publication explore the association of risk factors and 
numbers of local physicians’ offices and pharmacies.  Therefore, this study aims to describe the 
local food and health care environment, where residents can obtain food, care and 
pharmaceuticals in their neighborhood.   
 It is our objective to determine if there is an association between the availability of food 
stores, food service places, health care locations and the risk factors associated with 
complications of diabetes in a rural area.  Because of the previous positive associations between 
diet and availability of supermarkets (25) and full-service restaurants, it is hypothesized that the 
presence of supermarkets, full-service restaurants, physicians’ offices, and pharmacies will be 
 133 
associated with a lower prevalence of risk factors for diabetes complications in individuals with 
diabetes.  
 
9.3 METHODS 
9.3.1 Study Population 
In an effort to improve diabetes education and care, the University of Pittsburgh Diabetes 
Institute started a regional health care collaboration, the Pittsburgh Regional Initiative for 
Diabetes Education (PRIDE).  Nine counties (Allegheny, Armstrong, Cambria, Fayette, Greene, 
Indiana, Somerset, Washington, and Westmoreland) were selected from the study area where the 
partners of PRIDE diabetes centers are located.  Data on individuals with diabetes were collected 
using a data management system, Delphi.  This system was used by the University of Pittsburgh 
Diabetes Institute in order to collect data on individuals with diabetes attending diabetes centers 
throughout southwestern Pennsylvania.  The participating centers include: The Center for 
Diabetes Care at the Indiana Regional Medical Center, Community Medical Services, 
Centerville Clinics, Inc., Conemaugh Diabetes Institute, The Diabetes Center at Uniontown 
Hospital, Highlands Hospital Diabetes Center and the Washington Hospital Diabetes Education 
& Management Program.  The Delphi Data Management System allowed the staff of these 
centers to enter patient data into an organized system.  Individual-level data such as home street 
addresses, demographics, lab test data, medications, health indicators, co-morbid conditions, and 
complications were entered into this data system from June 2005 to January 2007.  The variable 
list is included in Table 9.6, Appendix B.  All of the individuals 18 years and older that were 
entered into the Delphi system (n=3367) were diagnosed by their physician with diabetes prior to 
be being referred to the diabetes center.   
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9.3.2 Measurement of the Local Environment 
Data containing the 2007 location of businesses for the study area was purchased from the 
Environmental Sciences Research Institute (ESRI), Redlands, CA.  Types of businesses in this 
data set include fast food, limited-service and full-service restaurants, convenience and grocery 
stores, and supermarkets; physicians’ offices, hospitals and pharmacies.  A list of these variables 
is displayed in Table 9.7, Appendix B.  Characteristics and the location (shape files for 
geocoding) of zip codes were obtained from the U.S. Census Bureau, 2000.  The 1997 North 
America Industry Classification System (NAICS) codes were modified to define the types of 
food stores.  Supermarkets were defined as large corporate owned “chain” food stores (e.g. Giant 
Eagle, Shop and Save).  These stores contain frozen and canned foods, bakery items, fresh fruits 
and vegetables, meat, fish, poultry, and may have delicatessens.  Grocery stores were 
distinguished as smaller non-corporate-owned food stores.  Convenience stores included all food 
stores that carry a limited selection of foods, mostly snack foods, whether or not attached to gas 
station.  In addition to food stores, other types of places where residents buy food were classified 
as full-service restaurants, franchised fast food (e.g. McDonald’s, Burger King, Pizza Hut), and 
limited-service restaurants.  Cafeterias were grouped with full-service restaurants.  Carry-out 
eating places such as sandwich shops, delis, ice cream and smoothie shops were included with 
limited-service restaurants.  Other types of places to obtain food, not mentioned above were not 
included in these analyses because of their small proportion of annual sales of foods and 
beverages in the United States.  Also, establishments that sell food items in bulk were excluded 
since they require a membership (Table 9.7, Appendix B). 
This study was only interested in the availability of food stores and food service places 
through local, routine sources.  Consequently, churches, community centers, schools, nursing 
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homes, and hospitals were excluded.  Shopping areas and places that are primarily for 
entertainment such as bowling alleys were also excluded because it can be assumed that few 
individuals rely on these places for a significant portion of their diet.  Physicians’ offices that do 
not pertain to diabetes and related complications (i.e. pediatricians, plastic surgeons, 
psychologists) were excluded from the data set since patients were unlikely to visit such offices 
for purposes important to this study. 
 Census tracts, national geographic boundaries containing approximately 3000 to 4000 
individuals, were used as proxies for neighborhoods.  The Delphi patients were collected from a 
total of 168 census tracts throughout six counties.  ArcGIS software (ESRI, Redlands, CA) was 
used to calculate the number of facilities in each census tract (Table 9.1).  
Table 9.1: Location Descriptions for the Entire Study Area Containing 1383 
Locations in 168 Census Tracts 
  n                    
Number of Census Tracts 
with the Location Type 
Locations (N=1383)     
Local Food Environment     
Supermarkets 45 36(21.4) 
Grocery Stores 124 86(51.2) 
Convenience Stores 142 90(53.6) 
Full Service Restaurants 92 67(39.9) 
Limited Service Restaurants 98 60(35.7) 
Fast Food Restaurants 187 88(52.4) 
Health Care     
Hospitals 15 13(7.8) 
Pharmacies 166 82(48.8) 
Physicians’ Offices 514 101(60.1) 
 
9.3.3 Definitions of Outcomes 
Laboratory values of the patients who were entered into the Delphi Data Management System 
were used to define the risk factor values for diabetes complications.  The first lab values that 
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were entered for each patient were used in the analysis.  Two categories of body weight 
(overweight and obesity), hypercholesterolemia and hypertension were created because of their 
importance as risk factors for diabetes complications and their association with diet.  Body Mass 
Index (BMI) was calculated as [weight in kilograms/height in meters2].  Individuals with a BMI 
≥25 were classified as overweight and those with a BMI ≥30 as obese.  Individuals were 
categorized as having hypercholesterolemia if they had a LDL >100 mg/dL, and/or who reported 
taking cholesterol lowering medications in the system.  Patients were considered to have 
hypertension if they had a systolic blood pressure measurement ≥130 mmHg or a diastolic 
measurement ≥80 mmHg and/or if they reported taking anti-hypertensive medications.  Subjects 
were classified as having hyperglycemia if they had an A1c level > 7.0% or reporting taking 
anti-diabetic medications. 
 
9.3.4 Statistical Analysis 
To estimate odds ratios (OR) of diabetes complications risk factors associated with the presence 
of different types of food stores, generalized estimating equations (GEE) logistic regression was 
performed using the PROC GENMOD program in SAS 9.1 (28).  This is a multilevel test that 
takes census tract and individual-level data into account and the repeated measures option was 
used to account for the clustering of subjects within the census tracts.  Each of the risk factors of 
hypertension, hypercholesterolemia, overweight, obese, and hyperglycemia was modeled 
separately.  First, dichotomous variables characterizing ‘any’ versus ‘none’ of that type of 
facilities within the census tract were created for each type food service place (fast food, limited-
service, and full-service restaurants), food store (supermarkets, grocery stores, and convenience 
stores), offices of physicians and pharmacies.  Indicator variables were also created to represent 
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the presence of specific combinations of types of food stores: (a) Supermarkets only, (b) Grocery 
stores only, (c) Convenience stores only, (d) Supermarkets, grocery stores, and convenience 
stores, (e) None, (f) Combination of stores; and food service places: (a) Full-service restaurants 
only, (b) Limited-service restaurants only, (c) Fast food restaurants only, (e) None, and (f) 
Combination of places.  The dichotomous variables were modeled for each of the risk factors, 
while controlling for age, gender, and duration of diabetes.  Since individual-level 
socioeconomic status (SES) information was not available, census tract information was used in 
the model to control for these factors.  The percentage of residents living below the poverty 
level, percentage of residents reporting Black as their race, median household income, and 
percentage of residents with a high school education or higher for each census tract were also 
considered in the regression models.  Descriptive analysis was conducted to calculate the mean 
and percentages of laboratory values, age, gender, duration of diabetes, co-morbidities and 
complications of diabetes.    
 
9.4 RESULTS 
 
9.4.1 Description of the Population 
The analysis included 3,367 individuals with diabetes from seven diabetes management centers 
in Southwestern Pennsylvania.  They were predominantly older (mean age = 67.9), female 
(57.6%), and Caucasian (94.6%).  Over 75% of the individuals had hypertension, 52.7% had 
hypercholesterolemia, 68.7% were overweight, 46.4% were obese and 50.4% have uncontrolled 
diabetes.  Nearly 57% of the individuals lived in census tracts with convenience stores, 51.6% 
lived near grocery stores, while only 24.3% lived in census tracts with large supermarkets.  A 
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similar trend can be seen in food service places; 59.8% of individuals lived in census tracts with 
fast food restaurants while only 41.0% lived in areas with full-service restaurants.  Fifty-seven 
percent of the population lived in census tracts with a physician’s office, 56.7% lived in an area 
with a pharmacy and only 8.0% lived near a hospital.      
 
9.4.2 GEE Regression 
The associations between the food and healthcare locations and the diabetes complications risk 
factors are presented in Table 9.3.  The associations were adjusted for individual-level factors 
such as age, duration of diabetes, race, and gender.  Since individual-level SES variables were 
unavailable, census track information for the percentage of residents living below the poverty 
level, median household income, percentage of residents with a high school education or higher, 
and percentage of residents reporting Black as their race were included in the model adjustment.  
Multi-collinearity was assessed between median household income, poverty level, and education.  
Theses variables were significantly correlated however the R value was low and the model did 
not change significantly when all three of these factors were entered into the model, so they were 
all included in the final model.  
The existence of supermarkets in the census track was associated with a lower likelihood 
of having hypertension and hypercholesterolemia.  Individuals who resided in a census tract with 
at least one supermarket were 13% less likely to have hypertension (OR=0.87, 95% confidence 
interval [CI] =0.78, 0.97) and 17% less likely to have hypercholesterolemia (OR=0.83, 95% CI 
=0.70, 0.89) than those living in census tracts without supermarkets, after adjusting for 
individual and census tract level characteristics.  Individuals who lived in an area with a grocery 
store were 5% less likely to have hypertension (OR =0.95, 95% CI =0.79, 1.14), 15% less likely 
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to be overweight (OR=0.85, 95% CI =0.51-0.91), and 6% less likely to be obese (OR =0.94, 95% 
CI 0.72-0.99) compared to those without a grocery store in their census track.  Conversely, the 
presence of at least one convenience store was associated with a higher likelihood of risk factors.  
Those with a convenience store in their census track were 58% more likely to have hypertension 
(OR=1.58, 95%CI =1.31, 1.91), 19% more likely to have  hypercholesterolemia (OR= 1.19, 95% 
CI = 1.00, 1.42), 82% more likely to be overweight (OR= 1.82, 95% CI= 1.47, 2.26), 45% more 
likely to be obese (OR= 1.45, 95% CI= 1.23, 1.72), and 19% more likely to have uncontrolled 
diabetes (OR= 1.19, 95%CI= 1.00, 1.41).   
The presence of food service locations was also found to have an effect on risk factors for 
diabetes complications.  Individuals with diabetes who lived in an area with a full-service 
restaurant were 39% less likely to have hypertension (OR=0.61, 95% CI= 0.50, 0.74), 36% less 
likely to be overweight (OR= 0.64, 95% CI= 0.52, 0.79) and 25% less likely to be obese (OR= 
0.75, 95% CI= 0.59, 0.83).  Those who reside in a census tract with at least one limited-service 
restaurant were 22% more likely to have hypercholesterolemia (OR= 1.22, 95% CI = 1.16, 1.73), 
80% more likely to be overweight (OR= 1.79, 95% CI 1.36, 2.37) and 43% more likely to be 
obese (OR= 1.43, 95% CI 1.17, 1.74) compared to those who do not have this restaurant in their 
census tract.  The presence of fast food restaurants was also associated with an increased 
likelihood of having risk factors of diabetes complications.  Individuals in the study who lived in 
a census tract with at least one fast food restaurant, were 78% more likely to have hypertension 
(OR= 1.78, 95% CI = 1.45, 2.19), 22% more likely to have hypercholesterolemia (OR=1.22, 
95% CI 1.01, 1.47), 62% more likely to be overweight (OR= 1.62, 95% CI=1.28, 2.06), and 61% 
more likely to be obese (OR= 1.61, 95% CI= 1.34, 1.94) compared to those who lived in a 
census tract without a fast food restaurant. 
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The existence of health care locations within an individual’s census track was also 
associated with a decrease in the likelihood risk factors.  Those who lived in an area with at least 
one pharmacy were 38% less likely to have hypertension (OR= 0.62, 95% CI = 0.51, 0.76) and 
31% less likely to have hypercholesterolemia (OR= 0.69, 95% CI= 0.58, 0.83).  The presence of 
a pharmacy was not significantly associated with being overweight, obese, or having and A1c > 
7.0%.  Compared to those who lived in an without an office of a physician, those who resided in 
a census tract with at least one office were 15% less likely to have hypertension (OR=0.85, 95% 
CI= 0.72, 0.90), 25% less likely to have hypercholesterolemia (OR=0.75, 95% CI= 0.65, 0.78) 
and 34% less likely to be overweight (OR=0.66, 95% CI= 0.53, 0.82).  Individuals who resided 
in a census tract with a hospital were 30% less likely to have hypertension (OR=0.70, 95% CI= 
0.52, 0.95) and 37% less likely to have hypercholesterolemia (OR= 0.63, 95% CI= 0.47, 0.85) 
compared to those who do not have a hospital within their census tract.  Complete results are 
reported in Table 9.3. 
The associations between certain combinations of food stores and service locations and 
risk factors were also explored.  These associations compare the likelihood of risk factors among 
individuals with diabetes in census tracts with different combinations of types of local food 
environment locations to those who live in a census tract with no locations.  The ratios displayed 
in Table 9.4 are adjusted for individual level age, race, gender and duration of diabetes, census 
level SES variables, and the presence of health care locations (pharmacies, offices of physicians, 
and hospitals).  Individuals who lived in a census tract with only one or more supermarkets were 
60% less likely to have hypertension (OR=0.40, 95% CI= 0.28, 0.57), 36% less likely to have 
hypercholesterolemia (OR=0.64, 95% CI= 0.47, 0.86), 20% less likely to be overweight 
(OR=0.80, 95% CI= 0.67, 0.94), 47% less likely to be obesity (OR=0.53, 95% CI=0.37, 0.75) 
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compared to those who had no food stores in their census tracts.  Individuals with only a grocery 
store in their census tract were 29% (OR=0.71, 95%=0.51, 0.99) less likely to have hypertension, 
43% more likely to have hypercholesterolemia (OR=1.43, 95% CI= 1.06, 1.93), and 10% less 
likely to be overweight (OR=0.90, 95% CI= 0.85, 0.98) compared to those who have no food 
stores in their area.  Those who resided in a census tract with only convenience stores were 68% 
more likely to have hypercholesterolemia (OR=1.68, 95% CI= 1.24, 2.27), 26% more likely to 
be overweight (OR= 1.26, 95% CI= 1.17, 1.94), and 37% more likely to be obese (OR=1.37, 
95% CI= 1.01, 1.85).  Subjects who lived in a census tract with all three types of food stores 
were nearly 4 times more likely to have hypercholesterolemia (OR=3.79, 95% CI= 2.49, 5.77) 
and 7% less likely to be overweight (OR=0.93, 95% CI= 0.28, 0.98).compared to those without a 
food store in their area.  There were no significant associations found between the combinations 
of food stores and glycemic control. 
Associations between risk factors for diabetes complications and certain combinations of 
restaurants within each census tract were also explored.  These associations followed a similar 
pattern to the food stores.  For example, those who lived in areas with only full-service 
restaurants were 59% less likely to have hypertension (OR=0.41, 95% CI = 0.30, 0.55), 63% less 
likely to be overweight (OR=0.37, 95% CI= 0.26, 0.50), and 55% less likely to be obese 
(OR=0.45, 95% CI=0.34, 0.60) compared to those who lived in census tracts without any 
restaurants.  Subjects who lived in census tracts with only fast food restaurants were 71% more 
likely to have hypertension (OR= 1.71, 95% CI= 1.12, 2.61), 98% more likely to be overweight 
(OR=1.98, 95% CI=1.17, 3.35) and 67% more likely to be obese (OR=1.67, 95% CI=1.19, 2.33).  
Those who lived in areas with only limited-service restaurants were 62% more likely to have 
hypercholesterolemia (OR=1.62, 95% CI=1.09, 2.40), 85% more likely to be overweight 
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(OR=1.85, 95% CI=1.02, 3.38).  Individuals who resided in areas with all three types of 
restaurants were 56% more likely to have hypertension (OR=1.56, 95% CI 1.06, 2.31), 2.3 times 
more likely to have hypercholesterolemia (OR= 2.3, 95% CI= 1.61, 3.29) compared to those 
without any restaurants in their census tracts.  Having more than one type of restaurant in your 
area is associated with a 73% increase in the likelihood of having hypertension (OR=1.73, 95% 
CI= 1.23, 2.44), 2.5 times more likely to be overweight (OR=2.53, 95% CI= 1.64, 3.92), and 
50% increase in the likelihood obesity (OR=1.50, 95% CI= 1.12, 2.01) compared to those who 
do not have any restaurants in their census tract, adjusting for individual and community level 
factors..  
 
9.5 CONCLUSION 
 
Results from this study indicated that the local food and health care environment at the 
neighborhood level is a possible ecological determinant of health.  There is a clear association 
between the presence of food stores and service places, and health care locations with risk factors 
of diabetes complications among individuals with diabetes.  The study subjects have type 2 
diabetes and many have risk factors for diabetes complications such as retinopathy, nephropathy, 
and neuropathy, macrovascular complications (i.e., stroke, coronary heart disease, lower 
extremity arterial disease).  Over 75% of the individuals had hypertension, 52.7% had 
hypercholesterolemia, 68.7% were overweight, 46.4% were obese and 50.4% had A1c values > 
7.0%.  Many of the subjects are from rural areas of Southwestern Pennsylvania, where it has 
become apparent that there is less access to healthy food and health care.  Nearly 57% of the 
individuals lived in census tracts with convenience stores, while only 24.3% lived in census 
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tracts with supermarkets.  A similar trend was observed for food service places; 59.8% of 
individuals lived in census tracts with fast food restaurants while only 41.0% lived in areas with 
full-service restaurants.  Roughly 57% of the population lived in census tracts with a physician’s 
office, 56.7% lived in an area with a pharmacy and only 8.0% lived near a hospital.  While 
supermarkets and grocery stores were associated with a decrease in the likelihood of 
hypertension, hypercholesterolemia, being overweight and obese, the presence of convenience 
stores was associated with an increase in the likelihood of individuals having hypertension, 
hypercholesterolemia, being overweight, obese, and an A1c > 7.0%, after adjusting for 
individual and community level factors.   
A similar trend was found in food service places.  The presence of full-service and 
limited-service restaurants was associated with a decrease in the likelihood of hypertension, 
being overweight and obese while the existence of fast food restaurants was associated with an 
increase in these factors.  The presence of any of the health care locations was associated with a 
decrease in the likelihood of these factors in those with Type 2 diabetes.   
Additionally, analyses were conducted to determine associations between risk factors and 
specific combinations of food locations and food service places.  Individuals who resided in a 
census tract with only a supermarket or only a grocery store were less likely to have 
hypertension, hypercholesterolemia, be overweight and obese, while those who lived in a census 
tract with only a convenience store were more likely to have these risk factors, compared to 
those who live in a census tract with no food stores, adjusted for individual and community level 
factors.  Furthermore, those who lived in census tracts with more than one type of store or all 
type of stores were more likely to be obese and have hypertension.  This may be because the 
presence of a convenience store in the census tract was driving the model.  As expected, a similar 
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trend was found in the restaurant models.  Subjects who lived in a census tract with only at least 
one full-service restaurant were less likely to have hypertension, be overweight and obese while 
those with only a fast food restaurant in their area were more likely to have hypertension, be 
overweight, or obese compared to those living in a census tract with no restaurants in their area.  
The local food and health care environment was not as associated with glycemic control as the 
other risk factors.  It was only associated with the presence of fast food restaurants.  This may be 
an artifact of the variability of A1c values over time. 
These findings expand on those of Moreland, Roux, and Wing (8) who conducted 
multilevel modeling in order to calculate prevalence ratios of the associations between the 
presence of specific types of food stores and cardiovascular disease risk factors.  The researchers 
used 2004 data from a cross-sectional study of men and women participating in the third visit 
(1993-1995) of the Atherosclerosis Risk Communities (ARIC) Study.  This analysis 
demonstrated that the presence of supermarkets was associated with a lower prevalence of 
obesity and overweight (obesity prevalence ratio [PR] = 0.83, 95% CI=0.75-0.92; overweight 
PR=0.94, 95% CI=0.90-0.98), and the presence of convenience stores was associated with a 
higher prevalence of obesity and overweight (obesity PR=1.16, 95% CI=1.05-1.27; overweight 
PR=1.06, 95% CI=1.02-1.10).  The results from this study suggest that characteristics of local 
food environments may play a role in the prevention of overweight and obesity (8).  Although 
our study focused on those with diabetes and risk factors of complications, and Moreland et al. 
used a cross-sectional population from major metropolitan areas, the results strengthen the 
associations between the local food environment and health.   
Inagami et al. (27) found residents in poor neighborhoods have a higher body mass index 
(BMI) and eat less healthfully. One possible reason might be the quality of available foods in 
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their area. The researchers examined the location of grocery stores where individuals shop and 
its association with BMI.  The 2000 U.S. Census data were linked with the Los Angeles Family 
and Neighborhood Study (L.A.FANS) database, which consists of adults sampled from 65 
neighborhoods in Los Angeles County.  Inagami and colleagues aimed to estimate the 
associations between BMI and socioeconomic characteristics of grocery store locations after 
adjustment for individual-level factors and socioeconomic characteristics of residential 
neighborhoods.  They found that individuals had a higher BMI if they reside in disadvantaged 
areas and in areas where the average person frequents grocery stores located in more 
disadvantaged neighborhoods.  They were able to conclude that where people shop for groceries 
and distance traveled to grocery stores are independently associated with BMI.  Our study also 
demonstrated that after controlling for SES factors of the census tract, the significant associations 
between food stores, food service places, and health care locations and risk factors for 
complications remained.      
Our study also investigated the associations between health care locations and risk factors 
for diabetes complications.  Results indicate that individuals who live in census tracts with at 
least one pharmacy or hospital were less likely to have hypertension and hypercholesterolemia.  
Those with an office of a physician within their census tract were less likely to have 
hypertension, hypercholesterolemia or be overweight.  Several mechanisms may contribute to 
this relationship.  Longer driving distances may mean fewer office visits and less monitoring of 
these risk factors.  Some researchers have also found that rural residence is a significant risk 
factor for never receiving an ophthalmic examination, which can detect early signs of 
complications such as diabetic retinopathy (26).  
 146 
 Travel burden might influence therapy through the frequency of medical contact.  The route 
distance used in this study is a proxy for many factors that affect an individuals’ travel burden. 
Conceptually, transportation distance can be examined from many perspectives.  The physical 
distance an individual has to travel may affect how often they visit the management center or the 
time between visits.  The longer the distance, the less likely they may be the travel for visits.  
Distance may also be a psychosocial barrier.  Individuals that have a greater distance to travel 
may perceive this distance as a barrier to accessing care.  Individuals may also be in denial as to 
the severity of their disease.  In addition, traveling greater distances may cause an individual to 
change their health care seeking behavior.    Within the Health Behavior Model, it is an 
important enabling factor for accessing health care (144), particularly in rural areas.  Recent 
analyses have begun to focus on the effects of transportation access in rural communities.  Lovett 
and colleagues (146) use GIS analysis to show that in rural areas there are pockets in which car 
journeys to the nearest general practitioner are greater than 10 miles and there is no regular bus 
service.  These pockets of limited transportation have the highest health need indicators.  Nemet 
and Bailey (147) measured perception of ease in getting a needed ride among rural elders.  Their 
measure of transportation access (“If you have to get somewhere in a car, how difficult is it for 
you to get there? -very difficult, somewhat difficult, not at all difficult?”) was not significant in 
predicting health care visits in the face of distance from provider.   
It may be useful to minimize travel burden for patients with diabetes, perhaps by 
enhanced public transportation, more clinic locations in rural areas, telephone or other electronic 
links, or home care.  It is important to note that the results from this study demonstrate that the 
food environmental factors were more significant in contributing to risk factors of diabetes 
complications that the health care locations.  The models adjusted for risk factors of diabetes 
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complications that can not be controlled such as age, gender, race, and the SES factors at the 
census tract level.  However, even after adjusting for these factors, the controllable 
environmental factors still had a significant association with risk factors.  This is evidence that 
the environment can play a role in the health of residents and should be changed in order to 
control important risk factors. 
This is the first study, to our knowledge, to examine the impact of the built environment 
and risk factors for diabetes complications.  This study also used patient-level data in 
combination with community-level factors that may contribute to the likelihood of risk factors.  
The use of the census tract level was also a unique aspect of this study.   
Although this study demonstrates the need for greater attention on the local food and 
health care environment, there were some limitations in the study.  The patient data was 
collected from a clinic population who are making office visits and may be healthier than a 
population with diabetes that do not visit a diabetes management center.  This may skew the 
results away from the null.  The subjects were not surveyed on where they shopped, the 
restaurants in which they ate, or where they went for health care, so misclassification may have 
occurred if the census tract did not represent the area where the subjects patronage.  Also, market 
research has an impact on where food stores, food service and health care places are located (8).  
Businesses may be located in more populated areas or areas with a higher SES.  Also, the food 
and health care locations were aggregated to the census tract level, which was used as a proxy for 
a neighborhood.  However, individuals often leave their census tract for services or go to a 
neighboring area because the location may actually be closer than one within their census tract.  
Examining the locations that are nearest to the individuals may be a more accurate measure, 
particularly if the individuals can be surveyed on their shopping, dining and health care habits.   
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Finally, the local environment has a significant impact on public health by possibly 
restricting a population’s food and health care choices and opportunities that affect health.  In 
addition to previous work, this study demonstrates that the local food and health care 
environment may play a central role in the prevention of risk factors of diabetes complications. 
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9.6 TABLES 
Table 9.2 Population Characteristics and Laboratory Values (N=3367) 
  
Males 
(n=1450) 
Females 
(n=1917) 
Total 
(N=3367) p-value 
Hypertension1 0.345 
n(%) 1111(76.6) 1443(75.3) 2554(75.8)   
Hypercholesterolemia2  0.01 
n(%) 801(55.2) 972(50.7) 1773(52.7)   
Overweight3 0.01 
n(%) 962(66.3) 1351(70.4) 2313(68.7)   
Obese4  <0.0001 
n(%) 556(38.3) 1006(52.5) 1562(46.4)   
Uncontrolled Glycemia5   0.02 
n(%) 764(52.7) 932(48.6) 1696(50.4)   
Age   0.081 
Mean [sd] 67.3[14.9] 68.3[16.5] 67.8[15.8]   
Range 19.0 - 98.3 18.4 - 101.0 18.4 - 101.0   
Ethnicity n(%) 0.845 
Caucasian 1300(94.7) 1673(94.9) 2951(94.6)   
Black or African American 59(4.4) 76(4.2) 135(4.4)   
Asian 1(0.1) 4(0.2) 5(0.2)   
Hispanic/Latino 3(0.2) 2(0.1) 5(0.2)   
American Indian/Alaskan 1(0.1) 2(0.1) 3(0.1)   
Other 8(0.5) 11(0.6) 19(0.5)   
Missing = 249         
LDL 0.464 
Mean [sd] 105.0 [33.6] 104.2 [33.7] 104.5 [33.7]   
Range 30.0 - 348.0 26.0 - 256.0 26.0 - 348.0   
Systolic Blood Pressure 0.773 
Mean [sd] 134.5[18.1] 135.6[18.2] 135.5 [18.2]   
Range 90 - 189 90 - 192 90 - 192   
Diastolic Blood Pressure 0.163 
Mean [sd] 78.5 [10.3] 77.9 [10.5] 78.2 [10.4]   
Range 40 - 104 40 - 100 40 - 104   
Body Mass Index (BMI)6 <0.0001 
Mean [sd] 30.7 [6.8] 34.6 [8.5] 32.8 [8.1]   
Range 16.6 - 59.7 18.9 - 60.8 18.9 - 60.8   
A1c 0.0004 
Mean [sd] 7.5 [1.8] 7.3 [1.7] 7.4 [1.8]   
Range 4.2 -16.2 4.3 - 18.7 4.2 - 18.7   
Duration of Diabetes (years) 0.675 
Mean [sd] 5.7 [4.2] 5.8 [4.7] 5.8 [4.5]   
Range 2.2 - 43.2 2.2 - 59.2 2.2 - 59.2   
1 = SBP ≥130 or DBP ≥80 or treatment                                 2 = LDL > 100 mg/dL 
3 = BMI ≥ 25;                                                                         4 = BMI ≥ 30;                                                                                                                                      
5 =A1c > 7.0                                                                          6 = BMI = weight(kg)/height(m)2 
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Table 9.3 Adjusted* Multi-Level GEE Regression Models 
Supermarkets (n=45) OR 95% CI p-value 
 
Full-Service Restaurants (n=92) OR 95% CI p-value 
Hypertension  0.87 0.78, 0.97 0.002 Hypertension 0.61 0.50, 0.74 <0.0001 
Hypercholesterolemia 0.83 0.70, 0.89 0.002 Hypercholesterolemia 0.97 0.82, 1.16 0.77 
Overweight 0.50 0.49, 1.03 0.09 Overweight 0.64 0.52, 0.79 <0.0001 
Obese 1.02 0.99, 1.05 0.08 Obese 0.75 0.59, 0.83 <0.0001 
Glycemic Control 1.07 0.80, 1.31 0.49 Glycemic Control 0.92 0.78, 1.09 0.36 
 
Grocery Stores (n=124) OR 95% CI p-value   Limited-Service Restaurants (n=98) OR 95% CI p-value 
Hypertension 0.95 0.79, 1.14 0.01   Hypertension 0.93 0.90, 1.18 0.08 
Hypercholesterolemia 1.29 1.07, 1.56 0.61   Hypercholesterolemia 1.22 1.16, 1.73 0.0007 
Overweight 0.85 0.51, 0.91 <0.0001   Overweight 1.80 1.36, 2.37 <0.0001 
Obese 0.94 0.72, 0.99 0.001   Obese 1.43 1.17, 1.74 0.0006 
Glycemic Control 1.10 0.92, 1.32 0.28   Glycemic Control 0.89 0.73, 1.08 0.23 
 
Convenience Stores (n=142) OR 95% CI p-value   Fast Food Restaurants (n=187) OR 95% CI p-value 
Hypertension 1.58 1.31, 1.91 <0.0001   Hypertension 1.78 1.45, 2.19 <0.0001 
Hypercholesterolemia 1.19 1.00, 1.42 0.04   Hypercholesterolemia 1.22 1.01, 1.47 0.04 
Overweight 1.82 1.47, 2.26 <0.0001   Overweight 1.62 1.28, 2.06 <0.0001 
Obese 1.45 1.23, 1.72 <0.0001   Obese 1.61 1.34, 1.94 <0.0001 
Glycemic Control 1.19 0.99, 1.41 0.05   Glycemic Control 1.03 0.86, 1.23 0.77 
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Table 9.3 Continued 
Pharmacies (n=166) OR 95% CI p-value 
 
Physicians' Offices (n=514) OR 95% CI p-value 
Hypertension 0.62 0.51, 0.76 <0.0001 Hypertension 0.85 0.72, 0.90 <0.0001 
Hypercholesterolemia 0.69 0.58, 0.83 <0.0001 Hypercholesterolemia 0.75 0.65, 0.78 <0.0001 
Overweight 0.86 0.69, 1.08 0.19 Overweight 0.66 0.53, 0.82 0.0003 
Obese 0.86 0.72, 1.02 0.09 Obese 0.77 0.75, 1.01 0.08 
Glycemic Control 0.96 0.81, 1.15 0.66 Glycemic Control 0.72 0.68, 1.03 0.07 
     
Hospitals (n=15) OR 95% CI p-value 
Hypertension 0.70 0.52, 0.95 0.02 
Hypercholesterolemia 0.63 0.47, 0.85 0.003 
Overweight 0.62 0.55, 1.06 0.07 
Obese 0.99 0.74, 1.33 0.96 
Glycemic Control 1.17 0.88, 1.54 0.29 
 
 
 *Adjusted for individual age, gender, race, and duration of diabetes, and census tract level % residents living below the poverty level, 
median income, % Black, and % residents with a high school degree or higher.
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Table 9.4: Adjusted* Odds Ratios and 95% Confidence Intervals for the Associations Between the Likelihood of 
Risk Factors of Diabetes Complications and Specific Combinations of Food Stores 
 Hypertension  Hypercholesterolemia 
All Food Stores Available OR 95% CI P-value   OR 95% CI P-value 
No Stores (n=33)   Reference       Reference   
Only Supermarkets (n=11) 0.40 0.28, 0.57 <0.0001   0.64 0.47, 0.86 0.001 
Only Grocery (n=30) 0.71 0.51, 0.99 0.05   1.43 1.06, 1.93 0.02 
Only Convenience (n=33) 1.18 0.84, 1.66 0.35   1.68 1.24, 2.27 <0.0001 
All stores (n=16) 1.23 0.79, 1.92 0.35   3.79 2.49, 5.77 <0.0001 
More than one type (n=45) 2.03 1.44, 2.86 <0.0001   1.08 0.80, 1.45 0.62 
 
 Overweight  Obesity  Uncontrolled Diabetes 
All Food Stores Available OR 95% CI P-value   OR 95% CI 
P-
value   OR 95% CI 
P-
value 
No Stores (n=33)   Reference       Reference       Reference   
Only Supermarkets (n=11) 0.80 0.67, 0.94 <0.0001   0.53 0.37, 0.75 0.0003   1.09 0.78, 1.52 0.62 
Only Grocery (n=30) 0.90 0.85, 0.98 <0.0001   0.80 0.60, 1.06 0.12   1.04 0.78, 1.39 0.80 
Only Convenience (n=33) 1.26 1.17, 1.94 <0.0001   1.37 1.01, 1.85 0.04   1.17 0.87, 1.58 0.29 
All stores (n=16) 0.93 0.28, 0.98 0.0002   0.98 0.66, 1.45 0.90   1.31 0.89, 1.94 0.17 
More than one type (n=45) 2.31 0.91, 3.52 0.61   1.59 1.19, 2.13 0.002   1.26 0.95, 1.67 0.10 
 
 
*Adjusted for individual age, gender, race, and duration of diabetes, and census tract level % residents living below the poverty level, 
median income, % Black, and % residents with a high school degree or higher.
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Table 9.5: Adjusted Odds Ratios and 95% Confidence Intervals for the Associations Between the Likelihood of Risk 
Factors of Diabetes Complications and Specific Combinations of Restaurants 
 Hypertension  Hypercholesterolemia  Overweight 
All Available Food 
Service Places OR 95% CI P-value  OR 95% CI P-value  OR 95% CI P-value 
No Restaurants   Reference     Reference     Reference   
Only Full-Service 
Restaurants 0.41 0.30, 0.55 <0.0001  0.98 0.96, 1.29 0.06  0.37 0.26, 0.50 <0.0001 
Only Limited-Service 
Restaurants 1.49 0.92, 2.42 0.10  1.62 1.09, 2.40 0.02  1.85 1.02, 3.38 0.04 
Only Fast Food 1.71 1.12, 2.61 0.01  1.14 1.04, 2.27 <0.0001  1.98 1.17, 3.35 0.01 
All types 1.56 1.06, 2.31 0.03  3.79 1.61, 3.29 <0.0001  1.08 0.73, 1.62 0.69 
More than one type 1.73 1.23, 2.44 0.002  1.01 0.75, 1.37 0.94  2.53 1.64, 3.92 <0.0001 
 
 Obesity  Uncontrolled Diabetes 
All Available Food Service Places OR 95% CI P-value  OR 95% CI P-value 
No Restaurants  Reference    Reference  
Only Full-Service Restaurants 0.45 0.34, 0.60 <0.0001  0.91 0.69, 1.20 0.50 
Only Limited-Service Restaurants 1.19 0.81, 1.76 0.37  0.70 0.48, 1.02 0.06 
Only Fast Food 1.67 1.19 - 2.33 0.003  0.86 0.62, 1.19 0.35 
All types 1.28 0.92, 1.80 0.15  1.17 0.84, 1.64 0.35 
More than one type 1.50 1.12, 2.01 0.01  1.04 0.78, 1.39 0.78 
 
*Adjusted for individual age, gender, race, and duration of diabetes, and census tract level % residents living below the poverty level, 
median income, % Black, and % residents with a high school degree or higher.
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10.1 ABSTRACT 
 
Objective: To examine the association between glycemic control and improvement in 
individuals with type 2 diabetes, and travel burden to diabetes management centers in 
southwestern Pennsylvania. 
Hypothesis: Individuals who have uncontrolled diabetes will be less likely to live as close to 
their diabetes management center as those who have controlled diabetes.  Also, those who live 
closer to diabetes management centers will be more likely to have improved glycemic control 
than those who live farther from the centers.  
Research Design and Methods: Addresses, demographics and risk factor and laboratory data on 
3369 individuals with type 2 diabetes who receive diabetes management education at seven 
diabetes centers was collected.  The shortest driving distance by route from the subject’s home to 
the diabetes management center they visited was calculated.  The route driving distances (≥10 
miles versus < 10 miles) of subjects who were in good control (HbA1c<7.0%) were compared to 
the distances of those who are not in control (HbA1c>7.0%) using Χ2 tests.  Logistic regression 
was also used to test the association between glycemic control (present or absent) and each 
marker of travel burden, adjusting for age, gender, Body Mass Index (BMI), and duration of 
diabetes.  To investigate improvement in HbA1c values over time and the association with travel 
burden, the differences between the first visit HbA1c and last visit HbA1c value was calculated.  
Similar Χ2, t-tests and logistic regression analysis was conducted to find associations between 
improvement in HbA1c levels and travel burden, adjusting for individual and community level 
factors. 
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Results: The analysis included 3,369 individuals with diabetes from seven diabetes centers in 
Southwestern Pennsylvania.  They were predominantly older (mean age = 67.9), female (57.6%), 
and Caucasian (94.6%).  50.6% individuals were categorized as having uncontrolled diabetes.  
The mean distance by route subjects traveled to visit their diabetes management center were 13.3 
miles.  Fifty-five percent of the subjects lived less than 10 miles from their diabetes center.  The 
associations between the dichotomous distance subjects traveled to their center and the glycemic 
control were modeled.  Those who lived more than 10 miles from their diabetes management 
center were 91% more likely to have an HbA1c level greater than 7.0% compared to those who 
lived less than 10 miles from their center, adjusted for individual-level factors such as age, sex, 
race, duration of diabetes, and BMI as well as community level factors such as percent of 
residents with a high school degree or higher, median household income and percent of residents 
living below the poverty level.  The association between the numbers of miles from the center as 
a continuous variable and glycemic control was also modeled.  For every mile the subjects lived 
from their diabetes management center, they are 2% more likely to have an HbA1c level greater 
than 7.0%, adjusted for individual and community level factors.  In addition, those who lived 
within 10 miles from their center, were 2.24 times more likely to have improved their HbA1c 
values between their first and last office visits, adjusted for individual and community level 
factors.   
Conclusions: Specialists who provide diabetes care should be aware of travel burden as a 
potential barrier to proper management of diabetes.  In the future, it may be useful to minimize 
driving distance for individuals with diabetes, perhaps by improved public transportation, more 
diabetes center locations in rural areas, telemedicine, or home visits. Additional research should 
focus on more effective ways to connect diabetes care providers and patients in rural areas.  In 
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addition to previous work, this study demonstrates that the travel burden may play a central role 
in glycemic control and improvement in those with type 2 diabetes. 
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10.2 INTRODUCTION 
 
Diabetes is a group of diseases marked by high levels of blood glucose resulting from defects in 
insulin production, insulin action, or both.  Diabetes can lead to serious complications and 
premature death, but people with diabetes can take steps to control the disease and lower the risk 
of complications (1).  Diabetes is a major public health challenge due to the enormous impact on 
the affected individual, their families and the health care system.  However, recent research has 
shown that diabetes related mortality and morbidity can be prevented or delayed by controlling 
risk factors (2).   
Glycemic control refers to the typical levels of blood sugar (glucose) in an individual 
with diabetes (1).  There is much evidence to suggest that many of the long-term complications 
of diabetes, especially the microvascular complications, result from many years of 
hyperglycemia (elevated levels of glucose in the blood).  Good glycemic control, in the sense of 
a "target" for treatment, has become an important goal of diabetes care (2).  Because blood sugar 
levels fluctuate throughout the day and glucose records are imperfect indicators of these changes, 
the percentage of hemoglobin which is glycosylated is used as a proxy measure of long-term 
glycemic control (2). This test, the hemoglobin HbA1c reflects average glucoses over the 
preceding 2-3 months.  In those with normal glucose metabolism, the glycosylated hemoglobin 
level is usually 4-6%.  Accepted "target levels" of HbA1c for those with diabetes is less than 7% 
(1). 
Certain environmental aspects play an important role in the prevention and treatment of 
chronic diseases such as diabetes.  Studies have shown that access to health care, diet, physical 
activity, housing, income, and environmental exposures contribute to diabetes, which are all part 
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an individual’s environment or community (4).  While there are many ways to define 
community, geographic location is one important way to understand the context in which people 
live.  Until recently, there has not been a valid method for defining and analyzing geographic 
areas that make up a community where these risk factors and chronic diseases may cluster.  
Geographical modeling may allow for better identification of the geographic area of 
communities that provide risk for diabetes.  There is great variability in the health and well being 
of residents depending upon where they live.  Health-promotion interventions may need to be 
designed to target the geographic areas that represent clusters of health problems and unhealthy 
lifestyles.   
The seven diabetes centers included in this study provide diabetes prevention and 
treatment classes, diabetes self-management education, meal planning and nutrition counseling, 
and insulin and medication therapies.   Diabetes management education has been shown to 
reduce the severity of diabetes and risk factors for diabetes complications.  Along with 
pharamacological interventions, several recent controlled trials on diabetes prevention have 
confirmed that lifestyle changes targeting diet, activity patterns, and weight regulation (7, 8, 10).  
Traditionally, diabetes education has emphasized increasing knowledge about diabetes, risk 
factors, and diabetes self-care.  In spite of the availability of these services, adequate 
management of diabetes remains an indefinable goal. 
Because diabetes self-management education has been shown to be effective at 
improving short-term behavioral and physiologic outcomes for patients with diabetes, decreased 
access to education is an important barrier in rural settings.  In addition, busy rural primary care 
practices often lack the organizational support and computerized tracking systems to initiate 
practical interventions to improve diabetes care (8).  For rural communities, one of the key areas 
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in which change is needed may be improving access to diabetes education.  This could be 
accomplished through distance communication strategies, such as telemedicine, or through the 
provision of educational support and resources to assist health professional to improve their 
diabetes education skills and their ability to develop quality education programs (8).   
    Geographical Information Systems (GIS) may allow investigators to conduct analysis 
that can to be used to increase comprehension of chronic disease pathogenesis.  First, 
geographical studies may suggest possible causal factors based on geography and play an 
important role in the understanding of the development and control of diabetes (3).  Associations 
between disease and place imply that the population living there possesses inherent traits that 
make it more susceptible to disease.  However, it has been shown that there are certain risk 
factors that cluster in these areas that cause increased risk for disease.  Second, spatial analysis 
can help identify how populations adapt and relate to their environment (3).   
Diabetes is preventable and can be controlled with intervention.  However, some areas 
may not have resources that would enable its residents to lead a healthy lifestyle.  Geospatial 
mapping techniques can be used to show areas with higher prevalence of diabetes and where 
funds need to be targeted. Geospatial analysis tools can be used to discover and analyze cause 
and affect relationships based on geographic proximities.    The use of GIS is a relatively 
inexpensive way to determine the most direct driving route between two addresses (5).  For rural 
areas, where the routes are often circuitous, driving distance have been shown to be a more 
accurate measure of travel burden than straight-line Euclidean measures (6).  In this study, the 
relationship between glycemic control and the driving distance from a patient’s home to the 
diabetes management center they visited was examined.   
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10.3 METHODS 
 
10.3.1 Study Population 
In an effort to improve diabetes education and care, the University of Pittsburgh Diabetes 
Institute started a regional health care collaboration, the Pittsburgh Regional Initiative for 
Diabetes Education (PRIDE).  Data on individuals with type 2 diabetes was collected from seven 
diabetes management centers who are PRIDE partners, using a data management system, Delphi.  
This system was used by the University of Pittsburgh Diabetes Institute in order to collect data 
on individuals with diabetes attending these diabetes centers throughout southwestern 
Pennsylvania.  The participating centers include: The Center for Diabetes Care at the Indiana 
Regional Medical Center, Community Medical Services, Centerville Clinics, Inc., Conemaugh 
Diabetes Institute, The Diabetes Center at Uniontown Hospital, Highlands Hospital Diabetes 
Center and the Washington Hospital Diabetes Education & Management Program.  The Delphi 
Data Management System allowed the staff of these centers to enter patient data into an 
organized system.  Individual-level data such as home street addresses, demographics, lab test 
data, medications, health indicators, co-morbid conditions, and complications were entered into 
this data system from June 2005 to January 2007.  The variable list is included in Table 9.6, 
Appendix B.  All of the individuals 18 years and older that were entered into the Delphi system 
(n=3369) were diagnosed by their physician with diabetes prior to be being referred to the 
diabetes center.   
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10.3.2 Measurement of Travel Burden and Definitions of Outcomes   
The home addresses of the subjects and the location of PRIDE Diabetes Centers they attend were 
geocoded to the street address level using ArcGIS software (ESRI, Redlands, CA).  The ESRI 
street centerline datasets for each county in the study area was used to geocode the location data 
and was used for the network analysis.  The driving distance from each subject’s house to the 
diabetes centers was calculated using the Network Analyst tool.  This tool uses the centerline 
street data to calculate the shortest route driving distance based on the street segment distance of 
the route.  The route distances the subjects lived from the diabetes management centers were also 
measured and dichotomized as living less than or greater than ten miles from the center they 
visit.  A ten mile distance was chosen because several examples in the literature also used ten 
miles based on recommendations from the Rural Health Association (30, 31, 32).  In addition, 
the South Carolina Rural Health Research Center took advantage of a highly detailed, nationally 
representative survey of travel conducted by the U.S. Department of Transportation, the 2001 
National Household Travel Survey (NHTS), to explore the potential for disparities in access 
associated with rural residence.  The researchers found that nationally, the average distance 
traveled for medical/dental care was 10.2 miles (35).  Rural trips averaged 17.5 miles, versus 8.3 
miles for urban residents.  Several state health departments have proposed a standard in which 
rural residents should not have to travel more than 30 minutes to see a physician (30). 
 Using Network Analyst, an origin-destination (OD) cost matrix was created for the homes of 
subjects to each diabetes centers they visited.  The parameters for the OD cost matrix were 
specified and paths from each home to the particular center they visit. 
Laboratory values of the patients who were entered into the Delphi Data Management 
System were used to define the risk factor values.  The first lab values that were entered for each 
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patient were used in the analysis.   Glycemic control was measured by the glycosolated 
hemoglobin HbA1c assay.  Subjects were classified as having hyperglycemia if they had an 
HbA1c level > 7.0%.  A dichotomous variable for glycemic control was created and used as the 
main outcome of interest.  Subjects visited the management several times during the study 
period.  The difference between the first visit HbA1c values and the last visit HbA1c values were 
calculated to determine if the subjects HbA1c improved over time.  Body Mass Index (BMI) was 
calculated as [weight in kilograms/height in meters2].  Individuals with a BMI ≥25 were 
classified as overweight and those with a BMI ≥30 as obese.  Individuals were categorized as 
having hypercholesterolemia if they had a LDL >100 mg/dL, and/or who reported taking 
cholesterol lowering medications in the system.  Patients were considered to have hypertension if 
they had a systolic blood pressure (SBP) measurement ≥130 mmHg, a diastolic (DBP) 
measurement ≥80 mmHg and/or if they reported taking anti-hypertensive medications.   
 
10.3.3 Statistical Analysis 
To estimate odds ratios (OR) of having uncontrolled glycemia and the association with the 
distance to diabetes management centers, generalized estimating equations (GEE) logistic 
regression was performed using the PROC GENMOD program in SAS 9.1.  This is a multilevel 
test that takes census tract and individual-level data into account and the repeated measures 
option was used to account for the clustering of subjects within the census tracts.  Logistic 
regression was performed using the PROC LOGISTIC program in SAS 9.1 when census track 
data was not included in the model.  Each of the risk factors of age, gender, race, duration of 
diabetes, and BMI was modeled separately for each marker of travel burden (distance as a 
continuous variable and as a dichotomous variable).  Since individual-level socioeconomic status 
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(SES) information was not available, census tract information was used in the model to control 
for these factors.  The percentage of residents living below the poverty level, percentage of 
residents reporting Black as their race, median household income, and percentage of residents 
with a high school education or higher for each census tract were also considered in the 
regression models.  Descriptive analysis was conducted to calculate the mean and percentages of 
laboratory values, age, gender, duration of diabetes, co-morbidities and complications of 
diabetes.  Descriptive analysis was conducted to calculate the mean and percentages of 
laboratory values, age, gender, duration of diabetes, co-morbidities and complications of 
diabetes.  Univariate analysis was conducted to find significant difference between glycemic 
control and population characteristics as described above. 
To investigate improvement in HbA1c values over time and the association with travel 
burden, the differences between the first visit HbA1c and last visit HbA1c value was calculated.  
Similar Χ2, t-tests and logistic regression analysis was conducted to find associations between 
improvement in HbA1c levels and travel burden, adjusting for individual and community level 
factors. 
 
10.4 RESULTS 
 
10.4.1 Description of the Population 
The analysis included 3,369 individuals with diabetes from seven diabetes centers in 
Southwestern Pennsylvania.  They were predominantly older (mean age = 67.9), female (57.6%), 
and Caucasian (94.6%).  Approximately fifty percent (n=1704) of individuals were categorized 
as having uncontrolled diabetes (HbA1c > 7.0).  Seventy-two percent of the individuals had 
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hypertension (mean SBP = 135.4; mean DBP = 78.1), 52.7% had hypercholesterolemia (mean 
HDL = 40.3; mean LDL = 104.6; mean triglycerides = 181.3), 68.7% were overweight (mean 
BMI = 32.9), and 46.4% were obese.  The mean duration of diabetes was 5.8 years and those 
with uncontrolled glycemia had significantly longer diabetes duration than those who were in 
control (6.1 and 5.4 years, respectively).  Of those who reported insurance information (n=2116), 
24.9% use Medicare, 1.6% self-paid, and 73.4 % used commercial or government health 
insurance.  The mean distance subjects traveled to visit their diabetes management center were 
13.3 miles (range 0.06 – 85.1 miles).  Approximately 55% of the subjects lived less than ten 
miles from their diabetes center.   
 
10.4.2 GEE Regression 
The associations between the distance subjects traveled to their diabetes management centers and 
the glycemic control are presented in Table 10.2.  The associations were adjusted for individual-
level factors such as age, duration of diabetes, race, and gender.  Since individual-level SES 
variables were unavailable, census track information for the percentage of residents living below 
the poverty level, median household income, percentage of residents with a high school 
education or higher, and percentage of residents reporting Black as their race were included in 
the model adjustment. 
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Table 10.2: Adjusted Odds Ratios (OR) and 95% Confidence Intervals (CI) for Likelihood 
of Having Uncontrolled Diabetes Associated with Travel Burden (Dichotomous) 
Parameter OR 95% CI p-value 
Diabetes Center ≥10 miles 1.91 1.59, 2.30 <0.0001 
Age (Years) 0.99 0.98, 0.99 0.00015 
Sex (Male) 1.12 0.94, 1.34 0.22 
Race (White) 1.05 0.69, 1.59 0.80 
Duration of Diabetes (Years) 1.03 1.01, 1.06 0.0007 
BMI  0.99 0.98, 1.01 0.83 
% High School Degree 0.99 0.97, 1.01 0.31 
Median Income (2000 US Dollars) 0.99 0.99, 1.00 0.11 
% Living Below Poverty Level 0.97 0.95, 0.99 0.03 
% Black (County) 1.01 0.99, 1.03 0.19 
 
The results indicated that residing more than ten miles from the diabetes management 
center (OR = 1.88, p = <0.0001), being younger (OR = 0.99, p = 0.001), and having a longer 
duration of diabetes (OR = 1.03, p = 0.0009) were significant contributors to the model.  
Therefore, those who live more than ten miles from their diabetes management center are 91% 
more likely to have an HbA1c level greater than 7.0% compared to those who live less than 10 
miles from their center, adjusted for individual-level factors such as age, sex, race, duration of 
diabetes, and BMI as well as community level factors such as percent of residents with a high 
school degree or higher, median household income and percent of residents living below the 
poverty level.   
The association between the numbers of miles from the diabetes center as a continuous 
variable and glycemic control was also modeled (Table 10.3).  The results indicated that greater 
driving distance from diabetes management center (OR = 1.02, p = <0.0001), being younger (OR 
= 0.99, p = 0.007), having a longer duration of diabetes (OR = 1.03, p = 0.004), and living in a 
census tract with a higher percent of residents living below the poverty level (OR = 0.98, p = 
0.05) were significant contributors to the model.  Therefore, for every mile the subjects live from 
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their diabetes management center, they are 2% more likely to have an HbA1c level greater than 
7.0%, adjusted for individual-level factors such as age, sex, race, duration of diabetes, and BMI 
as well as community level factors such as percent of residents with a high school degree or 
higher, median household income and percent of residents living below the poverty level.   
Table 10.3: Odds Ratios (OR) and 95% Confidence Intervals (CI) for Likelihood of Having 
Uncontrolled Diabetes Associated with Travel Burden (Continuous) 
Parameter OR 95% CI p-value 
Miles to the Diabetes Center 1.02 1.01, 1.03 <0.0001 
Age (Years) 0.99 0.98, 0.99 0.007 
Sex (Male) 1.10 0.92, 1.31 0.31 
Race (White) 1.06 0.71, 1.61 0.77 
Duration of Diabetes (Years) 1.03 1.01, 1.05 0.004 
BMI 0.998 0.98, 1.01 0.72 
% High School Degree 0.99 0.97, 1.01 0.34 
Median Income (2000 US Dollars) 0.99 0.99, 1.00 0.08 
% Living Below Poverty Level 0.97 0.95, 0.99 0.04 
% Black (County) 1.01 0.98, 1.03 0.39 
 
Subjects visited the diabetes management center more than one time during the study 
period (mean = 1.86 visits).  The first visit was defined as the first HbA1c laboratory value that 
was collected on the office visit date.  The last visit was defined as the last HbA1c value that was 
entered into the Delphi system on the last office visit date.  The office visit date was in the 
definition to control for those laboratory values that were historical values entered into the 
system from medical records.  The difference between the first visit HbA1c values and the last 
visit HbA1c values were calculated to determine if the subjects’ HbA1c improved over time.  If 
the subject only had one office visit, they were removed from the analysis (n=230).  The mean 
time between visits was 0.36 years (range =0.3 – 1.7 years) and mean difference between HbA1c 
values was an improvement of -0.01 (Table 10.4).  There was a significant difference between 
travel burden and the number of visits (p= 0.0003).  Those who lived less than ten miles from 
their center had a mean of 2.0 office visits while those who lived greater than ten miles from the 
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center had a mean of 1.6 visits.  There was also significant difference between travel burden and 
change in HbA1c values over time (p< 0.0001).  Individuals who resided less than ten miles from 
their diabetes center, had a mean improvement in HbA1c value of -0.19; indicating that their 
mean HbA1c values decreased 0.19.  Those who lived greater than ten miles from their diabetes 
center had a mean increase in HbA1c values of 0.12.  Furthermore, 85.1% of those living more 
than ten miles from their center were able to improve their HbA1c values between their first and 
last visits while 91.9% were able to improve their HbA1c values (p<0.0001) if they lived less 
than or equal to 10 miles from the center. 
Table 10.4: Characteristics of A1c Values  
  
Center ≤ 10 mi 
(n=1737) 
Center > 10 mi 
(n=1402) Total (N=3139) p-value 
Difference between first and last A1c values <0.0001 
Mean [sd] -0.19[1.0] 0.12[1.1] -0.01[1.09]   
Range -7.6 -  9.0 -7.7 -  9.0 -7.6 - 9.0   
Time Between Visits (years)   <0.0001 
Mean [sd] 0.26[0.65] 0.43[0.97] 0.36[0.86]   
Range 0.1 - 3.2 0.1 – 3.1 0.1 – 3.2   
Improved A1c Values     <0.0001 
n(%) 1719(91.9) 1276(85.1) 2967(88.2)   
Number of Office Visits     0.0003 
Mean [sd] 2.0[2.1] 1.7[2.0] 1.8[2.1]   
Range 2 - 15 2 - 19 2 - 19   
 
 The association between living less than or greater than ten miles from the diabetes 
center and improvement in HbA1c values over time was also modeled (Table 10.5).  The results 
indicated that those who lived within ten miles of their diabetes management center (OR = 2.48, 
p = <0.0001), being older (OR = 1.01, p = 0.004), having a shorter duration of diabetes (OR = 
0.95, p = 0.0001), and having more office visits (OR = 1.47, p= <0.0001) were significant 
contributors to the model.  Therefore, those who lived less than ten miles from their diabetes 
management center, were than 2.49 times more likely to have improved their HbA1c values 
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between their first and last office visits, adjusted for individual and community level factors.  
Additionally, those who live less than ten miles from their center had a significantly shorter time 
between visits compared to those who lived ten or more miles from the center (0.26 years and 
0.43 years, respectively).   
Table 10.5: Odds Ratios (OR) and 95% Confidence Intervals (CI) for Likelihood of Having 
Improved HbA1c Values Associated with Travel Burden (Dichotomous) 
Parameter OR 95% CI p-value 
Diabetes Center <10 miles 2.48 1.65, 3.71 <0.0001 
Age (Years) 1.01 1.00, 1.02 0.004 
Sex (Male) 1.01 0.73, 1.41 0.94 
Race (White) 1.74 0.91, 3.33 0.09 
Duration of Diabetes (Years) 0.95 0.93, 0.98 0.001 
BMI 1.00 0.98, 1.02 0.83 
% High School Degree 0.99 0.95, 1.03 0.57 
Median Income (US Dollars, 2000) 1.00 0.99, 1.00 0.63 
% Living Below Poverty Level 1.00 0.95, 1.05 0.99 
Number of Office Visits 1.47 1.38, 1.57 <0.0001 
% Black (County) 0.99 0.96, 1.03 0.86 
 
 A sub-analysis of those who reported health insurance information (n = 2116) indicated 
that type of insurance coverage was not significantly associated with glycemic control and travel 
burden (dichotomous or continuous) in this study. 
 
10.5 CONCLUSION 
 
Results from this study indicated that the distance patients live from their diabetes management 
center has an affect of glycemic control.  There is a clear association between travel burden and 
glycemic control among individuals with type 2 diabetes.  Many of the subjects are from rural 
areas of Southwestern Pennsylvania, where it has become apparent that there is less access to 
health care.  Those who live more than ten miles from their diabetes management center are 88% 
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more likely to have an HbA1c level greater than 7.0% compared to those who live less than 10 
miles from their center, adjusted for both individual and community level factors.  Additionally, 
for every mile the subjects live from their diabetes management center, they are 2% more likely 
to have an HbA1c level greater than 7.0, adjusted for individual and community level factors.  In 
addition, those who lived ten miles or less from their diabetes management center, were than 
2.24 times more likely to have improved their HbA1c values between their first and last office 
visits, adjusted for individual and community level factors.   
Patients in rural areas may use less medical care than those living in urban areas (10).  
This difference in access to health care in rural areas may be dependent on a number of variables.  
These include patient-specific factors such as age, race, ethnicity, and perceptions of quality, as 
well as extrinsic factors such as insurance coverage and health care costs (10).  Age and duration 
of diabetes were significant factors in the association between travel burden and glycemic 
control in this study.  A sub-analysis of those who reported health insurance information 
indicated that type of insurance coverage was not significantly associated with glycemic control 
and travel burden in this study indicating that health insurance coverage was not a factor in 
glycemic control.  However, there may have been a reporting bias since only two centers 
reported the information.  Another potential factor related to health care utilization is travel time 
and distance (11, 12).  Research has suggested that utilization is adversely affected by long travel 
times.  One study found that patients may forgo free care if it is greater than 20 miles away (11).  
Several state health departments have proposed a standard in which rural residents should not 
have to travel more than 30 minutes to see a physician (10). 
Our current framework of the rural-urban hierarchy of care is one in which rural areas are 
very dependent on urban ones for health care, in particular specialty care that is integral to 
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diabetes care.  In this “hub-and-spoke model,” rural patients must travel long distances for their 
care.  It also has been found that rural residents have fewer overall visits and see fewer medical 
specialists and more generalists for their care than their urban counterparts (133).  In addition, 
they found residents of small and isolated rural areas have greater travel distance and time 
compared to those living in urban areas.  Median one-way travel time was less than 30 minutes 
for all patients, including those living in isolated small rural areas.  However, some patients with 
specific diagnoses or undergoing specific procedures needed to travel much farther.  Less than 
30% of those living in all rural areas traveled to urban areas for their care.  The vast majority 
were seen in their area or traveled to a larger rural location (10).  Although this study 
concentrated only on rural residents, 45% of the subjects lived more than ten miles from their 
diabetes center.  It should also be noted that ten miles in rural areas may take more travel time 
due to lower speed limits, more mountainous terrain, and less highways (9). 
Rural areas are frequently characterized by poorly developed and fragile economic 
infrastructures, resulting in fewer available per capita hospital beds, doctors, nurses, and other 
health care services (31).  In addition to socioeconomic hardships rural residents face substantial 
physical barriers, including a lack of public transportation, difficult terrain, and long distances to 
services (32, 33).  It still remains unclear how rural elders perceive barriers to health care access 
and how they cope with those perceived barriers.  Researchers Goins, Williams, Carter, Spencer, 
and Solovieva (30) examined what barriers rural elders report experiencing when accessing 
needed health care.  In response to the questions posed to focus group participants, five 
categories of barriers to health care emerged from the discussions: transportation difficulties, 
limited health care supply, lack of quality health care, social isolation, and financial constraints 
(30).   
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Social isolation reflected some aspects of rural norms and values, such as the strong sense 
of self-reliance and reluctance to use formal services.  Some participants were unaware of or did 
not have accurate information about available services.  Participants also suggested that it would 
be helpful if older adults had information on services that might help meet their needs (30). 
Financial constraints posed considerable barriers to accessing needed health care among 
study participants, including issues related to health care expense, inadequate health care 
coverage, income ineligibility to Medicaid, and the high cost of prescription medications.  
Participants commented they were not poor enough to qualify for Medicaid but did not have 
enough financial resources to afford health care (30).  Rural areas have significant gaps in the 
continuum of care since home-based and community-based long-term care services are often 
unavailable (32).  Beyond having a limited supply of health care providers, rural respondents 
also reported physicians are inadequate and lack professionalism.  In rural areas, local physicians 
are often perceived as having poor interpersonal skills and/or lower quality care than what is 
available in more populated areas (34).  
The findings of this study expand on those of Littenberg, Strauss, MacLean, and Troy (5) 
who conducted Wilcoxon rank-sum tests assess the role of travel burden as a barrier to the use of 
insulin in adults with diabetes.  The researchers recruited 781 adults receiving primary care for 
type 2 diabetes.  Travel burden was estimated as the shortest driving distance from the patient’s 
home to the site of primary care.  Medication use, age, sex, race, martial status, education, health 
insurance duration of diabetes, and frequency of care were self-reported.  The researchers found 
that driving distance was significantly associated with insulin use, controlling for the covariates 
and potential cofounders.  The odds ratio for using insulin associated with each kilometer of 
driving distance was 0.97.  They concluded that adults with type 2 diabetes who live farther from 
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their source of primary care are significantly less likely to use insulin.  The researchers 
hypothesize that this may be because patients and physicians are concerned about the risks of 
insulin and are reluctant to use it if they feel the patient lives too far way from care for rescue in 
the event of hypoglycemia.  However, they had no direct data on the attitudes of these decision 
makers in this regard.  Although our study focused on glycemic control and travel burden, and 
Littenberg et al. focused on insulin use in smaller population, the results strengthen the 
associations between the travel burden and glycemic control in those with diabetes. 
Despite the availability of effective treatments, many patients with diabetes do not 
receive optimal glycemic control.  Travel burden may be one of many obstacles for diabetes 
patients, especially in rural areas.  Travel burden often also includes arranging transportation, the 
time required to travel, arranging child care, the cost of missing work, and the cost of the 
transportation.  Driving distance is one aspect of travel burden, and may serve as a marker for at 
least some of the burden of obtaining diabetes care.  Strauss et al. (13) examined the relationship 
between glycemic control and the driving distance from a patient’s home to the site of primary 
care.  The authors found that driving distance was significantly associated with glycemic control 
in their population of older, rural subjects.  Each 22 miles of driving distance was associated with 
a 0.25% increase in HbA1c.  Although our study focused on subjects who visited diabetes 
management centers, and Strauss et al focused primary care offices, the results support the 
associations between the travel burden and health care in those with diabetes.  Our subjects 
received separate diabetes prevention classes, diabetes self-management education, meal 
planning and nutrition counseling, and insulin and medication therapies at the diabetes centers.  
The type of care received at a primary care office may not be as specialized as that received at 
the diabetes centers.  Strauss et al. did not collect data on those who may have visited diabetes 
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specialists and recruited patients only from primary care offices, and therefore who would be less 
likely to use insulin.    
This study demonstrates the need for more strategically located health care centers in 
rural areas.  Only increasing the number of facilities without conducting location analyses would 
not be as effective as including these analyses.  Including information on where the majority of 
residents’ live, road connectivity, and geography will allow for the deliberate placement of 
needed health care locations.   
There were some limitations in the study.  Since the study was conducted in rural 
southwestern Pennsylvania, the population was mostly white and older so these results may not 
be generalized to urban or more diverse populations.  Also, driving distance from the subject’s 
home to the center may not be a perfect measurement of travel burden.  Some subjects may take 
public transportation or have a friend or family member to drive them to the diabetes center.      
This study is unique to the literature because it is the only study, to our knowledge, that 
examines the association between diabetes outcomes and diabetes management services that the 
subjects actually received.  Having data on the number of visits, time between the visits and 
laboratory values is very distinctive and enabled us to find relationships between how the 
subjects are self-managing their diabetes and travel burden to a care site.  Furthermore, results 
from this study demonstrate that travel burden is a potential barrier to proper management of 
diabetes.  In the future, it may be useful to minimize driving distance for individuals with 
diabetes, perhaps by improved public transportation, more diabetes center locations in rural 
areas, telemedicine, or home visits. Additional research should focus on more effective ways to 
connect diabetes care providers and patients in rural areas.  In addition to previous work, this 
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study demonstrates that the travel burden may play a central role in glycemic control and 
improvement in those with type 2 diabetes. 
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TABLES 10.6 
Table 10.1: Population Characteristics 
  
Uncontrolled 
(n=1704) 
Controlled 
(n=1665) 
Total 
(n=3369) p-value 
Miles traveled to diabetes 
center       <0.0001 
Mean [sd] 14.9[16.4] 11.7[15.3] 13.3[15.9]   
Range 0.06 - 78.4 0.06 - 85.1 0.06 - 85.1   
Subjects within 10 miles of 
diabetes center        <0.0001 
n(%) 830(48.7) 1037(51.3) 1867(55.4)   
Gender n(%)       0.24 
Male 738(43.4) 688(41.3) 1943(57.6)   
Female 965(56.6) 978(58.7) 1426(42.4)   
Age (Years)       <0.0001 
Mean [sd] 66.7[15.7] 69.1[15.9] 67.9[15.9]   
Range 18.4 - 101.0 18.4 - 100.9 18.4 - 101.0   
Ethnicity n(%)       0.56 
Caucasian/White 1439(94.9) 1474(94.3) 2913(94.6)   
Black/African American 63(4.2) 72(4.6) 135(4.3)   
Asian 2(0.1) 3(0.2) 5(0.2)   
American Indian/Alaskan 3(0.2) 0(0.0) 3(0.1)   
Hispanic/Latino 2(0.1) 3(0.2) 5(0.2)   
Other 7(0.5) 10(0.7) 17(0.6)   
Missing=291         
HbA1c (%)       <0.0001 
Mean [sd] 8.6[1.6] 6.1[0.5] 7.4[1.7]   
Range 7.0 - 18.7 4.2 - 6.9 4.2 - 18.7   
Body Mass Index*       0.99 
Mean [sd] 32.8[8.1] 32.9[8.1] 32.9[8.1]   
Range 16.6 - 56.6 18.9 - 56.7 16.6 - 56.7   
Duration of Diabetes 
(Years)       0.0004 
Mean [sd] 6.1[5.2] 5.4[3.6] 5.8[4.5]   
Range 2.2 - 59.2 2.2 - 43.2 2.2 - 59.2   
Systolic Blood Pressure 
(mmHg)       0.44 
Mean[sd] 135.7[18.2] 135.2[18.2] 135.4[18.2]   
Range 90 - 189 90 - 192 90 - 192   
 
* BMI = [weight in kilograms/height in meters2] 
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Table 10.1: Population Characteristics Continued 
  
Uncontrolled 
(n=1704) 
Controlled 
(n=1665) Total (n=3369) 
p-
value 
Diastolic Blood 
Pressure (mmHg)       0.27 
Mean[sd] 78.3[10.4] 77.9[10.4] 78.1[10.4]   
Range 40 - 104 40 - 100 40 - 104   
HDL (mg/dL)       0.04 
Mean[sd] 39.8[11.4] 40.7[11.7] 40.3[11.6]   
Range 10.0 - 89.0 10.0 - 94.0 10.0 - 94.0   
LDL (mg/dL)       0.99 
Mean[sd] 104.6[33.7] 104.6[34.0] 104.6[33.9]   
Range 28 - 348 26 - 235 26 - 348   
Triglycerides (mg/dL)       0.17 
Mean[sd] 183.9 [114.6] 178.6[110.9] 181.3[112.9]   
Range 46 - 605 43 - 438 43 - 605   
% Living Below the 
Poverty Level       0.09 
Mean [sd] 13.1[7.9] 13.6[9.3] 13.4[8.6]   
Range 3.8 - 57.1 3.8 - 59.6 3.8 - 59.6   
Median Income       0.57 
Mean [sd] 29434.5[6709.2] 29572.0[7402.2] 29502.4[7095.5]   
Range 10490 - 53580 10490 - 65540 10490 - 65540   
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11.0 CONCLUSIONS 
 
Diabetes mellitus is a serious chronic disease with rates increasing substantially over the past 
decade and is expected to grow drastically over the next several years (1).  It is a significant 
public health problem as it places a serious burden on patients, the health care system, and 
society.  Diabetes has always been difficult to manage because of the complexity of the disease.  
It is more than a disease of abnormal glucose metabolism due to the related macro and 
microvascular complications.  Management of diabetes involves clinical, behavioral, 
psychosocial and environmental factors.  Despite many advances in the understanding of its 
pathophysiology (5), factors that affect its care (5), and improved treatment options (5), diabetes 
remains a complex and challenging chronic condition.  Often, diabetes management falls below 
recommended standards regardless of patient related factors, emphasizing the necessity for 
changes in the built environment.  
The built environment is defined as human-modified places such as homes, schools, 
workplaces, parks, industrial areas, farms, roads, and highways (154).  The built environment 
encompasses all buildings, spaces and products that are created or modified by people.  It 
impacts the indoor and outdoor environments such as indoor/outdoor air quality, as well as social 
environments such as community participation and investment, and subsequently our health and 
quality of life (154).  Much discussion of the built environment has focused on the challenges of 
providing adequate transportation, urban sprawl, air pollution and the diminishing natural 
environment.  However, new research increasingly recognizes that the places we live and work 
clearly affect our health (155,156).  Access to green open space can increase physical activity 
and mental wellbeing; because evidence demonstrates that the most sustained exercise is 
incorporated into daily routine activities (163).  Recent research also explores the effect the built 
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environment on physical activity (157), asthma (158), obesity (159), cardiovascular disease, lung 
cancer mortality (160), and mental health (161,162).  The growing health burdens and rising 
economic costs associated with higher chronic disease incidence require such research efforts.  
These complex diseases are attributable to an interaction of genetic and environmental 
influences, and many of the latter can be directly connected to the built environment.  Research 
investigating the association between public health and quality-of-life benefits of sustainable 
communities is necessary. 
Certain environmental aspects play an important role in the prevention and treatment of 
chronic diseases such as diabetes.  Studies have shown that access to health care, diet, and 
physical activity contribute to diabetes, which are all part an individual’s environment or 
community (4).  While there are many ways to define community, geographic location is one 
important way to understand the context in which people live.  Until recently, there has not been 
a valid method for defining and analyzing geographic areas that make up a community where 
these risk factors and chronic diseases may cluster.  Geographical modeling may allow for better 
identification of the geographic area of communities that provide risk for diabetes or diabetes 
complications.  There is great variability in the health and well being of residents depending 
upon where they live.  Health-promotion interventions may need to be designed to target the 
geographic areas that represent areas of health problems and unhealthy lifestyles.     
Diabetes is preventable and can be controlled with intervention.  However, some areas 
may not have resources that would enable its residents to lead a healthy lifestyle.  Geospatial 
mapping techniques can be used to show areas with higher likelihood of diabetes, risk factors for 
diabetes complications, or unmanaged diabetes and where funds need to be targeted.  This type 
 184 
of analysis can provide important clues about the geographic variability of risk factors, disease 
states and clinical services utilization.   
 
11.1 SUMMARY OF FINDINGS 
This dissertation examined geographical patterns of diabetes hospitalizations, risk factors for 
diabetes complications and glycemic control among individuals with type 2 diabetes in rural 
regions.  The aims were to: 1.) identify an association between county rurality hospitalization 
rates for uncontrolled diabetes; 2.) determine if there is an association between the availability of 
disease prevention and health care facilities, the local food environment and risk factors for 
complications of diabetes; 3.) examine the association between glycemic control and 
improvement in individuals with type 2 diabetes, and travel burden to diabetes management 
centers in southwestern Pennsylvania. 
In the first aim, we sought to determine if individuals who reside in counties with 
increased rurality will be more likely to be hospitalized for uncontrolled diabetes than counties 
that are more urbanized.   We found that during 2007 calendar year, diabetes was the principal 
diagnosis upon admission in 14.5 per 10,000 adult residents, and for any-listed diagnosis in 
246.8 per 10,000 adult residents for the entire study area.  Hospitalization rates for uncontrolled 
diabetes as any-listed diagnoses upon admission were also calculated for the study area.  The rate 
was 8.2 per 10,000 adult residents.  Results of this study indicate an association between the 
rurality of a county and the diabetes hospitalization rates of the county’s residents.  Residents of 
more rural counties are 11% more likely to be hospitalized for uncontrolled diabetes compared to 
those living in areas that are less rural for every increase in rurality ranking. 
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In specific aim two, the association between the presence of supermarkets, full-service 
restaurants, physicians’ offices, hospitals and pharmacies and risk factors for diabetes 
complications in individuals with type 2 diabetes was explored.  We found that nearly 57% of 
the individuals lived in census tracts with convenience stores, while only 24.3% lived in census 
tracts with large supermarkets.  Sixty-percent of individuals lived in census tracts with fast food 
restaurants while only 41.0% lived in areas with full-service restaurants.  Approximately 57% of 
the population lived in census tracts with a physician’s office, 56.7% lived in an area with a 
pharmacy and only 8.0% lived near a hospital.   
Furthermore, we demonstrated that while supermarkets and grocery stores were 
associated with a decrease in the likelihood of hypertension, hypercholesterolemia, being 
overweight and obese, the presence of convenience stores was associated with an increase in the 
likelihood of individuals having hypertension, hypercholesterolemia, being overweight, obese, 
and hyperglycemia, after adjusting for individual and community level factors.   
A similar trend was found in food service places.  The presence of full-service and 
limited-service restaurants was associated with a decrease in the likelihood of having 
hypertension, being overweight and obese while the existence of fast food restaurants was 
associated with an increased likelihood of having in these factors.  The presence of any of the 
health care locations was associated with a decrease in the likelihood of having these factors.  
Results from this study indicate that the local food and health care environment at the 
neighborhood level is a possible ecological determinant of health.  There is a clear association 
between the presence of food stores and service places, and health care locations with risk factors 
for diabetes complications among individuals with diabetes.  The local environment has a 
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significant impact on public health by possibly restricting a population’s food and health care 
choices and opportunities that affect health.  
In specific aim three, we sought to explore the relationship between travel burden to a 
diabetes management center and glycemic control and improvement.  Approximately 50.6% 
(n=1704) individuals were categorized as having uncontrolled diabetes (HbA1c > 7.0).  We 
found that the mean distance subjects traveled to visit their diabetes management center were 
13.3 miles (range 0.06 – 85.1 miles).  Fifty-five percent of the subjects lived less than ten miles 
from their diabetes center.  The associations between the distance subjects traveled to their 
diabetes management centers and the glycemic control were modeled.  Those who live more than 
ten miles from their diabetes management center are 88% more likely to have an HbA1c level 
greater than 7.0% compared to those who live less than ten miles from their center, adjusted for 
individual-level factors such as age, sex, race, duration of diabetes, and BMI as well as 
community level factors such as percent of residents with a high school degree or higher, median 
household income and percent of residents living below the poverty level.  The association 
between the numbers of miles from the diabetes center as a continuous variable and glycemic 
control was also modeled.  For every mile the subjects live from their diabetes management 
center, they are 2% more likely to have an HbA1c level greater than 7.0%, adjusted for 
individual and community level factors.  In addition, those who lived within ten miles from their 
diabetes management center, were 2.24 times more likely to have improved their HbA1c values 
between their first and last office visits, adjusted for individual and community level factors.  
This study demonstrates that the travel burden may play a central role in glycemic control and 
improvement in those with type 2 diabetes.   
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11.2 CONTRIBUTION TO THE LITERATURE 
The findings of this dissertation are significant and help to fill the gap in the literature by 
examining associations between diabetes and the built environment.  There is a paucity of 
literature on geographic studies in diabetes research.  The first manuscript incorporated into this 
report provides supporting evidence that there is a need for more services in rural areas.  This 
current study adds to the existing literature by describing a population at the individual-level for 
a small geographic area.  Most of the data collected for diabetes rates are extrapolated from 
larger random surveys and exact rates are not available at the county-level for many states.  This 
study uses individual-level data to calculate both county-level and individual-level rates.  It also 
focuses on hospitalizations for uncontrolled diabetes which can be an indication of how well the 
health care system in an area is performing.  Hospitalizations for diabetes, particularly for 
uncontrolled diabetes, may be preventable because appropriate care can generally be provided on 
an outpatient basis (7).  If a patient reaches the point where hospitalization for diabetes is 
required, a breakdown in care, or access to care, may have already occurred. The majority of the 
literature on the geographic variation of chronic diseases and diabetes examines urban areas and 
does not focus on rural populations.  This is the first study, to our knowledge, to look at diabetes 
hospitalization rates at the geographic scale of the county-level and links it to the rurality of the 
county.   
The second manuscript that is incorporated into this dissertation adds significantly to the 
literature, as little is known about the how the local food and health care environment is 
associated with the health of a population.  The literature demonstrates that diabetes 
encompasses behavioral, environmental, social, and clinical factors, all which play an important 
role in the management of the disease.  It is assumed that behavioral characteristics of 
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individuals with diabetes are affected by their access to health care and disease prevention 
facilities, a healthy local food environment and physical activity locations.  Furthermore, it is 
believed that those living in more rural areas have less access to these locations and therefore 
will have higher rates of disease.  We believe that our work in this manuscript will provide 
further evidence for this theory. 
These findings expand on those of Moreland, Roux, and Wing (192) who conducted 
multilevel modeling in order to calculate prevalence ratios of the associations between the 
presence of specific types of food stores and cardiovascular disease risk factors.  This analysis 
demonstrated that the presence of supermarkets was associated with a lower prevalence of 
obesity and overweight (obesity prevalence ratio [PR] = 0.83, 95% CI=0.75-0.92; overweight 
PR=0.94, 95% CI=0.90-0.98), and the presence of convenience stores was associated with a 
higher prevalence of obesity and overweight (obesity PR=1.16, 95% CI=1.05-1.27; overweight 
PR=1.06, 95% CI=1.02-1.10).  The results from this study suggest that characteristics of local 
food environments may play a role in the prevention of overweight and obesity (192).  Although 
our study focused on those with diabetes and risk factors of complications, and Moreland et al. 
used a cross-sectional population from major metropolitan areas, the results strengthen the 
associations between the local food environment and health.   
Inagami et al. (206) found residents in poor neighborhoods have a higher body mass 
index (BMI) and eat less healthfully. One possible reason might be the quality of available foods 
in their area. The researchers examined the location of grocery stores where individuals shop and 
its association with BMI.  Inagami and colleagues aimed to estimate the associations between 
BMI and socioeconomic characteristics of grocery store locations after adjustment for 
individual-level factors and socioeconomic characteristics of residential neighborhoods.  They 
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were able to conclude that where people shop for groceries and distance traveled to grocery 
stores are independently associated with BMI.  Our study also demonstrated that after controlling 
for SES factors of the census tract, the significant associations between food stores, food service 
places, and health care locations and risk factors for complications remained.      
Our study also investigated the associations between health care locations and risk factors 
for diabetes complications.  There have been few studies focusing on associations between risk 
factors and health care locations.  Dabney and Gosschalk found that rural residence is a 
significant risk factor for never receiving an ophthalmic examination, which can detect early 
signs of complications such as diabetic retinopathy (178).  However, this study only focused on 
ophthalmic offices.  It is also important to note that the results from our study demonstrate that 
the food environmental factors were more significant in contributing to risk factors of diabetes 
complications that the health care locations.  However, even after adjusting for age, gender and 
race, the controllable environmental factors still had a significant association with risk factors.  
This is evidence that the environment can play a role in the health of residents and should be 
changed in order to control important risk factors.  This is first study to our knowledge that 
shows a difference in the role of food environmental factors and health care locations. 
The third manuscript also adds to the existing literature by demonstrating that the travel 
burden may play a central role in glycemic control and improvement in those with type 2 
diabetes.  The majority of the literature on this subject does not focus on travel burden and visits 
to a diabetes management center.  It is also unique that the particular center that the subjects 
visited, the number of office visits, and the time between the visits was recorded and included as 
a part of the dataset. 
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The findings of this manuscript expand on those of Littenberg, Strauss, MacLean, and 
Troy (150) who conducted Wilcoxon rank-sum tests assess the role of travel burden as a barrier 
to the use of insulin in adults with diabetes.  They concluded that adults with type 2 diabetes who 
live farther from their source of primary care are significantly less likely to use insulin.  
Although our study focused on glycemic control and travel burden, and Littenberg et al. focused 
on insulin use in smaller population, the results strengthen the associations between the travel 
burden and glycemic control in those with diabetes.  Strauss et al. (149) examined the 
relationship between glycemic control and the driving distance from a patient’s home to the site 
of primary care.  The authors found that driving distance was significantly associated with 
glycemic control in their population of older, rural subjects.  Each 22 miles of driving distance 
was associated with a 0.25% increase in HbA1c.  Although our study focused on subjects who 
visited diabetes management centers, and Strauss et al focused primary care offices, the results 
support the associations between the travel burden and health care in those with diabetes.  Our 
subjects received separate diabetes prevention classes, diabetes self-management education, meal 
planning and nutrition counseling, and insulin and medication therapies at the diabetes centers.  
The type of care received at a primary care office may not be as specialized as that received at 
the diabetes centers.  Strauss and colleagues did not collect data on those who may have visited 
diabetes specialists and recruited patients only from primary care offices, and therefore would be 
more likely to using insulin.    
 
11.3 STUDY LIMITATIONS 
In conducting geographical-based ecological studies, all circumstances are not “controllable”; 
therefore, limitations exist.  First, due to the Health Information Protection and Portability Act 
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(HIPPA), and the Institutional Review Board (IRB) at the university associated with this 
research, the subjects could not be depicted geographically at a reasonable scale.  There are also 
issues and limitations with geographic data.  The subjects’ home addresses were entered into the 
data management system as mailing addresses.  Approximately 5% of the home addresses could 
not geocoded because PO Boxes were given as the address.  An attempt was made to match 
some of the PO Boxes (n=12) with street addresses using 9-1-1 emergency data.  A limitation in 
the first manuscript is that the number of total hospitalizations for 2007 in the study area from 
the PHC4 dataset was unavailable.  This did not allow for the calculation of rates based on all 
hospitalizations and allow for comparisons of age, gender, and race for those who were not 
hospitalized for diabetes.  Although a number of potential confounders were controlled for in the 
multivariate analyses, residual confounding by unmeasured variables such as health care 
insurance cannot be ruled out.  In the second manuscript, the subjects from the Delphi Data 
Management System were not surveyed on where they shopped, the restaurants in which they 
ate, or where they went for health care, so misclassification may have occurred if the census tract 
did not represent the area where the subjects patronage.  Also, market research has an impact on 
where food stores, food service and health care places are located (192).  Businesses may be 
located in more populated areas or areas with a higher SES.  Since the study was conducted in 
rural southwestern Pennsylvania, the population was mostly white and older so these results may 
be able to be generalized to urban or more diverse populations.  Another possible limitation to 
our study is that nearly all of our data are self-reported, with the exception of the laboratory data, 
which inherently biases the results toward the null.  Lastly, in the third manuscript, driving 
distance from the subject’s home to the center may be a perfect measurement of travel burden.  
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Some subjects may take public transportation or have a friend or family member to drive them to 
the diabetes center.      
11.4 PUBLIC HEALTH SIGNIFICANCE 
Diabetes is a complex chronic disease with many causes, complications and management needs.  
It affects a large proportion of people of varying ages, income levels, races/ethnicities and 
geographic areas.  Diabetes is becoming more common in the United States and shifts in the 
patterns of disease have occurred.  There are no longer epidemics of acute illnesses.  Instead they 
have been replaced by epidemics of chronic diseases such as diabetes (7).  From 1980 through 
2007, the number of Americans with diabetes increased from 5.6 million to 17.9 million (2).  It is 
estimated that another 5.7 million Americans are undiagnosed (2).  Approximately 762,000 or 
7.0% of Pennsylvanians have been diagnosed with diabetes and is responsible for nearly 4,000 
deaths in Pennsylvania (6).  Diabetes is a major public health challenge due to the enormous 
impact on the affected individual, their families and the health care system.  However, recent 
research has shown that diabetes related mortality and morbidity can be prevented or delayed by 
controlling risk factors (7).   
Certain environmental aspects play an important role in the prevention and treatment of 
chronic diseases such as diabetes.  There is great variability in the health and well being of 
residents depending upon where they live.  Health-promotion interventions may need to be 
designed to target the geographic areas that represent clusters of health problems and unhealthy 
lifestyles.  More research is needed to study how the built environment relates geographically to 
chronic diseases such as diabetes in order to develop public health prevention programs and 
improve diabetes management and outcomes. 
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Based on the findings of the first manuscript, residents of rural counties have higher rates 
of uncontrolled diabetes hospitalizations compared to all diabetes hospitalizations.  This is 
significant to public health because diabetes is a serious, costly disease, in which hospitalizations 
continue to rise.  It is responsible for $174 billion in direct medical costs and indirect (work loss, 
disability, premature death) medical expenditures every year.  Diabetes also has an enormous 
impact on the affected individual, their families, and the health care system.  Understanding 
where gaps in health care and diabetes educations exist may lead to changes in policy and the 
local neighborhood environment to increase the access of rural patients.  It is important to further 
investigate the access residents of these counties have to health care facilities, other disease 
prevention facilities, and the local food and physical activity environments.  This will shed more 
light on how the environment of individuals with diabetes affects their overall health and their 
ability to control their diabetes. 
Given the considerable public health burden of diabetes, improving care for individuals 
with diabetes should be a priority in the majority of communities.  In selecting and improving 
access within the built environment to improve care and management for diabetes, communities 
should strive to develop comprehensive strategies to promote healthy lifestyles and to assist 
people with diabetes improve glycemic control, decrease diabetes complications, and improve 
quality of life, just as we did in this research.  Choosing interventions based on geographically 
targeted areas and that are well matched to local neighborhood needs are vital steps toward 
improving outcomes for people with diabetes. 
Results from the second manuscript indicate that the local environment has a significant 
impact on public health by possibly restricting a population’s food and health care choices and 
opportunities that affect health.  In addition to previous work, this study demonstrates that the 
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local food and health care environment may play a central role in the prevention of risk factors of 
diabetes complications.  Furthermore, results from the third manuscript demonstrate that travel 
burden is a potential barrier to proper management of diabetes.  In the future, it may be useful to 
minimize driving distance for individuals with diabetes, perhaps by improved public 
transportation, more diabetes center locations in rural areas, telemedicine, or home visits. 
Additional research should focus on more effective ways to connect diabetes care providers and 
patients in rural areas.  In addition to previous work, this study demonstrates that the travel 
burden may play a central role in glycemic control and improvement in those with type 2 
diabetes. 
There is a growing recognition that the built environment has an impact on health. For 
example, one may expect more physical activity and healthier diets among persons in 
communities with convenient, safe walking paths and accessible sources of fresh fruits and 
vegetables. On the other hand, poorer health indicators may be expected among residents of 
communities with high crime rates, few parks or walking paths, numerous alcohol and tobacco 
outlets, and little access to fresh food.  Low-income and/or rural communities are more likely to 
be sites of hazards and less likely to be conducive to physical activity and healthy eating.   
 
11.5 FUTURE RESEARCH 
Important decisions about the built environment have traditionally been made without active 
inclusion of public health.  It is clear from the results of this dissertation that the built 
environment is associated with the health of a population and should be considered in 
community planning and policy making.  Future research should focus on the connections 
between the built environment and health, focusing on access to health care, healthy food, 
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physical activity locations, transportation and neighborhood characteristics such as sidewalk 
conditions, and lighting.  More research should be focused on the issues of the built environment 
in rural areas, lower socioeconomic strata, and minority populations.  Studies on sustainable 
communities exploring the planning that is needed to create an environment that is conducive to 
the mental and physical well-being of residents should be conducted.  There is also limited 
research on measures and methods to quantify the health benefits of improved community 
planning.  Multidisciplinary research investigating the positive and negative health impacts of 
planned communities is needed to develop models to incorporate programs that improve health 
for community development in less desirable areas.  The available evidence lends itself to the 
argument that a combination of urban design, land use patterns, and transportation systems that 
promote access to healthy lifestyle factors will help create more active, healthier, and more 
livable communities.  Collaborative research efforts that build on the research models of the 
fields of both public health and community planning are essential to making further progress in 
the effort to build healthier and more livable communities.  
 
 
12.0 RECOMMENDATIONS 
In this research, the associations between the environment and diabetes, risk factors for diabetes 
complications and glycemic control were investigated.  As the burden of diabetes continues to 
escalate, new approaches for diabetes care and self-management education are needed if we are 
to advance care at the patient, provider, community, and health care systems levels.  Chronic 
diseases, such as diabetes, are leading health concerns which are influenced by the built 
environment.  Decisions about zoning, transportation, land use and community design influence 
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the distances people travel to health care facilities, the convenience of purchasing healthy foods, 
and the safety and attractiveness of neighborhoods for walking.  It is clear from the health 
implications of these decisions that public health should be a strong ally to ensure that decisions 
about neighborhood design are made with the health of community members at the forefront.  
Future location analysis should be conducted to find the most strategic places to build new health 
care facilities, physicians’ offices, supermarkets, and farmer’s markets.  
However, decisions about the built environment have traditionally been made without 
active inclusion of public health.  To facilitate public health's participation, this project provides 
a concrete example that demonstrates the importance of the built environment for chronic 
diseases and illustrates potential roles for public health.  A greater understanding of opportunities 
to improve health outcomes through altering the built environment will strengthen linkages 
between public health and community planners.  
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APPENDIX A: TABLES AND FIGURES 
Table 8.5: 2003 Rural-Urban Continuum Codes 
Code Description 
Metro counties: 
1 Counties in metro areas of 1 million population or more 
2 Counties in metro areas of 250,000 to 1 million population 
3 Counties in metro areas of fewer than  250,000 population 
Nonmetro counties: 
4 Urban population of 20,000 or more, adjacent to a metro area 
5 Urban population of 20,000 or more, not adjacent to a metro area 
6 Urban population of 2,500 to 19,999, adjacent to a metro area 
7 Urban population of 2,500 to 19,999,  not adjacent to a metro area 
8 Completely rural or less than 2,500 urban population, adjacent to a metro area 
9 Completely rural or less than 2,500 urban population, not adjacent to a metro area 
 
 
 
 
Table 8.6: Rural-Urban Continuum Codes for Counties in the Study Area 
County Name 2003 Rural-Urban Continuum Code 2000 Population 
Cambria County  3 152,598 
Allegheny County 1 1,281,666 
Armstrong County 1 72,392 
Fayette County 1 148,644 
Greene County 6 40,672 
Indiana County 4 89,605 
Somerset County 4 80,023 
Westmoreland County 1 369,993 
Washington County 1 202,897 
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Table 8.7 International Classification of Diseases, 9th Revision, Clinical Modification 
Codes (ICD-9) 
 
250.0 Diabetes mellitus without mention of complication 
 -250.00 Diabetes mellitus without complication type ii or unspecified type not stated as 
uncontrolled 
 -250.01 Diabetes mellitus without complication type i not stated as uncontrolled 
 -250.02 Diabetes mellitus with complication type ii or unspecified type uncontrolled 
 -250.03 Diabetes mellitus with complication type i uncontrolled 
 
250.1 Diabetes with ketoacidosis (A complication of diabetes mellitus, primarily with Type 1 
with sever insulin deficiency and extreme hyperglycemia) 
 -250.10 Diabetes mellitus with ketoacidosis type ii or unspecified type not stated as 
uncontrolled 
 -250.11 Diabetes mellitus with ketoacidosis type i not stated as uncontrolled 
 -250.12 Diabetes mellitus with ketoacidosis type ii or unspecified type uncontrolled 
 -250.13 Diabetes mellitus with ketoacidosis type i uncontrolled 
 
250.2 Diabetes with hyperosmolarity (A complication of Type 2 Diabetes characterized by 
extreme hyperglycemia and dehydration) 
 -250.20 Diabetes mellitus with hyperosmolarity type ii or unspecified type not stated as 
uncontrolled 
 -250.21 Diabetes mellitus with hyperosmolarity type i not stated as uncontrolled 
 -250.22 Diabetes mellitus with hyperosmolarity type ii or unspecified type uncontrolled 
 -250.23 Diabetes mellitus with hyperosmolarity type i uncontrolled 
 
250.3 Diabetes with other coma (A state of unconsciousness as a complication of diabetes) 
 -250.30 Diabetes mellitus with other coma type ii or unspecified type not stated as 
uncontrolled 
 -250.31 Diabetes mellitus with other coma type i not stated as uncontrolled 
 -250.32 Diabetes mellitus with other coma type ii or unspecified type uncontrolled 
 -250.33 Diabetes mellitus with other coma type i uncontrolled 
 
250.4 Diabetes with renal manifestations (Kidney injuries associated with diabetes and 
affecting kidney glomerulus; arterioles; kidney tubules) 
 -250.40 Diabetes mellitus with renal manifestations type ii or unspecified type not stated 
as uncontrolled 
 -250.41 Diabetes mellitus with renal manifestations type i not stated as uncontrolled 
 -250.42 Diabetes mellitus with renal manifestations type ii or unspecified type 
uncontrolled 
 -250.43 Diabetes mellitus with renal manifestations type i uncontrolled 
 
250.5 Diabetes with ophthalmic manifestations 
 -250.50 Diabetes mellitus with ophthalmic manifestations type ii or unspecified type not 
stated as uncontrolled 
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 -250.51 Diabetes mellitus with ophthalmic manifestations type i not stated as 
uncontrolled 
 -250.52 Diabetes mellitus with ophthalmic manifestations type ii or unspecified type 
uncontrolled 
 -250.53 Diabetes mellitus with ophthalmic manifestations type i uncontrolled 
 
250.6 Diabetes with neurological manifestations (Peripheral, autonomic, and cranial nerve 
disorders that are associated with diabetes) 
 -250.60 Diabetes mellitus with neurological manifestations type ii or unspecified type not 
stated as uncontrolled 
 -250.61 Diabetes mellitus with neurological manifestations type i not stated as 
uncontrolled 
 -250.62 Diabetes mellitus with neurological manifestations type ii or unspecified type 
uncontrolled 
 -250.63 Diabetes mellitus with neurological manifestations type i uncontrolled 
250.7 Diabetes with peripheral circulatory disorders  
 -250.70 Diabetes mellitus with peripheral circulatory disorders type ii or unspecified type 
not stated as uncontrolled 
 -250.71 Diabetes mellitus with peripheral circulatory disorders type i not stated as 
uncontrolled 
 -250.72 Diabetes mellitus with peripheral circulatory disorders type ii or unspecified type 
uncontrolled 
 -250.73 Diabetes mellitus with peripheral circulatory disorders type i uncontrolled 
250.8 Diabetes with other specified manifestations  
 -250.80 Diabetes mellitus with other specified manifestations type ii or unspecified type 
not stated as uncontrolled 
 -250.81 Diabetes mellitus with other specified manifestations type i not stated as 
uncontrolled 
 -250.82 Diabetes mellitus with other specified manifestations type ii or unspecified type 
uncontrolled 
 -250.83 Diabetes mellitus with other specified manifestations type i uncontrolled 
250.9 Diabetes with unspecified complication (Conditions or pathological processes 
associated with diabetes.  Due to the impaired control of blood glucose level in diabetic patients, 
pathological processes develop in numerous tissues and organs including the eye, the kidney, the 
blood vessels, and the nerve tissue.)  
 -250.90 Diabetes mellitus with unspecified complication type ii or unspecified type not 
stated as uncontrolled 
 -250.91 Diabetes mellitus with unspecified complication type i not stated as uncontrolled 
 -250.92 Diabetes mellitus with unspecified complication type ii or unspecified type 
uncontrolled 
 -250.93 Diabetes mellitus with unspecified complication type i uncontrolled 
 
 200 
585 Chronic Kidney Disease 
586 Renal failure unspecified 
V420 Kidney replaced by transplant 
V560 Aftercare involving extracorporeal dialysis 
V568 Aftercare involving other dialysis 
996.62 Infection and inflammatory reaction due to vascular device, implant and graft 
996.73 Other complications due to renal dialysis device implant and graft 
996.81 Complications of transplanted kidney 
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Table 8.8: Pennsylvania Health Care Cost Containment Council Data File Variables  
Field Name Data Description Notes 
 
SYSID 
 
YEAR 
QUARTER 
Record Identification 
System assigned unique record 
sequence number 
Processing year 
Processing Quarter 
 
 
Unique code for each quarter 
 
PAF 
HREGION 
Facility Identification 
PA Facility Number 
Facility Region Code 
 
 
PHC4 assigned code 
PHC4 assigned code 
 
PTSEX 
ETHNIC 
RACE 
PSEUDOID 
 
AGE 
 
County 
STATE 
Patient Data 
Patient Sex Code 
Hispanic/Latino Origin  
Race Code 
Pseudo Patient Identifier 
 
Patient Age in Years 
 
Patient Home County Code 
Patient State Code 
 
Gender 
Ethnic descent 
Race 
PHC4 assigned unique patient 
code 
Age of patient; Zero if less than 1 
year or unknown 
PA county code (1-67) 
USPS standard state code 
 
ADTYPE 
 
ADSOURCE 
 
ADMDX 
ADHOUR 
Admission Date 
Priority (Type of Visit) 
 
Point of Origin for Admission 
 
Admitting Diagnosis 
Admission Hour 
 
Defines urgency level of 
admission 
Defines point of origin for 
admission 
Defines diagnosis at admission 
Military time 
 
DCSTATUS 
LOS 
DCHOUR 
Discharge Data 
Patient Discharge Status 
Length of Stay 
Discharge Hour 
 
 
Defines discharge destination 
Number of hospitalization days 
Military time 
 
PDX 
SDX1-SDX8 
Diagnosis Codes 
Principal Diagnosis Code 
Secondary Diagnosis Code (1)-(8) 
 
Defines diagnosis at discharge 
Defines additional diagnosis 
conditions 
 
PAYTYPE1 
PAYTYPE2 
PAYTYPE3 
HEALTHPALNID1 
Payer Identification 
Primary Payer 
Secondary Payer 
Tertiary Payer 
Health Plan Identification Number 
(NAIC/NPI) 
 
Defines primary payer 
Defines secondary payer 
Defines tertiary payer 
Primary health plan 
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Figure 8.0 Age-Adjusted Diabetes Hospitalization Rates*, Any-Listed Diagnosis, by County, 2007 
*Rates are based on individual-level hospitalization data among those who were hospitalized for diabetes (Pennsylvania Health Cost 
Containment Council (PHC4) 
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Figure 8.1: Age-Adjusted Diabetes Hospitalization Rates*, Principal Diagnosis, by County, 2007 
*Rates are based on individual-level hospitalization data among those who were hospitalized for diabetes, PHC4 
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Figure 8.2: Age-Adjusted Uncontrolled Diabetes Hospitalization Rates, Any-Listed Diagnosis, by County, 2007 
*Rates are based on individual-level hospitalization data among those who were hospitalized for diabetes, PHC4 
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Figure 8.3: Age and Sex-Adjusted Diabetes Hospitalization Rates, Any-Listed Diagnosis, by County, 2007 
*Rates are based on individual-level hospitalization data among those who were hospitalized for diabetes, PHC4 
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Figure 8.4: Age and Sex-Adjusted Diabetes Hospitalization Rates, Principal Diagnosis, by County, 2007 
*Rates are based on individual-level hospitalization data among those who were hospitalized for diabetes, PHC4 
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Figure 8.5: Age and Sex-Adjusted Uncontrolled Diabetes Hospitalization Rates, Any-Listed Diagnosis, by County, 2007 
*Rates are based on individual-level hospitalization data among those who were hospitalized for diabetes, PHC4 
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Figure 8.6: Age-Adjusted Hospitalization Rates, Short-Term Complications of Diabetes, Any-Listed Diagnosis, by 
County, 2007 
*Short-term complications of diabetes include diabetic coma and diabetic ketoacidosis (ICD.9 250.xy; where, x = 1,2,3 and y = 
0,1,2,3). Rates are based on individual-level hospitalization data among those who were hospitalized for diabetes 
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Figure 8.7: Age-Adjusted Hospitalization Rates, Long-Term Complications of Diabetes, Any-Listed Diagnosis, 2007 
*Long-term complications of diabetes include chronic problems such as stroke, kidney disease, neurological complications (ICD.9 250.xy; where, x 
= 4,5,6,7,8,9 and y = 0,1,2,3). Rates are based on individual-level hospitalization data among those who were hospitalized for diabetes 
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Figure 8.8: Age-Adjusted Hospitalization Rates, ESRD, Any-Listed Diagnosis, by County, 2007 
*Rates are based on individual-level hospitalization data among those who were hospitalized for diabetes, PHC4 
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Figure 8.9: Age-Adjusted Hospitalization Rates, Short-Term Complications of Diabetes, Principal Diagnosis, 2007 
*Short-term complications of diabetes include diabetic coma and diabetic ketoacidosis (ICD.9 (250.xy; where, x = 1,2,3 and y = 0,1,2,3). Rates are 
based on individual-level hospitalization data among those who were hospitalized for diabetes 
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Figure 8.10: Age-Adjusted Hospitalization Rates, Long-Term Complications of Diabetes, Principal Diagnosis, 2007 
*Long-term complications of diabetes include chronic problems such as stroke, kidney disease, neurological complications (ICD.9 250.xy; where, 
x = 4,5,6,7,8,9 and y = 0,1,2,3). Rates are based on individual-level hospitalization data among those who were hospitalized for diabetes 
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Figure 8.11: Adjusted Hospitalization Rates, ESRD, Any-Listed Diagnosis, by County, 2007 
*Rates are based on individual-level hospitalization data among those who were hospitalized for diabetes, PHC4 
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Figure 8.12: Moran’s I Spatial Autocorrelation, Hospitalization Rates for Diabetes, Any-Listed Diagnosis 
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Figure 8.13: Moran’s I Spatial Autocorrelation, Hospitalization Rates for Diabetes, Principal Diagnosis 
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Figure 8.14: Moran’s I Spatial Autocorrelation, Hospitalization Rates for Uncontrolled Diabetes 
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Figure 8.21: Proportion of Diabetes Hospitalizations by Insurance Type, 2007 
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Figure 8.22: Proportion of Diabetes Hospitalizations by Admission Type, 2007 
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Figure 18.23: Proportion of Uncontrolled Diabetes Hospitalizations by Admissions Type, 2007
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APPENDIX B: TABLES 
Table 9.6: Delphi Data Management System Data File Variable Descriptions 
Patient Demographics 
Patient ID 
Gender: (Male or Female) 
Ethnicity: (White, Black, Hispanic, Native American, Asian or Pacific Islander, Arabic,         
Other) 
Type of Diabetes: (Type 1, Type 2, Gestational, Pre-Diabetes) 
Year of Diabetes Diagnosis 
Health Insurance (Yes/No) 
Health Plan ID/Health Plan Name 
Date of Birth 
First Visit Date (Initiation of Care) 
Date of Death 
Street Address, including zip code 
Employment Status: (Working full-time, Working part-time, Unemployed and looking for work, 
Unemployed and not looking for work, Homemaker, In school, Retired,  Disabled, Not able to 
work, Other)  
 
Clinical Lab Information and Standards of Care 
 
HbAlc: (Date and Values) 
Lipid Profile: (Date and Total Cholesterol, Triglycerides, LDL, HDL values) 
Urinalysis: For proteinuria/microalbuminuria; (Date and Values) 
Serum Creatinine: (Date and Values) 
Blood Pressure: Systolic and Diastolic (Date and Values) 
Body Mass Index 
Weight 
Height 
Co-morbid Conditions: (Patient reported - Coronary Heart Disease, Congestive Heart 
 Failure, Cerebrovascular Disease, Depression) 
Complications: (Patient reported – Coronary Artery Disease, TIA, Peripheral Vascular 
 Disease, Retinopathy, Neuropathy, Nephropathy, Gastroparesis, Erectile  Dysfunction, 
Other)  
Medications: (Patient reported- Insulin; Oral Diabetes Medications; Other Medications) 
Smoking Status: (Non-smoker, Ex-smoker (Quit Date), Current smoker) 
 
Exams in the Previous Year 
 
Dilated Eye Exam: (Yes/No) 
Foot Exam: (Yes/No) 
Flu Vaccine: (Yes/No) 
Pneumonia Vaccine: (Yes/No) 
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Table 9.7 North America Industry Classification System (NAICS) codes8  
Industry Group  1997 NAICS definitions  NAICS Index 
Supermarkets 445110 Supermarkets  445110 Supermarkets 
Grocery stores 445110 Other grocery 
(excluding convenience) 
stores 
44511013 Grocery Stores 
44511014 Food stores 
Convenience stores 445120 Convenience Stores 445120 Convenience Stores 
Convenience stores with gas 
stations 
447110 Gasoline stations with 
convenience stores 
447110 Gasoline stations with 
convenience stores 
Full-service restaurants 722110 Full-service 
restaurants 
722110 Restaurants, full- 
             service 
722110 Steak houses 
722110 Pizzerias, full-  
             service 
722110 Fine dining  
722110 Family restaurants 
722110 Diners, full-service 
722212 Cafeterias 
Fast-food restaurants 
 
Carryout eating places 
722211 Limited-service 
restaurants 
722211 Fast-food  
             restaurants              
722211 Pizza parlor, limited 
              service   
722211 Pizza delivery  
             shops 
722211 Sandwich shops 
722110 Bagel shops, full- 
             service 
Carryout specialty places 722213 Snack and 
nonalcoholic beverage bars 
722213 Beverage bars 
722213 Doughnuts shops 
722213 Ice cream shops 
722213 Pretzel shops 
Health care and Social 
Assistance 
621111 Offices of Physicians  621111 Offices of  
             Physicians (except  
             mental health 
             specialists)     
621320 Offices of      
             Optometrists 
621391 Offices of  
              Podiatrists 
 62 Other Health care 621492  Kidney Dialysis  
              Centers 
Retail Trade 4461 Pharmacies and Other 446110 Pharmacies and  
             Drug Stores 
446199 All Other Health  
             And Personal Care 
             Stores 
446191 Food (Health)    
             Supplement Stores 
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APPENDIX C: DATA USE AGREEMENT AND DISCLAIMER 
 
This research was sponsored by funding from the United States Air Force administered by the 
U.S. Army Medical Research Acquisition Activity, Fort Detrick, Maryland, and Award Number 
W81XWH-04-2-003.  Review of material does not imply Department of the Air Force 
endorsement of factual accuracy or opinion.   
The Pennsylvania Health Care Cost Containment Council (PHC4) is an independent state 
agency responsible for addressing the problem of escalating health costs, ensuring the quality of 
health care, and increasing access to health care for all citizens regardless of ability to pay. PHC4 
has provided data to this entity in an effort to further PHC4’s mission of educating the public and 
containing health care costs in Pennsylvania.  PHC4, its agents, and staff, have made no 
representation, guarantee, or warranty, express or implied, that the data -- financial, patient, 
payor, and physician specific information -- provided to this entity, are error-free, or that the use 
of the data will avoid differences of opinion or interpretation. This analysis was not prepared by 
PHC4. This analysis was done by Laura Bettencourt, MPH. PHC4, its agents and staff, bear no 
responsibility or liability for the results of the analysis, which are solely the opinion of this 
entity. 
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